Molecular interactions and dynamics in cyclic AMP signalling by BALAKRISHNAN SHENBAGA MOORTHY
MOLECULAR INTERACTIONS AND DYNAMICS IN 


















NATIONAL UNIVERSITY OF SINGAPORE 
 
2011 
MOLECULAR INTERACTIONS AND DYNAMICS IN 





BALAKRISHNAN SHENBAGA MOORTHY 
(Master of Technology in Biotechnology) 
 
A THESIS SUBMITTED FOR THE DEGREE OF 









DEPARTMENT OF BIOLOGICAL SCIENCES 







Completing my doctor of philosophy (PhD) is possible only because of the continuous 
support I received throughout my graduate career from many people. In addition to my 
friends and family members, I would like to thank the following people who supported in 
all the aspect of my personal and career life. 
I would like to express my sincere thanks to my project supervisor Dr. Ganesh Srinivasan 
Anand. I am proud to address myself as his first PhD graduate student. I express my deep 
sense of gratitude for his continuous guidance, timely advice, discussions and support 
through all the stages of my project. He also taught me in solving various problems 
encountered during my project. His passion for science provided me encouragement to 
successfully complete this project and to become a scientist. I am very much grateful to 
National University of Singapore for providing me the environment, facilities and full 
support to carry out my graduate study. 
I would like to extend my thanks to my PhD qualifying examiners, Prof. Liou Yih 
Cherng, Prof. Sanjay Swarup and Prof. Naweed Naqvi for their invaluable advices during 
discussions. I thank Prof. Ivana Mihalek, Bioinformatics Institute, Singapore and Prof. 
Giuseppe Melacini from McMaster‟s University, Hamilton for their current and future 
collaborations on my project. I would also like to thank Prof. Susan S. Taylor, Prof. 
William Loomis from University of California, San Diego and Prof. Linda Kenney from 
Mechanobiology Institute, Singapore for sharing clones and reagents for our studies. I 
would like to thank Prof. K Swaminathan and Prof. J Sivaraman for their scientific ideas 
in encouraging me to extend my project for crystallographic studies. 
ii 
 
I thank our lab post-doc Dr. Gao Yunfeng for her help in molecular cloning and initial 
support in learning lab safety procedures. I appreciate my labmates, Suguna Badireddy, 
Tanushree Bishnoi, Srinath Krishnamurthy, Wang Loo Chien, Anusha Vedagiri, Jane Lin 
Liqin, Aparna Sankararaman, Christina Yap Xiaojun, Liang Yuan Yuan for their useful 
discussions and friendship. I thank Mr. Lim Teck Kwang for his technical support with 
mass spectrometry. I take this opportunity to thank my roommates, Raghu, Jayaraj, 
Thanneer, Kiran, Lakshmi, Vamsi and Prashant for their help and support in Singapore. I 
like to specially thank Dr. B. C. Karthik for his useful discussions and advice during 
lunch and tea sessions. I declare my thanks to my friends here in Singapore and in India 
for their continuous encouragements and help throughout my graduate career.       
I should thank my family members Amma, Appa, Sisters, Athai and Maama for their love 
and affection on me and making my life colorful. Last but not least, I wish to thank my 
wife Poornima for her love and continuous support during difficult situations. I thank 












                                    TABLE OF CONTENTS                                 PAGE NO 
 
ACKNOWLEDGEMENT       i 
TABLE OF CONTENTS       iii 
LIST OF ABBREVIATIONS      viii 
SUMMARY         x 
LIST OF TABLES        xiii 
LIST OF FIGURES        xiv 
LIST OF PUBLICATIONS       xxv 
INTRODUCTION        1 
 
CHAPTER 1:  
Cooperativity and allostery in cAMP-dependent activation of Protein Kinase A: 
Monitoring conformations of intermediates by amide hydrogen/deuterium exchange 
1.1 Introduction         16 
1.2 Materials and Methods 
1.2.1 Reagents        20 
1.2.2 Purification of RIα(92-379)(R209K) and C- subunit   21 
1.2.3 Amide HDXMS        21 
1.3 Results and Discussion 
1.3.1 Pepsin digestion of  RIα(92-379)R209K and C- subunit  24 
1.3.2 Evidence that cAMP binding to RIα(92-379)R209K:C  31  
  holoenzyme does not lead to dissociation of the complex   
 
1.3.3 cAMP binding to RIα(92-379) R209K:C holoenzyme   31  
 decreases deuterium exchange in PBC:B 
 
1.3.4 cAMP binding to CNB-B increases deuterium exchange  33 
iv 
 
 at interface between CNB-B and C-subunit 
 
1.3.5 Effects of cAMP binding to RIα(92-379)R209K:C   34  
  holoenzyme: Changes in PBC:A of RIα  
 
1.3.6 Global conformational changes in RIα     35 
  1.3.6.1. Pseudosubstrate region      35 
  1.3.6.2. αB/C:Α, αC‟:A  and αA:B helix    35 
1.4 Conclusion         38 
 
CHAPTER 2: 
Phosphodiesterases Catalyze Hydrolysis of cAMP-bound to Regulatory Subunit of 
Protein Kinase A and Mediate Signal Termination 
2.1 Introduction         41 
2.2 Materials and Methods 
 2.2.1     Materials         45 
 2.2.2     Cloning and Expression of a C-terminal deletion   46 
       domain mutant of RegA 
 
 2.2.3  Protein Expression and Purification     47 
   
2.2.4 Pull-Down Assays       47 
2.2.5 Fluorescence Spectroscopy      48 
2.2.6 Phosphodiesterase Assay      49 
2.2.7 Fluorescence Polarization (FP) Assay for cAMP   51  
 Dissociation 
 
2.2.8 Amide HDXMS - (LC-ESI-QTOF-MS)    52  
  





2.3 Results  
   2.3.1 Deletion Mutagenesis Indicates that the Catalytic   56 
   Domain of RegA Mediates AKAP-independent 
   Interactions with the CNB:A Domain 
   2.3.2 Measurement of Binding Affinity of RIα to RegA   59  
   by Fluorescence Quenching 
 
   2.3.3 RIα Binding Induces a 13X Increase in RegA    60  
   Phosphodiesterase Activity 
  
   2.3.4 Mapping RIα-RegA Interactions by Amide HDXMS   63  
    
   2.3.5 Three Regions on RIα showed Decreased Solvent   69 
    Accessibility in the RegA-RIα Complex: Phosphate  
   Binding Cassette, β-stands 1-2 and a:B-C-helices 
 




   2.4.1 RegA Phosphodiesterase is capable of Hydrolyzing   77  
    cAMP-bound to RIα 
 
  2.4.2 Dual Function of RIα as Inhibitor of C-subunit and   80  
    Activator of PDEs 
 
2.4.3 RIα Mediates Distinct but Overlapping Interactions   80  








3.2 Materials and Methods 
 




3.2.2. Protein Expression and Purification     85 
3.2.3. Amide HDXMS        86 
           




3.3.1. Peptide Array Analysis for RegA:RIα Interactions   88 
 
3.3.2. Pepsin digestion and peptide identification    91 
for RegA 
 
3.3.3. Amide HDXMS        92 
       
3.3.4. RegA-Rα interactions alter regions within    94  
metal binding site 
 
3.3.5. Substrate binding pocket is stabilized     95  
during RegA- RIα interactions 
 
3.3.6. RegA primes RIα for reassociation     98  
with C-subunit 
 
3.4 Discussion         99 
 
3.5 Conclusion         101 
 
CHAPTER 4: 
Multi-State Allostery in Response Regulators: Phosphorylation and Mutagenesis Activate 
RegA via Alternate Modes 
4.1 Introduction         106 
4.2 Materials and Methods 
 4.2.1     Reagents         110 
 4.2.2     Cloning, expression and purification of RegA     110 
     and mutants 
vii 
 
 4.2.3  Phosphodiesterase activity assay     111 
4.2.4 Amide HDXMS studies       111 
4.3 Results  
        4.3.1 Mutation of the aromatic switch residue enhances    114 
phosphodiesterase catalysis of RegA 
 
   4.3.2 Phosphorylation causes decreased exchange across   116  
   the Receiver Domain which reflects large scale stabilization  
   and reduction in backbone dynamics    
 
  4.3.3 Interdomain linker and catalytic loop residues also show  119 
   decreased deuterium exchange upon phosphorylation 
  
  4.3.4 Receiver domain of activating mutant (RegA F262W) is  120  
   more dynamic compared to phosphorylated as well as  
   unphosphorylated RegA 
 
   4.3.5 Deuterium exchange of the linker and catalytic domains  120 
    in activating mutant, RegA F262W are distinct but overlap 
    with phosphorylated RegA 
 
   4.3.6.  Receiver domain decreases deuterium exchange within  121  
   the catalytic PDE domain without altering activity 
 
4.4 Discussion 
   4.4.1 Allosteric coupling of phosphorylation and aromatic    131 
    switch residue 
 
  4.4.2 Dynamics of the catalytic domain in phosphorylated   132  
    RegA and RegA F262W are overlapping yet distinct 
 
4.4.3 Phosphorylation-dependent activation of RegA through  133  
decreases in protein-wide dynamics 
 
4.5 Conclusion         139  
FUTURE DIRECTIONS        142 
REFERENCES         146 
        
viii 
 
LIST OF ABBREVIATIONS 
 
AKAP: A- Kinase anchoring protein 
AC: Adenylyl cyclase  
BME: β- Mercaptoethanol 
C subunit: Catalytic subunit of PKA 
cAMP: Cyclic adenosine 3‟, 5‟- monophosphate 
CIAP: Calf intestinal alkaline phosphatase 
CNB-A and CNB-B: cyclic nucleotide binding domain A and B respectively 
FM: Fluorescein maleimide 
GST: Glutathione S-Transferase 
FP: fluorescence polarization 
LC-ESI QTOF: Liquid chromatography- Electrospray ionization Quadrupole Time-of-flight 
MALDI-TOF: Matrix-Assisted Laser Desorption Ionization Time-of-Flight 
NHS: N-hydroxysuccinimide 
PCR: polymerase chain reaction 
PDE: cyclic nucleotide phosphodiesterase 
PKA: Protein kinase A 
R-subunit: Regulatory subunit of PKA 
ix 
 
RR: Response regulator 
TCA: Trichloroacetic acid 
TFA: Trifluoroacetic acid 










































The key role of cAMP in mammalian cells is mediated through the activation of 
cAMP dependent Protein Kinase A (PKA). cAMP binding induces large conformational 
changes within the R-subunit leading to dissociation of the active C-subunit. Although 
crystal structures of end-point, inactive and active states are available, the molecular basis 
for cooperativity in cAMP-dependent activation of PKA is not clear. In this study 
(Chapter 1) application of amide hydrogen/deuterium exchange (HDX) mass 
spectrometry (MS) on tracking the stepwise cAMP-induced conformational changes has 
been reported. Amide exchange results reveal that binding of one molecule of cAMP 
enhances dynamics of two key regions α:C/C‟:A and αA:B helix coupling the two CNBs 
and this forms the basis for positive cooperativity in the cAMP-dependent activation of 
PKA.  
While extensive structural and biochemical studies have provided molecular 
insights into the mechanism of PKA activation, little is known about signal termination 
and the role of PDEs in regulatory feedback. In this study (Chapter 2) a novel mode of 
AKAP (A-kinase-anchoring protein)-independent feedback regulation between RegA and 
the PKA regulatory (RIα) subunit has been identified. Results indicate that RegA, in 
addition to its well-known role as a PDE for bulk cAMP in solution, is also capable of 
hydrolyzing cAMP-bound to RIα. Furthermore results indicate that binding of RIα 
activates PDE catalysis several fold demonstrating a dual function of RIα, both as an 
inhibitor of the C-subunit and as an activator for PDEs. Deletion mutagenesis and amide 
HDXMS results revealed that the cAMP-binding site (phosphate binding cassette) along 
with proximal regions important for relaying allosteric changes mediated by cAMP, are 
xi 
 
important for interactions with the PDE catalytic domain of RegA. These sites of 
interactions together with measurements of cAMP dissociation rates demonstrate that 
binding of RegA facilitates dissociation of cAMP followed by hydrolysis of the released 
cAMP to 5‟AMP. In Chapter 3 the key regions in PDE important for interactions with 
RIα followed by activation are identified. The amide HDXMS data reveals the regions 
critical for RegA-RIα interactions include the metal binding M site and substrate binding 
Q pocket in RegA. Results from the pull down experiment show that RegA binding 
primes cAMP-bound RIα for reassociation with the C-subunit. When RegA interacts and 
hydrolyses the bound cAMP from RIα, the cAMP-free RIα generated as an end product 
remains bound to RegA. The PKA C-subunit then displaces RegA and reassociates with 
cAMP-free RIα to regenerate the inactive PKA holoenzyme thereby completing the 
termination step of cAMP signaling. These results reveal a novel mode of regulatory 
feedback between PDEs and RIα which has important consequences for PKA regulation 
and cAMP signal termination. 
cAMP specific phosphodiesterase (PDE), RegA in Dictyostelium discoideum 
tightly regulates the intracellular levels of cAMP through various stages of cell growth. 
RegA is known to be activated through the two-component system in which phospho-
transfer occurs from RdeA to the receiver domain of RegA. But the mechanistic basis by 
which the enzyme gets activated is not yet well understood. In this study (Chapter 4), 
phosphorylation dependent conformational changes in RegA has been mapped using 
amide HDXMS. Dynamics within RegA and the conformational changes due to 
accompanying phosphorylation at D212 suggests that phosphorylation stabilizes regions 
xii 
 
within RegA and keeps the molecule in active state, whereas the unphosphorylated RegA 

































1.1 Effect of cAMP binding on the R-subunit peptides from RIα(92-
379)R209K:C holoenzyme and RIα(92-379)R209K measured by 
amide HDX. 
27 
1.2 Effect of cAMP binding on the C-subunit peptides from RIα(92-
379)R209K:C holoenzyme measured by amide HDX. 
29 
2.1 Summary of HDX data for cAMP-free RIα(91-244) and cAMP-
free RIα(91-244):RegA 
64 
2.2 Peptides detected and analyzed from MALDI-TOF for RIα (91-
244) both in free and in complex with RegA 
66 
3.1 Peptides detected and analyzed from peptide array data. RegA 
peptide sequences which interacted specifically with RIα are 
listed. 
89 
4.1 Summary of HDXMS data for RegA, phosphorylated RegA 
(RegA~P), RegA F262W and RegA D212N under 


















i 3‟ 5‟ - cyclic adenosine monophosphate Signaling: Activation and 
termination phases. Hormonal stimulation of membrane bound 
GPCRs leads to activation of ACs. Generation of cAMP from ACs 
leads to activation of PKA. PDEs terminate the cycle by 
hydrolyzing 3‟ 5‟ cAMP to 5‟ AMP. 
2 
ii Mechanism of type I PKA regulation. In PKA holoenzyme, the C- 
subunit (blue) is kept inactivated when bound to the R- subunit 
(Moorthy et al.) (structure of the RIα(92-379):C holoenzyme 
complex (PDB ID: 2QCS)) (Kim et al., 2007). Binding of 2 
molecules of cAMP to CNB-A and CNB-B of the holoenzyme 
leading to dissociation of the C-subunit (PDB ID: 1L3R) 
(Madhusudan et al., 2002) from R-subunit (PDB ID: 1RGS) (Su et 
al., 1995) and its activation. 
5 
iii Domain organization for 11 phosphodiesterase families. Schematic 
representation showing varied regulatory domain/s and the highly 
conserved PDE catalytic domain (Conti, 2000). 
6 
iv Evolution of different phosphodiesterase families. The 
phylogenetic tree was generated using the PDE catalytic domain as 
a template. The red circle indicates the position of RegA in the tree 
(Conti and Beavo, 2007). 
 
8 
v Schematic representation of deuterium exchange and the mass 
spectrometry analysis for isolated protein (A) and in complex with 
other molecule (AB) are shown. Protein samples are incubated with 
D2O buffer for exchange reaction for various time points. 
Reactions are quenched at pH 2.5; the samples are then digested 
with pepsin and subjected to mass spectrometry analysis. The 
number of deuterons exchanged for the protein (A) are compared 
with complex (AB). 
11 









1.1  (Α): Domain organization of RIα showing an N-terminal 
dimerization/docking domain (D/D) (gray hashed box) connected 
by a linker to two tandem cAMP-binding domains, CNB-A and 
CNB-B in green. The linker contains a PKA pseudosubstrate which 
is essential for facilitating interactions of RIα with the C-subunit in 
red. (B): Mechanism of type I PKA regulation. In PKA 
holoenzyme, the C- subunit (gray) is kept inactivated when bound 
to the R- subunit (green) (structure of the RIα(92-379):C 
holoenzyme complex (PDB ID: 2QCS)), (Kim et al., 2007). ATP 
and the pseudosubstrate region occupy the active site cleft formed 
by the two lobes of the C-subunit. Binding of 2 molecules of 
cAMP to CNB-A and CNB-B of the holoenzyme induces 
conformational changes leading to dissociation of the C-subunit 
and its activation. The R-subunit thus adopts distinct 
conformations, bound to C-subunit (green, H-conformation) (Kim 
et al., 2007) and bound to cAMP (brown, B-conformation) (PDB 
ID: 1RGS) (Su et al., 1995). (C): Close-up views of the Phosphate 
binding cassettes (PBC) (brown) from both CNB-A and CNB-B. In 
PBC:A, the critical conserved residues Arg 209 and Glu 200 and in 
PBC:B, Arg 333 and Glu 324 anchor the cyclic phosphate and 
2‟OH moieties of cAMP (yellow) respectively. 
19 
1.2 Cartoon showing step-wise cAMP-mediated activation of PKA (R-
subunit in red, C-subunit in blue, *- represents a molecule of 
cAMP, X- represents mutation that abolishes high-affinity binding 
of cAMP). Activation of type I PKA is cooperative and sequential 
with cAMP binding first to CNB-B and then to CNB-A. Mutation 
of Arg 209 to a Lys in CNB-Α of R- subunit abolishes high-affinity 
cAMP binding to the CNB-Α without significantly affecting 
binding of cAMP to CNB-B. The holoenzyme, RIα(92-
379)R209K:C provides an ideal model system to probe the effects 
of a single cAMP binding to CNB-B and studying effects of a 
single cAMP bound intermediate in the cAMP–dependent 
activation pathway of PKA. 
20 
1.3 Amino acid sequence of RIα(92-379)R209K (Α) and C(1-350) (B) 
showing secondary structure elements with boundaries. Solid lines 
with arrow at two ends indicate the pepsin digest fragments 
analyzed in the study with total sequence coverage of 90% and 
88% for RIα and C subunits respectively. 
25 
1.4 ESI-QTOF mass spectra of pepsin digest fragments from different 
regions of RIα(92-379)R209K in RIα(92-379)R209K:C 




The isotopic envelope for the peptides from cAMP bound RIα(92-
379)R209K subunit after 10 min deuteration (ii) The isotopic 
envelope for the peptides from cAMP bound RIα(92-379)R209K:C 
holoenzyme after 10 min deuteration; (iii) The isotopic envelope 
for the peptides from cAMP free RIα(92-379)R209K:C 
holoenzyme after 10 min deuteration and (iv) undeuterated isotopic 
envelope. 
1.5 Time course of deuterium exchange for peptides from RIα(92-
379)R209K. Open circle (○), RIα(92-379)R209K:C in the absence 
of cAMP; Close circle (●), RIα(92-379)R209K:C in the presence 
of cAMP. The solid lines denote the best fit of the data to a one-
phase association non linear exponential curve fit (GraphPad Prism 
5.0 (San Diego, CA)). 
32 
1.6 cAMP binding to the CNB-B domain shows increased exchange at 
the CNB-B:C-subunit interface, amide HDX data mapped onto the 
crystal structure of holoenzyme, RIα(92-379)R333K:C (the only 
available type I holoenzyme structure with both CNB-Α and CNB-
B domains , PDB ID: 2QCS) (Kim et al., 2007). The R- subunit 
and the C- subunit are shown in green and gray respectively. 
Regions showing increased exchange upon binding cAMP are in 
red and suggest disruption of the specific intersubunit contacts 
mediated by the CNB-B domain with the C-subunit (yellow arrow), 
(site 4 of R-C intersubunit interactions, (Kim et al., 2007)). 
33 
1.7 Increased exchange upon binding of a single molecule of cAMP to 
RIα(92-379) R209K:C holoenzyme, within residues 230-270 
(spanning α:B/C and α:A of CNB-B) region of the R-subunit 
reflects increased dynamics and is shown  in red. This region 
reflects the large conformational changes between the H (green) 
and B (gray) -conformations shown by superposition of PBC:A of 
cAMP-bound RIα (113-379) (PDB ID: 1RGS) and PBC:A of C-
subunit-bound RIα (92-379) (PDB ID: 2QCS). The yellow arrow 
shows alternate positioning of α:B/C helix between the H and the B 
forms.  Regions spanning PBC:B show decreased exchange upon 
binding of cAMP (blue). The inset figure shows residues that are 
critical for cAMP binding to PBC:B. 
36 
1.8 Importance of CNB-B α:A in mediating allosteric cooperativity in 
the cAMP-activation of PKA. Crystal structure of RIα(92-379) in 
C-subunit bound, H-conformation (A) (PDB ID: 2QCS) is 
compared with the crystal structure of RIα(113-379) in cAMP 




showing salt bridges between Q370-E255, E261-R366, R241-D267 
and E143-K240 are critical when the R- subunit is in the H-
conformation. Binding of a single molecule of cAMP to CNB-B 
leads to disruption of these critical salt bridges and increases the 
mobilities of α:A and α B/C helices facilitating binding of a second 
molecule of cAMP at CNB-A and leading to activation of PKA. 
2.1 Overview of cAMP signaling and regulation of PKA. Adenylyl 
cyclases catalyze synthesis of cAMP from ATP while 
phosphodiesterases (PDEs) catalyze hydrolysis of cAMP to 5‟ 
AMP. cAMP activates PKA by mediating dissociation of the PKA 
holoenzyme to release R and C-subunits via a largely well-
understood mechanism. Little is known, on how cAMP-bound R-
subunits reassociate with C-subunit to generate inactive PKA, and 
the potential role of PDEs in cross-talk with the R-subunits leading 
to signal termination. 
42 
2.2 Domain organization of RegA showing an N-terminal (REC) 
receiver domain (RegA(127-335)) in red and a C-terminal 
phosphodiesterase (PDE) catalytic domain (RegA(385-780)) in 
green. 
56 
2.3 GST pull down of cAMP-free RIα(91-379) with the PDE catalytic 
domain, GST RegA (385-780) shows direct binding to cAMP-free 
RIα(91-379) (Lane 1). GST was used as control (Lane 3). 
Hexahistidine pull down of cAMP-free RIα(91-379) with 
hexahistidine tagged RegA(127-335) (Lane 2). 
57 
2.4 GST pull down of cAMP-free RIα(91-244) with GST RegA(385-
780) (Lane1). GST was used as control (Lane 2). (MW: Molecular 
weight marker). For clarity, all future references to RegA in the 
figure legends denote the GST-tagged RegA(385-780) and all 
future references to RIα denote RIα(91-244) unless otherwise 
stated. 
58 
2.5 cAMP-bound and cAMP-free RIα bind RegA with identical 
affinities. Plot of relative fluorescence of fluorescein-labeled 
RIα(91-244) R239C (0.5 μM)  and concentrations of RegA (0.5 - 
10 μM) (Excitation wavelength: 490 nm, Emission wavelength: 
520 nm). Y-axis shows normalized values of relative fluorescence 
where 100% represents the maximum value for F0/F. Open triangle 
(∆), cAMP-free RIα and inverted open triangle (∇), cAMP-bound 
RIα. The curves were fit to the equation for one-site specific 




2.6 Deletion of the N-terminal domain of RegA does not affect PDE 
activity. Comparison of specific activity (pmol 5‟AMP released/ 
pmol RegA/ min) of full-length RegA and GST-RegA(385-780). 
60 
2.7 cAMP-free RIα is an activator of PDE catalysis. Figure 4A, EC50 
for cAMP-free RIα-mediated activation of RegA. Concentrations 
of RegA and cAMP were 50 nM and 200 μM respectively. 
Triplicate reactions were carried out at 30˚C for 15 min with a 
range of concentrations of cAMP-free RIα (1 nM – 30 μM). The 
plot was fit to an equation describing a sigmoidal dose response 
curve (Activity vs. Log Agonist) (Graphpad Prism version 5 (San 
Diego, CA)) and an EC50 of 132 nM was calculated. These results 
indicate that a maximal increase (~ 13 X) in activity is seen when 
RegA is fully saturated with RIα. Inset shows PDE-mediated 
5‟AMP synthesis over time for free RegA and in the presence of 
RIα (3 µM). 
61 
2.8 RIα activates RegA by increasing the Vmax of the phosphodiesterase 
reaction. PDE assays of RegA (50 nM) were carried out in the 
absence (○) or presence (●) of cAMP-free RIα (3 μM).  Rates of 
5‟-AMP product formed were plotted versus a range of cAMP 
concentrations and fitted to the Michaelis-Menten equation (Graph 
Pad Prism software version 5 (San Diego, CA)). The Vmax for the 
PDE reactions catalyzed by RegA was 8.1±0.5 pmol 5‟AMP 
released/ min (kcat = 3.2 min
-1) and that for RegA + RIα is 
107.6±1.3 pmol 5‟AMP released/min (kcat= 43.0 min
-1
); The KM 
for RegA was calculated to be 35.0 μM and for RegA + RIα, 32.5 
μM. Data are average measurements from three replicate 
experiments. Error bars indicating standard deviation are too small 
to be clearly seen on the graph. 
62 
2.9 Amino acid sequence of RIα(91-244) showing secondary structure 
elements with boundaries. Solid lines indicate the 36 pepsin digest 
fragments analyzed in the study with a total sequence coverage of 
~90%. 
65 
2.10 ESI-QTOF mass spectra for a peptides spanning RIα(202-217) (A) 
and RIα(162-172) (B) in the top showing decreased exchange in 
the RIα–RegA complex. (i) The isotopic envelope for the same 
peptides from RIα alone after 10 min deuteration (ii) The isotopic 
envelope for the same peptides from RIα:RegA after 10 min 
deuteration; (iii) Undeuterated sample. Time course of deuterium 
exchange for same peptides (bottom) fit to an equation for one-
phase association (Graph Pad Prism software version 5 (San Diego, 





2.11 Matrix-assisted laser-desorption/ionization time-of-flight (MALDI-
TOF) spectra of one of the peptides spanning the PBC residues 
204-221 (m/z = 1931.15) (A) and residues 239-244 (m/z = 881.51) 
(B) in RIα (91-244). The spectra are expanded to show the isotopic 
distribution for the same peptides (top). (i) Isotopic envelope of 
undeuterated sample. The isotopic envelope for the same peptide 
after 10 min of deuteration from RIα (91-244) (ii) in the absence of 
RegA, (iii) bound to RegA. Time course of deuterium 
incorporation into backbone amides of the same peptides (bottom). 
(○) Peptide from RIα (91-244) alone, () Peptide from RIα (91-
244) in complex with RegA. The solid lines denote the best fit of 
the data to a single exponential equation. 
68 
2.12 Amide HDXMS data mapped on to the crystal structure (surface 
representation) of cAMP-bound RIα(113-379) (PDB ID: 1RGS), 
CNB:A is in green and CNB:B is in gray (Su et al., 1995). The 
phosphate binding cassette (PBC-A) (residues 199-212), B-helix 
(residues 229, 230), C-helix (residues 239-244) (From subtractive 
analysis and with amide exchange MALDI-TOF MS data) and 1 
segment from the β-subdomain (residues 162-172) showed 
decreased exchange in the RIα:RegA complex. cAMP is yellow 
and protected regions are blue.  Structure of RIα (113-379) is 
displayed using Pymol (DeLano Scientific, Mountain View, CA). 
70 
2.13 RegA catalyzes hydrolysis of cAMP-bound to RIα. 
Phosphodiesterase activity of RegA was measured by a 
colorimetric assay described in materials and methods using 
cAMP-bound RIα as substrate. 50 μM cAMP-bound RIα was 
incubated with different concentrations of RegA (0-120 μM). Plot 
shows PDE activity as a function of concentration of RegA (□). 
The plots were fit to an equation describing a sigmoidal dose 
response curve (Activity vs. Log Agonist) (Graphpad Prism 
version 5 (San Diego, CA)). 
71 
2.14 (A) RegA mediates dissociation of cAMP from RIα. Dissociation 
of 8-Fluo-cAMP from RIα (7.2 μM) was monitored by measuring 
the fluorescence polarization (FP) under different conditions, (○) 
control: Buffer A (20 mM Tris-HCl, pH 7.5, 50 mM NaCl, 10 mM 
MgCl2, 5 mM BME), (●) presence of unlabeled cAMP (Buffer A, 1 
mM cAMP), (▲) presence of C- subunit (36 μM), (Buffer A, 0.2 
mM ATP), (X) presence of RegA (36 μM) (Buffer A). FP 
measurements were as described in materials and methods. FP 
values are plotted versus time, arrow indicates the time point (30 
min) of addition of RegA (36 μM) to all samples. (B), RegA 




Dissociation rates were calculated by fitting the data for the early 
time points (0-18 min) to an equation describing  one phase 
exponential decay using Graph Pad Prism software version 5 (San 
Diego, CA). Data are average measurements from three 
independent experiments. Error bars indicating standard deviation 
are too small to be clearly seen on the graph. 
2.15 (A), Proposed mechanism for RegA mediated hydrolysis of cAMP-
bound to RIα. Structure of cAMP-bound RIα is shown (from PDB 
ID: 1RGS) highlighting the cAMP binding site and αC:A helix 
which are part of the three regions showing decreased exchange 
upon interactions with the catalytic PDE domain of RegA (red 
cartoon). Binding of RegA induces release of cAMP which is 
consequently hydrolyzed to 5‟ AMP. (B), RegA binding disrupts 
conserved electrostatic charge relays anchoring cAMP to RIα at 
binding site (step 1) which in turn facilitates release of cAMP (step 
2) leading to its subsequent hydrolysis. 
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2.16 Multiple Sequence Alignment for RIα; Partial multiple sequence 
alignment of RIα sequences. The RIα from species along with the 
accession number are, Bos taurus (bRIα, P00514); Dictyostelium 
discoideum (DictR, P05987); Rattus norvegicus (rRIα, P09456); 
Homo sapiens (hRIα, P10644). Highlighted residues (D170, E200, 
R209, and R241) are critical for cAMP binding or allosteric 
activation of PKA. Regions around these residues are important for 
interactions with RegA. (*) denotes invariant, (:), conserved and 
(.), partially conserved residues. 
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3.1 Peptide array data shows interaction of RIα with RegA. Peptide 
libraries were made on cellulose membrane as 15-mer peptides 
each shifted along by five amino acids to the entire RegA sequence 
and probed for interaction with cAMP free RIα. The interactions 
are detected by immunoblotting. Peptides interacts positively with 
RIα generate dark spots whereas non-interacting peptide leave 
white (blank) spots and peptides interacts specifically with RIα are 
shown in red box. Spot numbers (A2 to D8) relate to peptides in 
the scanned array (A2 to D8,  spot A2 → 301-315 residues, spot 
A3 → 306-320 residues and so on to D8→ 781-793) and whose 
sequence which interacts specifically are listed in Table 3.1. 
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3.2 (A) Homology model (SWISS-MODEL) of RegA (418-731) 
(green) based on the crystal structure of PDE8A (PDB ID: 3ECM) 
(orange). Yellow and purple spheres represent the divalent metal 
ions, which plays key role in the hydrolysis of substrate. (B) 




(418-731). Regions highlighted in blue are the overlapping peptides 
which show binding with RIα. 
3.3 Sequence coverage (83%) map for RegA (385-780). Amino acid 
sequence of RegA (385-780) with solid lines denotes the pepsin 
digest fragments analyzed in the study of RegA (385-78) 
interactions with cAMP free RIα (91-244). 
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3.4 (A) ESI-QTOF mass spectra of pepsin digest fragments from 
different regions of RegA (385-780) that showed significant 
changes in amide H/D exchange upon interactions with RIα (91-
244). (i) The isotopic envelope for the peptides from RegA (385-
780) in the presence of RIα (91-244) after 10 min deuteration (ii) 
The isotopic envelope for the peptides from RegA (385-780) in the 
absence of RIα (91-244) after 10 min deuteration; (iii) undeuterated 
isotopic envelope  of peptides from RegA (385-780). (B): Time 
course (1 - 10 min) of deuterium exchange for peptides from RegA 
(385-780). Open circle (○), RegA (385-780) in the absence of RIα 
(91-244); Close circle (●), RegA (385-780) in the presence of RIα 
(91-244). 
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3.5 The metal ions binding sites are critical for RIα-RegA interactions. 
The amide HDX and mass spectrometry data was mapped on to the 
homology model of RegA (418-731). Regions showing decreased 
deuterium exchange in the presence of RIα (91-244) are labeled 
blue, regions with no difference are in green and regions missing in 
the analysis are grey. The inset figure shows residues that are 
critical for metal ions binding; purple and yellow spheres represent 






3.6 (A) Butterfly plot showing the relative fractional exchange (y-axis) 
for all the peptic peptides (x-axis) from RegA (385-780) during 
amide HDXMS. The data for RegA (385-780) alone (top) and in 
complex with RIα (91-244) (bottom) are plotted in different colors, 
orange, red, cyan, blue and black for 0.5, 1, 2 5 and 10 min 
respectively. (B) Differences in HDX levels between RegA (385-
780) alone and in complex with RIα (91-244) are plotted in 
different colors as in Figure 3.6A.  Blue dashed boxes highlight 
regions within RegA showing decreased deuterium exchange upon 
complexation with RIα. Plots are the average from two independent 
HDXMS experiment generated using the DynamX software (beta 




3.7 RegA primes RIα for reassociation with C-subunit; Biotinylated 
cAMP-bound RIα (91-244)(R92C) was bound to Streptavidin-
agarose and incubated with C-subunit in the presence and absence 
of RegA as described in materials and methods, the samples were 
then analyzed by SDS-PAGE. Lane 1: C-subunit and immobilized 
RIα in the absence of RegA; Lane 2: C-subunit and immobilized 
RIα in the presence of RegA; Lane 3: C-subunit and Maleimide-
PEG2-Biotin-Streptavidin agarose beads (control). 
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3.8 Proposed model for the role of PDEs in signal termination of PKA. 
cAMP activates PKA by facilitating dissociation of the 
holoenzyme into cAMP-bound R-subunit and free C-subunit which 
then catalyzes the phosphorylation of numerous intracellular 
substrates. PDEs bind the cAMP-bound R-subunit, induce cAMP 
dissociation and parallel hydrolysis of cAMP. The cAMP-free R 
subunit generated enhanced activity of the associated PDE and is 
primed to re-associate with the C-subunit regenerating the PKA 
holoenzyme. 
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3.9 Partial multiple sequence alignment of human (Homo sapiens) 
phosphodiesterases with RegA(385-780), The PDEs along with the 
accession number are, RegA (AAB03508); PDE9A (AAC39778); 
PDE8A (AAC39763); PDE7A (AAI26361); PDE4A (AAC35015); 
PDE10A (AAI04861); PDE11A (AAI14432); PDE6A 
(AAH35909); PDE5A (AAP21809); PDE3A (AAI17372); PDE2A 
(AAH40974); PDE1A (AAH22480). Highlighted residues in 
yellow are critical for interactions with substrate or cAMP while 
highlighted residues in green are important for coordination of 
divalent metal ions required for catalysis. (*) denotes invariant, (:), 
conserved and (.), partially conserved residues. 
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4.1 Domain organization of RegA and mutants showing Receiver 
domain in light gray and the effector PDE domain in dark gray. 
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4.2 The increase in PDE activity of RegA F262W is via increases in 
the catalytic turnover rates (kcat) for the cAMP hydrolysis reaction. 
RegA F262W (closed square, ■) is ~ 8 fold more active than RegA 
(open square, □). Rates of 5‟ AMP product formed were plotted 
versus a range of cAMP concentrations (10 – 400 μM) and fitted to 
the Michaelis-Menten equation (Graph Pad Prism software version 
5). The Vmax for the PDE reactions catalyzed by RegA was 11.14 ± 
0.38 pmol 5‟ AMP released/min (kcat  = 4.45 ± 0.15 min
-1
) and that 
for RegA F262W was 90.45 ± 2.25 pmol 5‟ AMP released/min (kcat 
= 36.18 ± 0.90 min
-1
); The Km for RegA was calculated to be 33.0 




measurements from three replicate experiments. 
4.3 Pepsin digest fragments and sequence coverage for RegA. Solid 
lines indicate peptic digest fragments used and analyzed in this 




4.4 Phosphorylation causes decreased exchange across the entire 
Receiver domain. A homology model of unphosphorylated 
Receiver domain of RegA was generated by SWISS-MODEL 
using crystal structure of CheY (PDB ID: 3GWG) showing 
secondary structure elements and conserved residues critical for 
phosphorylation. The structural model represents the percentage of 
deuteration following 10 min deuterium exchange in RegA (A), 
Phosphorylated RegA (B) and RegA F262W (C). Residues that are 
important for hydrogen bond and salt bridge formation in with the 
phosphate oxygen are highlighted in blue sticks. Color coding is as 
per legend key indicated. 
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4.5 (A) ESI-QTOF mass spectra of pepsin digest fragments from 
different regions of the Receiver domain of RegA that showed the 
largest differences in deuterium exchange upon phosphorylation or 
in the mutant, RegA F262W. Isotopic envelopes for peptides from 
undeuterated RegA (i) and isotopic envelopes for deuterium 
exchanged peptides from RegA (ii), phosphorylated RegA (iii) and 
RegA F262W (iv) following 10 min of deuteration are shown. Due 
to the differences in charge state, the spectra for peptides 164-178 
(m/z = 576.64, z = +3) and 262-280 (m/z = 560.11, z = +4) of 
RegA F262W could not be displayed together with the others. 
Ratios of mass to charge (m/z) and charge states shown in this 
figure for peptides 164-178, 179-193, 198-210, 213-223, 241-247 
and 262-280 are (m/z = 864.45, z = +2), (m/z = 879.98, z = +2), 
(m/z = 791.43, z = +2), (m/z = 630.81, z = +2), (m/z = 680.29, z = 
+1)  and (m/z = 733.47, z = +3), respectively. (B) Time course (30 
sec – 10 min) of deuterium exchange for the peptides; RegA, open 
circle (○), phosphorylated RegA, closed circle (●) and RegA 
F262W closed triangle (▲). Plots of the time course of deuterium 
exchange were fit to an equation for one-phase association (Graph 
Pad Prism software version 5 (San Diego, CA)). 
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4.6 Deuterium exchange within catalytic domains in activating mutant, 
RegA F262W are overlapping yet distinct with phosphorylated 
RegA. A structural homology model of catalytic PDE domain of 











and H critical for PDE action was generated by SWISS-MODEL 
using the crystal structure of PDE8 (PDB ID: 3ECM). Catalytic 
metal ions are shown as yellow (Zn
2+
) and magenta (Mg
2+
) spheres. 
Regions that show difference in deuteration in phosphorylated 
RegA (A) and RegA F262W (B) when compared to RegA; regions 
showing decreased deuteration are blue. Regions where no 
coverage could be obtained are in gray. 
4.7 (A) Comparison of relative HDXMS results for RegA and 
phosphorylated RegA. Each block represents the deuteration levels 
of respective peptide fragment at five time points (30 sec to 10 
min). The deuteration levels are color coded as indicated. (B) 
Comparison of relative HDXMS results of RegA and RegA 
F262W. The time points and the deuteration levels are color coded 
as in Figure 4.7A. 
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4.8 (A) Comparison of relative HDXMS results for RegA and RegAC. 
The time points and the deuteration levels are as labeled in Figure 
4.7A. Structural model of the catalytic PDE domain displaying the 
extent of deuterium exchange following 10 min deuteration 
reaction for RegA (B), RegAC (C). Color coding is as indicated. 
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4.9 Model explains the conformationally dynamic, stable and different 
states of RegA. The unphosphorylated RegA is dynamic and 
equilibrates between the inactive (I) and active state (II); this 
dynamic nature of RegA in the presence of cAMP shows basal 
activity. Phosphorylation stabilizes the enzyme and keeps RegA in 
the active conformation (III) to show full activity. On the other 
hand the constitutively active mutant RegA F262W shows actively 
different conformation (IV) when compared to the phosphorylated 
RegA. The domains in the inactive conformations are represented 
as rounded rectangle and the in the active conformations as oval. 
The active conformations of unphosphorylated, phosphorylated and 
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i. 3’ 5’ - cAMP dependent protein kinase pathway 
Among the various receptors found on cell surface, G-protein coupled receptors (GPCRs) 
are one of the largest families of plasma membrane proteins with seven transmembrane 
domains (Wess, 1997). GPCRs participate in regulation of various physiological 
functions and are the targets for various biomolecules such as, hormones, chemokines, 
neurotransmitters, lipids and nucleotides (Gurrath, 2001). Extracellular ligand upon 
binding to GPCR transduces a signal across the membrane and promotes interactions of 
GPCR with G-protein. G-proteins are made of three subunits, Gα, Gβ and Gγ with Gα 
having the GTPase activity. Gα exist in GTP bound active state and the GDP bound 
inactive state. When GPCR is activated by ligand, it induces Gα subunit to bind GTP and 
activates it. The activated Gα subunit dissociates from GPCR and Gβγ subunits to produce 
downstream signaling effect like the activation of enzyme adenylyl cyclases (ACs) 
(Levitzki et al., 1993).  The activated ACs synthesizes 3‟ 5‟ cyclic-adenosine 
monophosphate (cAMP) from ATP. The key target for cAMP in mammalian cell is the 
cAMP-dependent protein kinase, protein kinase A (PKA) (Meinkoth et al., 1993). PKA in 
its inactive form is a tetramer composed of two catalytic (C) subunits bound to the dimer 
regulatory (R) subunits (Corbin and Rannels, 1980; Francis and Corbin, 1994). When 
high levels of cAMP synthesized and released by ACs within the cell, the released cAMP 
binds to the regulatory subunits of PKA leading to the activation through release of the 
catalytic subunits from regulatory subunits. The released catalytic subunits phosphorylate 
the target substrate proteins on serine and/or threonine residues and thereby modifying its 

























(PDEs) is also involved in the regulation of PKA. PDEs catalyze the hydrolysis of cAMP 
to 5‟adenosine monophosphate (AMP) which is incapable of activating PKA (Conti, 
2000) (Figure: i). PKA has also been found to regulate numerous signaling pathways 
leading to integration of the key signaling molecule cAMP with a wide range of 















Figure i: 3‟ 5‟ - cyclic adenosine monophosphate Signaling: Activation and termination phases. 
Hormonal stimulation of membrane bound GPCRs leads to activation of ACs. Generation of 
cAMP from ACs leads to activation of PKA. PDEs terminate the cycle by hydrolyzing 3‟ 5‟ 
cAMP to 5‟ AMP. 
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ii. Protein Kinase A isoforms 
 There are 3 isoforms of the C-subunit and the Cα isoform is predominantly found 
in all eukaryotic cells. The R-subunits are classified broadly into RI and RII isoforms on 
the basis of whether an autophosphorylation site is present (RII) or not (RI). RII subunits 
are autophosphorylated while the RI subunits are not. These are further classified into α 
and β subtypes. Since Cα is the predominant isoform, PKA is primarily classified 
according to the R-subunit isoform as PKA-RIα, PKA-RIβ, PKA-RIIα and PKA-RIIβ. 
All of the R-subunit isoforms are nonredundant and the PKA isoforms each show 
different subcellular localization. PKA-RII is mostly found in association with specific 
cellular structures and organelles, whereas the PKA-RI is found mostly in the cytoplasm 
(Zaccolo et al., 2008). These PKA isoforms not only show different cellular localization, 
and also deliver specific responses and different biochemical properties. Localization of 
these proteins is achieved by scaffolding adaptor proteins called the A-kinase anchoring 
protein (AKAPs).  
iii. Unique role of RIα in eukaryotes 
 Inside the cell, RIα isoform plays a major role in regulating the C-subunit and 
facilitating cAMP-dependent regulation (Amieux and McKnight, 2002). Perhaps the 
strongest evidence for the preeminent role of RIα isoform comes from mouse knock-out 
experiments. Of all the isoforms, only the RIα knockout mice were found to be 
embryonically lethal. The RII knockout mice survived and showed unique phenotypes 
along with elevated levels of RIα in the cells, suggesting that RIα can compensate for 
other R-subunit isoforms. Furthermore, it was shown that the embryonic lethality was due 
to the lack of regulation of C-subunit activity, but not due to the absence of RIα. This 
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information indicates that RIα is uniquely required for effective regulation of the PKA 
kinase and stresses the importance of RIα localization, regulation and molecular 
interactions.  
iv. Tightly regulated PKA activation - Role of two cAMP binding domains 
 The mammalian RIα isoform is modular and extended proteins having a very 
similar domain organization with an N-terminal dimerization domain connected to two 
cAMP binding domains by a variable, disordered linker region. The proximal cAMP-
binding domain is referred to as the cAMP binding A domain and the distal domain is the 
cAMP binding B domain. The C-subunit on the other hand is a globular protein and can 
be shown to consist of an N and C-terminal lobe and enclosing an ATP and substrate-
binding cleft. The R-subunit consists of an N-terminal dimerization domain followed by 
pseudosubstrate or the inhibitor motif to which the catalytic core of C subunit interacts. 
The R-subunit lacking the N-terminal dimerization domain, RIα(92-379) and RIα(91-
244), retains high affinity binding to the C-subunit and provides a minimal monomeric 
model for examining R-C interactions as well as cAMP binding to CNB-A and CNB-B 
(Kim et al., 2007; Su et al., 1995). Crystal structures of the isolated subunits and the RIα-
C holoenzyme (Kim et al., 2005; Taylor et al., 2007) show snapshots of PKA in its two 
stable end states (inactive and active) (Figure: ii). So, understanding the mechanism of 
activation and the intermediates in PKA is highly important in cAMP Signaling. For 
activating this enzyme one molecule of cAMP has to bind to each of the cAMP binding 
domains, this is assumed to occur in a serial manner. First, one molecule of cAMP binds 
to the B domain (CNB-B) which cooperatively facilitates binding of a second molecule 

























subunit. The cAMP binding domain B is believed to act as “gatekeeper” for modulating 
cAMP access to domain A (Taylor et al., 2007). The role of B domain and the 










v.  Diversity within Phosphodiesterase families 
 In humans, 21 different genes are found to be associated with the expression of 
more than 60 isoforms of PDEs. The physicochemical properties and the biological 
functions of these PDEs have been widely studied. The PDEs are further classified into 
11 families (PDE 1-11) based on their amino acid sequences, substrate specificities, 
regulatory properties, tissue distribution and the pharmacological functions (Francis et 
al., 2011; Jeon et al., 2005). Each PDE contain a highly conserved catalytic domain, but 
shows high variability in regulatory domains (Figure: iii) for instance, calmodulin 
Figure ii: Mechanism of type I PKA regulation. In PKA holoenzyme, the C- subunit (blue) is kept 
inactivated when bound to the R- subunit (Moorthy et al.) (structure of the RIα(92-379):C 
holoenzyme complex (PDB ID: 2QCS)) (Kim et al., 2007). Binding of 2 molecules of cAMP to 
CNB-A and CNB-B of the holoenzyme leading to dissociation of the C-subunit (PDB ID: 1L3R) 
(Madhusudan et al., 2002) from R-subunit (PDB ID: 1RGS) (Su et al., 1995) and its activation. 
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binding domain, GAF (cGMP specific PDE, Adenylyl cyclase, and Fh1A) domain, UCR 
(Upstream Conserved Region) domain, PAS (Period clock protein, Aryl hydrocarbon 
receptor nuclear translocator, and Single minded protein) domain, REC (receiver) domain 











The PDEs can also be classified based on their specificity towards the 
nucleotides, cAMP specific (PDE 4, 7 and 8), cGMP specific (PDE 5, 6 and 9) and dual 
affinity (PDE 1, 2, 3, 10 and 11). Although numerous crystal structures of free catalytic 
domains and catalytic domains bound to various ligands have been solved, no structure 
for any full-length PDE has been reported (Conti and Beavo, 2007). Thus very little is 
Figure iii: Domain organization for 11 phosphodiesterase families. Schematic representation 




known about the mechanism by which the regulatory domain/s controls the PDE catalytic 
domain. Some of the known properties of PDE regulatory domains through which it 
regulates the catalytic domain include; ligand binding (cGMP/cAMP), phosphorylation 
by kinase (PKA/PKB/PKG), protein binding (calmodulin, PKA catalytic subunit or Iκ B) 
and oligomerization. PDE1 isoforms are found to be activated through 
calcium/calmodulin binding (Goraya and Cooper, 2005); PDE2, PDE5, PDE6 and 
PDE11 are regulated through cGMP binding (Heikaus et al., 2009), PDE10 is regulated 
through cAMP binding (Gross-Langenhoff et al., 2006); PDE3 is regulated by both PKA 
and PKB phosphorylation (Degerman et al., 1997); PDE4 is controlled by PKA and ERK 
phosphorylation (Conti et al., 2003); PDE7 is known to be controlled by PKA catalytic 
subunit interactions (Han et al., 2006) and PDE8 is activated upon interacting with Iκ B 
(Wu and Wang, 2004). 
vi. cAMP specific phosphodiesterase RegA from Dictyostelium discoideum 
Dictyostelium discoideum phosphodiesterase (DdPDE2) RegA is a class I cAMP specific 
PDE which plays a major role at various stages cell development (Shaulsky et al., 1996; 
Wessels et al., 2000). This protein is a remarkable hybrid of a bacterial type response 
regulator with Receiver (regulatory) domain and a mammalian type PDE catalytic 
domain (Figure iv). Phosphorylation at conserved Asp212 in the Receiver domain results 
in the activation of enzyme for the hydrolysis of cAMP (Thomason et al., 1999). The 
RegA catalytic domain shows high homology to mammalian PDEs (Conti and Beavo, 
2007). The residues coordinating the divalent metal binding and nucleotide binding are 
also highly conserved. It has been previously shown that RegA is also activated through 






therefore chosen as a model of choice to study regulatory feedback mechanisms in cAMP 
Signaling. In my current study I have used RegA to study and distinguish the various 
mechanisms of regulation of PDEs and PKA.  










vii. Evidence for novel anchoring mechanisms for tethering PKA RIα 
 Belying the inherent simplicity of the cAMP Signaling pathway described above, 
there is enormous complexity both as a result of compartmentation as well as diversity of 
nonredundant isoforms and families of cAMP Signaling proteins. Furthermore, cAMP 
concentrations inside the cell are not uniform, underscoring the importance of 
compartmentation of different elements of the cAMP Signaling pathway (Zaccolo, 2006). 
Figure iv: Evolution of different phosphodiesterase families. The phylogenetic tree was 
generated using the PDE catalytic domain as a template. The red circle indicates the position of 
RegA in the tree (Conti and Beavo, 2007a). 
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Earlier studies have shown that the RI and RII isoforms partition separately into two 
major fractions- the soluble fractions containing RI and the particulate fractions 
containing the RII isoforms. While most of the RII subtypes have been localized to 
subcellular compartments by means of AKAPs, there are very few AKAPs discovered 
that uniquely anchor the RIα isoform. One RII-specific AKAP has been shown to 
colocalize PKA and PDE4D3 suggesting a novel mechanism for negative feedback for 
cAMP Signaling (Michel and Scott, 2002). In contrast, there are very few AKAPs 
identified specific for the RI subtypes (Lim et al., 2007). A major question in the cAMP 
Signaling field is to identify AKAPs or AKAP-like tethering mechanisms for the RIα 
isoform. It is intriguing to speculate whether elements of the Signaling cascade can 
themselves function as anchoring proteins to promote formation of higher order Signaling 
complexes. Such interactions specific to RI isoform of the R-subunit would not only help 
in localizing the enzyme but also facilitate tight regulation of PKA inside the cell. This is 
one of the major research interests highlighted in this study. 
viii. Cross talk between PDEs and PKAs: 
 Traditionally all the elements of the cAMP Signaling pathway have been studied 
in isolation in vitro, however, there is increasing awareness of the cross-talk between the 
elements of this pathway in higher order complexes sometimes referred to as 
„signalosomes‟ which bring together the different elements of the Signaling pathway 
together. One of the major focuses of my research is to examine regulatory cross-talk 
interactions between PKA and PDEs in the context of higher order Signaling complexes. 
PDEs not only inhibit PKA by indirectly metabolizing cAMP, but also through direct 
protein-protein interactions. cAMP was initially considered to be a second messenger that 
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diffused freely throughout the cell with a theoretical range-of-action of 220 μm (Johnson 
et al., 2001). However, advances in live-cell imaging have visualized gradients, rather 
than a uniform intracellular distribution, of cAMP, which indicates that this second 
messenger accumulates at specific sites within the cell. Based on the level of cAMP 
inside the cell, the extent of PKA activation also should vary. Recent studies on the cross 
talk between PDEs and PKA reveals that either the PDEs directly bind with the catalytic 
subunit of PKA (Han et al., 2006) or the regulatory subunit of PKA interacts with PDE 
and  increases its PDE activity (Shaulsky et al., 1998), these regulatory feedback  
interaction would directly alter the PKA activation and impact consequences of cAMP 
Signaling. And we believe that these organized, tight mechanisms are widely applicable 
to all PDEs across all eukaryotic cells. With this background information, I have chosen 
focus on the following objectives for my graduate research. 
1. To monitor the conformations of PKA intermediates in the activation phase of 
cAMP Signaling. 
2. To understand the role of PDEs in signal termination in cAMP Signaling: To 
unravel the structural and functional mechanisms in RegA-RIα interactions using 
various biophysical and biochemical studies. 
3. To understand the basic mechanisms behind the activation of RegA by RIα and 
the novel role of RegA in PKA signal termination. 
4. To study the phosphorylation mediated activation and conformational changes in 
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ix. Amide Hydrogen Deuterium Exchange and Mass Spectrometry  
In the early 1990s, researchers have started exploring the application of 
electrospray ionization (Hoofnagle et al.) and matrix assisted laser desorption/ionization 
(MALDI) in the field of structural biology (Katta and Chait, 1991). The compatibility in 
using in-line high performance liquid chromatography (HPLC) column to separate 
peptides/proteins makes ESI-MS the first choice for many biological applications. 
Coupling amide HDX with ESI-MS analysis provides insights into macromolecular 
complexes mediated through protein–protein, protein-DNA and protein–ligand 
interactions. Hydrogens in O–H, N–H, and S–H of protein are labile to exchange with the 
OH- from solvent water molecules. The H atoms present in the side chains exchanges 
very fast and cannot be detected in the time course of exchange, whereas the H atoms 
present in the backbone amide group exchanges at a slower rate (milliseconds) and can be 









Figure v: Schematic representation of deuterium exchange and the mass spectrometry analysis 
for isolated protein (A) and in complex with other molecule (AB) are shown. Protein samples are 
incubated with D2O buffer for exchange reaction for various time points. Reactions are quenched 
at pH 2.5; the samples are then digested with pepsin and subjected to mass spectrometry analysis. 
The number of deuterons exchanged for the protein (A) are compared with complex (AB). 
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HDX reaction is carried out by exposing a protein to D2O, where the aqueous 
environment is replaced with deuterated environment. This leads to increase in the mass 
of protein by one atomic mass unit for every backbone amides undergoing exchange, 
which can be measured using mass spectrometry. Backbone amide that are accessible to 
the solvent, typically those found on the surface of the protein, can exchange more 
readily compared to those that are buried in the hydrophobic core or at the interface in 
protein-protein interactions having less access to solvent (Figure: v). The exchange also 
occurs during the short-lived transitions between the open and closed conformations of 
the protein. This mechanism further extends the application of this method to study 
protein dynamics and conformational changes during molecular interactions. Rate 
constants of opening and closing transitions are designated as kop and kcl, respectively. 
The overall exchange mechanism can now be described as follows, 
 
 
where, every N–H group may exhibit a unique combination of kop, kcl, and kch. Eqn (1) is 
typically discussed for two limiting regimes that are referred to as EX1 and EX2. In the 
former case kch ˃˃ kcl, where amide labeling occurs during the very first opening event 
such that  
kHDX = kop      (ii) 
In EX2 the rate limit is characterized by kcl >> kch, leading to the expression, 
kHDX = Kopkch      (iii) 








Where, Kop = (kop/kcl) is the equilibrium constant of the opening reaction. Under EX2 
conditions the probability of HDX occurring during a single opening event is small, and 
numerous opening/closing cycles may occur before a given amide undergoes isotope 
exchange. EX2 kinetics is more prevalent than EX1 exchange under physiological 
conditions (Konermann et al., 2011). 
In continuous labeling HDX experiments, deuterium labeling is carried out by 
diluting the protein sample in deuterated buffer, usually exchange reactions are carried 
out at pH 7.0 to 8.0.  As the exchange reaction is either acid or base catalyzed, it is 
mostly pH dependent. Once after the reactions are carried out for required time series, the 
reactions can be quenched by reducing the pH to 2.5 and at temperature 0°C (Figure vi). 
The rate of exchange is slowest under these conditions. In order to quantify region-
specific deuterium uptakes, deuterium-labeled protein can be digested with pepsin to 
generate peptic peptides. Pepsin is a non-specific protease active at acidic pH and can be 
effectively used. These peptides are then separated by HPLC, and a deuterium uptake of 







Figure vi: General procedure for HDXMS  
Protein 
Deuterium Labeled Protein 
D2O buffer 
Quench at pH 2.5 and 0°C 
Pepsin Digestion of Protein 
ESI-MS or MALDI-MS 
Time (Seconds to Hours)  
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For every amide hydrogen atom exchanged with deuterium, the mass of a peptide 
increases by one Dalton compared to the equivalent undeuterated sample. Deuterium 
uptake of peptide from a peptic digest protein sample is given by the following equation 
(Hoofnagle et al., 2003), 
   
     
         
          (iv) 
where, m = the mass of a deuterated peptide, m0% = the mass of a non-deuterated peptide, 
m100% = the mass of a fully deuterated peptide, and Nmax = the maximum possible number 
of deuterium incorporated in a given peptide. In order to account for back exchange 
during experimental analysis, a fully deuterated protein sample is made, digested with 























Cooperativity and allostery in cAMP-dependent activation of 
Protein Kinase A: Monitoring conformations of intermediates by 










cAMP binding to the CNBs of the R-subunits induces conformational changes, 
leading to dissociation of the C-subunit and activation of PKA (Johnson et al., 2001). Out 
of 4 isoforms of the C and R subunits, Cα and RIα are most widely distributed throughout 
all mammalian tissue and are the most important isoforms of PKA (Amieux and 
McKnight, 2002). PKA R-subunit is an extended molecule containing an N-terminal 
dimerization domain and pseudosubstrate region followed by CNB-A and CNB-B 
respectively (Figure: 1.1). The R-subunit lacking the N-terminal dimerization domain, 
RIα(92-379), retains high affinity binding to the C-subunit and provides a minimal 
monomeric model for examining R-C interactions as well as cAMP binding to CNB-A 
and CNB-B (Figure:1.1 A) (Kim et al., 2007; Su et al., 1995). A specific conserved set of 
residues critical for binding to cAMP is referred to as the phosphate binding cassette 
(PBC) (PBC:A and PBC:B for CNB-A and CNB-B respectively) (Berman et al., 2005).  
In contrast, PKA C-subunit is a globular protein with a bilobal structure characteristic of 
all kinases, where the small N-terminal lobe and larger C-terminal lobe enclose a cleft 
which binds ATP and provides binding sites for substrates or inhibitors (Zheng et al., 
1993).  
Structures of cAMP-bound conformations of the CNB domain, denoted the „B-
conformation‟, reveal a highly conserved architecture with two subdomains: a β-
subdomain with an eight-stranded β-sheet, containing the solvent-shielded pocket for 
binding cAMP and a non-contiguous α-subdomain.  The structure of a PKA holoenzyme 
complex (Kim et al., 2007; Kim et al., 2005) revealed a large conformational change in 
the R-subunit which is denoted as the „H-conformation‟ (Figure: 1.1 B). The PBC region 
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within the β:subdomain reveals a conserved hydrogen bonding network, connecting 
residues that are critical for specific binding to cAMP (Berman et al., 2005). The key 
residues include single conserved arginines in both domains, Arg 209 and Arg 333, 
which are important for anchoring the phosphate moiety of cAMP (Figure: 1.1 C). cAMP 
binding to CNB-Α and anchoring of the cyclic AMP phosphate with Arg 209 is critical 
for the activation of C- subunit as it has been shown that the R209K mutation abolishes 
the tight binding of cAMP at CNB-A (Herberg et al., 1996) and blocks activation of 
PKA.  
It has been known that cAMP binds to the PKA holoenzyme in a positive 
cooperative manner wherein a first molecule of cAMP binds first to the CNB-B domain 
followed by binding to CNB-A, leading to holoenzyme dissociation and activation 
(Herberg et al., 1996; Ogreid and Doskeland, 1983). Although numerous crystal 
structures of free individual R subunits and in complex with the C-subunit have been 
solved providing high-resolution insights into the end-point conformations of PKA, the 
molecular basis for cooperativity and allosteric coupling of the two cAMP binding events 
is not clear as it requires structural characterization of an intermediate state with the 
CNB-B domain alone bound to a single molecule of cAMP (Figure: 1.2). NMR studies 
on the wild-type and single point mutants of RIα (119-379) have revealed the 
connectivity between CNB-A and CNB-B domains (McNicholl et al.) but they still do not 
describe the conformation of an intermediate in the cAMP-mediated activation pathway, 
namely of the holoenzyme state bound to a single cAMP molecule at CNB-B. Amide 
HDXMS is a powerful tool to study protein-protein interactions and monitor 
conformational dynamics of proteins (Hoofnagle et al., 2003). We have used this 
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technique to characterize an important intermediate in the cAMP activation pathway of 
PKA by monitoring the effects of cAMP binding to the point mutant RIα(92-379) 
R209K.   The X-ray crystal structure of holoenzyme (PDB ID: 2QCS) has revealed four 
sites on the R-subunit that interact with the C-subunit in the holoenzyme complex (Kim 
et al., 2007), one site contributed by the pseudosubstrate site, two contributed by CNB-A 
and one by CNB-B. Our amide exchange results reveal that binding of one molecule of 
cAMP increases deuterium exchange within the CNB-B domain. Increased exchange was 
also seen at the interface between CNB-B and the C-subunit suggesting weakening of the 
R-C interface without dissociation. Importantly, binding of the first molecule of cAMP 
greatly increases the conformational mobility/dynamics of two key regions coupling the 
two CNBs, the αC/C‟ of CNB-Α domain (αC/C‟:Α) and αA helices of the CNB-B 
domain (αA:B). We believe that the enhanced dynamics of these regions forms the basis 
for the positive cooperativity in the cAMP-dependent activation of PKA. In summary, 
our results reveal the close allosteric coupling between CNB-A and CNB-B and the C-



















































Figure 1.1: (Α): Domain organization of RIα showing an N-terminal dimerization/docking 
domain (D/D) (gray hashed box) connected by a linker to two tandem cAMP-binding domains, 
CNB-A and CNB-B in green. The linker contains a PKA pseudosubstrate which is essential for 
facilitating interactions of RIα with the C-subunit in red. (B): Mechanism of type I PKA 
regulation. In PKA holoenzyme, the C- subunit (gray) is kept inactivated when bound to the R- 
subunit (green) (structure of the RIα(92-379):C holoenzyme complex (PDB ID: 2QCS)), (Kim 
et al., 2007). ATP and the pseudosubstrate region occupy the active site cleft formed by the two 
lobes of the C-subunit. Binding of 2 molecules of cAMP to CNB-A and CNB-B of the 
holoenzyme induces conformational changes leading to dissociation of the C-subunit and its 
activation. The R-subunit thus adopts distinct conformations, bound to C-subunit (green, H-
conformation) (Kim et al., 2007) and bound to cAMP (brown, B-conformation) (PDB ID: 
1RGS) (Su et al., 1995). (C): Close-up views of the Phosphate binding cassettes (PBC) (brown) 
from both CNB-A and CNB-B. In PBC:A, the critical conserved residues Arg 209 and Glu 200 
and in PBC:B, Arg 333 and Glu 324 anchor the cyclic phosphate and 2‟OH moieties of cAMP 
















1. 2 Materials and Methods 
1.2.1. Reagents 
BL21 (DE3) E.coli strains were from Novagen (Madison, WI). TALON metal affinity 
resin was from Clontech Laboratories (Mountain view, CA). 8-AminoEthylAmino 
(AEA)-cAMP was from Biolog Life Science Institute (Bremen, Germany). ATP and 
cAMP were obtained from Sigma-Aldrich Corp. (Singapore). Poroszyme immobilized 
Figure 1.2: Cartoon showing step-wise cAMP-mediated activation of PKA (R-subunit in red, C-
subunit in blue, *- represents a molecule of cAMP, X- represents mutation that abolishes high-
affinity binding of cAMP). Activation of type I PKA is cooperative and sequential with cAMP 
binding first to CNB-B and then to CNB-A. Mutation of Arg 209 to a Lys in CNB-Α of R- 
subunit abolishes high-affinity cAMP binding to the CNB-Α without significantly affecting 
binding of cAMP to CNB-B. The holoenzyme, RIα(92-379)R209K:C provides an ideal model 
system to probe the effects of a single cAMP binding to CNB-B and studying effects of a single 




pepsin cartridge was from Applied Biosystems (Foster city, CA). Deuterium oxide 
(99.9%  deuterium) was obtained from Sigma-Aldrich Corp. (Singapore). 
Trifluoroacetic acid (TFA) and acetonitrile were from Fisher Scientific (Singapore). 
All other chemicals were at least reagent grade. 
1.2.2. Purification of RIα(92- 379)(R209K) and C-  subunit 
cAMP affinity chromatography resin for R-subunit purification was synthesized by 
coupling 8-AEA-cAMP to the NHS-activated sepharose 4 Fast Flow
®
  beads as 
recommended (GE Healthcare, Singapore). cAMP-free RIα(92-379)R209K was 
expressed and purified as described previously (Anand et al., 2007; Herberg et al., 1996). 
Hexahistidine tagged C-subunit of PKA was expressed and purified as described 
previously (Herberg et al., 1993). The holoenzyme, RIα(92-379)R209K:C was purified 
by size exclusion-gel filtration chromatography on an AKTA system (GE Life Sciences) 
as described earlier (Herberg et al., 1996) by using the buffer 50 mM MOPS, pH 7.0, 50 
mM NaCl, 2 mM MgCl2, 0.2 mM ATP and 5 mM BME. 
1.2.3. Amide HDXMS 
The size exclusion chromatography purified cAMP-free RIα(92-379)R209K:C 
holoenzyme complex was concentrated to 50 μM using vivaspin concentrators (Sartorius 
Stedim Biotech GmbH, Goettingen, Germany). 2 μL of the samples in storage buffer (20 
mM Tris.HCl, pH 7.5, 50 mM NaCl, 10 mM MgCl2, 5 mM BME) were diluted and 
incubated with 18 μL of D2O (99.90%) resulting in a final deuterium concentration of 
90% in buffer A (20 mM MOPS, pHread 7.0, 50 mM NaCl, 2 mM MgCl2, 0.2 mM ATP, 5 
mM BME). Amide exchange was carried out at 20ºC for various time points (0.5, 1, 2, 5 
and 10min). In order to test the effects of cAMP binding to CNB-B of RIα of the 
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holoenzyme, we incubated the 50 μM protein complex with a final concentration of 70 
μM cAMP. Given a Kd of the CNB-B domain in the holoenzyme complex for cAMP (Kd 
~ 0.8 μM for CNB-B domain) (Herberg et al., 1996), we predicted that the CNB-B 
domain site of the protein complex would be completely saturated with cAMP allowing 
for characterization of a single cAMP-bound holoenzyme intermediate. Deuterium 
exchange reactions were carried out for both holoenzyme samples in the presence and 
absence of cAMP and cAMP-bound RIα(92-379)R209K as described previously (Anand 
et al., 2010). The exchange reaction was quenched by addition of 40 μL of pre-chilled 
0.1% TFA to get a final pHread of 2.5. 50uL of the quenched sample (~ 100 pmol protein 
sample) was then injected on to a chilled nano-UPLC sample manager (beta test version, 
Waters, Milford, MA) as previously described (Wales et al., 2008). The sample was run 
through a 2.1 x 30mm immobilized pepsin column (Porozyme, ABI, Foster City, CA) 
using 100uL/min 0.05% formic acid in water.  The digested peptides were trapped on a 
2.1 x 5 mm C18 trap (ACQUITY BEH C18 VanGuard Pre-column, 1.7 μm, Waters, 
Milford, MA) and eluted using an 8-40% gradient of acetonitrile in 0.1% formic acid at 
40uL/min, supplied by a nanoACQUITY Binary Solvent Manager (Waters, Milford, 
MA), on to a reverse phase column (ACQUITY UPLC BEH C18 Column, 1.0 x 100 mm, 
1.7 μm, Waters, Milford, MA) for resolution. Peptides were detected and mass measured 
on a SYNAPT HDMS mass spectrometer (Waters, Manchester, UK) acquiring in MS
E
 
mode (Bateman et al., 2002; Silva et al., 2005). 
 Peptides were identified from MS
E
 data in the un-deuterated samples using 
ProteinLynx Global Server 2.4 (beta test version) (Waters, Milford, MA) (Geromanos et 
al., 2009; Li et al., 2009). Identifications were only considered if they appeared at least 
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twice out of three replicate runs.  These identifications were mapped on to subsequent 
deuteration experiments using prototype custom software (HDX browser, Waters, 
Milford, MA).  Data on each individual peptide at all time points were extracted using 
this software, and exported to HX-Express (Weis et al., 2006) for analysis. 
 Continuous instrument calibration was carried out with Glu-Fibrinogen peptide 
(GFP) at 100fmol/μL. We also visually analyzed the data to ensure only well-resolved 
peptide isotopic envelopes were subjected to quantitative analysis. A control experiment 
was carried out to calculate the deuterium back exchange loss during the experiment as 
described previously (Anand et al., 2010). Briefly, this was carried out by incubating 
ligand-free RIα(91-244) with deuterated buffer A for 24 h at room temperature (20ºC). 
Even after extended deuteration, RIα(91-244) still showed some ordered regions that 
were not completely deuterated. For an accurate measurement of back exchange loss, we 
therefore focused only on peptides from within highly solvent exchangeable regions of 
the protein, identified as those regions that show greater relative exchange at shorter time 
points (10 min exchange). The region in RIα(91-244) spanning residues 111-130 is a 
highly solvent exchangeable region  and all 3 overlapping peptides used for calculations 
of back exchange span this region and showed nearly maximal exchange in ligand-free 
RIα(91-244) following 10 min deuterium exchange and would thus represent fully 
deuterated samples following 24 h exchange. An average deuteration back exchange of 
~33% was calculated from average back exchange values for 3 peptides: RIα(111-123) 
(m/z = 547.65) (back exchange - 34.4%), RIα(111-126) (m/z = 632.701) (back exchange 
= 30.4%) and RIα(111-119) (m/z = 595.34) (back exchange = 33.7%). All deuterium 
exchange values reported were corrected for a 33% back exchange by multiplying the 
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raw centroid values by a multiplication factor of 1.49 (Anand et al., 2010). The analyzed 
data were then mapped on to the crystal structures of PKA holoenzyme (PDB ID: 2QCS) 
(Kim et al., 2007) and that of cAMP-bound RIα(92-379) (PDB ID: 1RGS) (Su et al., 
1995).  
1. 3 Results and Discussion 
To monitor the step-wise cooperative activation of type I PKA by cAMP, we used amide 
HDX measured by ESI-QTOF mass spectrometry. The RIα(92-379)R209K:C 
holoenzyme was used as a model to monitor the effects of binding of a single cAMP 
molecule to the CNB-B domain, thereby enabling probing conformation of a key 
intermediate in the activation pathway. Furthermore, this also enabled us to unravel the 
role of CNB-B domain in mediating the cooperative activation of PKA. We first set out 
to measure amide HDX of the RIα(92-379) R209K:C holoenzyme both in the presence 
and the absence of cAMP as well as cAMP-bound RIα(92-379)R209K. Mutation of Arg 
209 to a lysine within the PBC:A of RIα abolishes high-affinity binding of cAMP to 
CNB-A site, without significantly altering cAMP binding to CNB-B (Herberg et al., 
1996).  
1.3.1. Pepsin digestion of RIα(92-379)R209K and C- subunit 
Α total of 29 pepsin digest fragments for RIα(92-379)R209K and 24 fragments for the C-
subunit were detected and analyzed in the study. These covered 90% and 88% of their 
respective primary sequences (Figure: 1.3 A and B). The maximum deuterons exchanged 
after 10 min are summarized in Tables 1.1 and 1.2. The data are reported as the average 
number of deuterons incorporated after ten minutes of deuterium exchange from two 
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envelopes for a subset of 6 peptides ( m/z = 762.44, z = 1, RIα (198-204); m/z = 523.81, z 
= 2, RIα (230-238); m/z = 643.84, z = 2, RIα (239-247); m/z = 872.48, z =3, RIα (248-
270); m/z = 873.91, z =2, RIα (275-290); m/z = 649.36, z =1, RIα (322-327)) from 
RIα(92-379)R209K under various conditions are shown in Figure: 1.4 These peptides 
from RIα(92-379)R209K in holoenzyme showed the largest changes in amide exchange 
between the presence and absence of cAMP following deuteration. The time course of 
deuteration for these 6 peptides and are shown in Figure: 1.5. The data presentation either 












Figure 1.3: Amino acid sequence of RIα(92-379)R209K (Α) and C(1-350) (B) showing 
secondary structure elements with boundaries. Solid lines with arrow at two ends indicate the 
pepsin digest fragments analyzed in the study with total sequence coverage of 90% and 88% 





















Figure 1.4: ESI-QTOF mass spectra of pepsin digest fragments from different regions of 
RIα(92-379)R209K in RIα(92-379)R209K:C holoenzyme that showed the largest changes in 
amide HDX. (i) The isotopic envelope for the peptides from cAMP bound RIα(92-379)R209K 
subunit after 10 min deuteration (ii) The isotopic envelope for the peptides from cAMP bound 
RIα(92-379)R209K:C holoenzyme after 10 min deuteration; (iii) The isotopic envelope for the 
peptides from cAMP free RIα(92-379)R209K:C holoenzyme after 10 min deuteration and (iv) 






Table 1 .1 : Effect of cAMP binding on the R-subunit peptides from RIα(92-379)R209K:C holoenzyme and RIα(92-379)R209K 
measured by amide HDX. 
    Maximum  Maximum Deuterons 
R- subunit pepsin digest fragments Charge  Exchangeable Exchanged after 10 min 
(Sequence) (m/z) (Z) Amides RIα(92-379) RIα(92-379) RIα(92-379) 
      R209K:C R209K:C + cAMP R209K + cAMP 
EVYTEE (101-106) (769.33) 1 5 3.0 ± 0.06 3.3 ± 0.00 4.0 ± 0.05 
YVRKVIPKDYKTMAA (111-125) (446.50) 4 13 10.5 ± 0.21 10.7 ± 0.10 12.1 ± 0.05 
YVRKVIPKDYKTMAALAKAIEKNVL (111-135) (573.34) 5 23 14.6 ± 0.28 15.9 ± 0.60 17.0 ± 0.07 
FSHLDDNERSDIF (136-149) (797.86) 2 12 1.7 ± 0.02 1.7 ± 0.01 3.7 ± 0.04 
IAGETVIQQGDEGDNF (157-172) (846.89) 2 15 6.7 ± 0.08 6.4 ± 0.10 6.7 ± 0.19 
YVIDQGEMDV (173-182) (1168.52) 1 9 1.3 ± 0.01 1.3 ± 0.00 1.8 ± 0.03 
DVYVNNE (181-187) (852.37) 1 6 3.1 ± 0.07 3.0 ± 0.10 2.6 ± 0.01 
WATSVGEGGSF (188-198) (1097.49) 1 10 5.0 ± 0.00 5.5 ± 0.10 6.8 ± 0.12 
FGELALI (198-204) (762.44) 1 6 2.5 ± 0.05 1.2 ± 0.10 0.1 ± 0.02 
ALIYGTPKAAT (202-212) (553.32) 2 9 5.7 ± 0.07 6.3 ± 0.00 7.9 ± 0.08 
ALIYGTPKAATVKAKT (202-217) (545.00) 3 14 6.1 ± 0.01 7.6 ± 0.30 9.1 ± 0.47 
VKAKTNVKL (213-221) (500.83) 2 8 1.7 ± 0.04 1.5 ± 0.10 1.8 ± 0.03 
WGIDRDSY (222-229) (506.23) 2 6 0.9 ± 0.00 0.8 ± 0.00 1.3 ± 0.02 





RKRKMYEEF (239-247) (643.84) 2 8 2.2 ± 0.02 4.1 ± 0.00 4.6 ± 0.05 
LSKVSIL (248-254) (759.50) 1 6 2.5 ± 0.02 3.1 ± 0.10 3.1 ± 0.02 
LSKVSILESLDKWERLTVADALE (248-270) (872.48) 3 22 8.6 ± 0.18 16.1 ± 0.50 10.0 ± 0.06 
TVADALEPVQ (264-273) (521.77) 2 8 3.1 ± 0.02 3.6 ± 0.00 3.4 ± 0.01 
PVQFEDGQKIVVQGEPGDE (271-289) (1036.00) 2 16 6.3 ± 0.09 5.3 ± 0.10 5.4 ± 0.09 
EDGQKIVVQGEPGDEF (275-290) (873.91) 2 14 4.2 ± 0.03 3.0 ± 0.20 3.0 ± 0.05  
IILEGSAAVL (292-301) (493.30) 2 9 3.7 ± 0.13 3.7 ± 0.10 4.5 ± 0.01 
QRRSENEEF (302-310) (597.78) 2 8 4.0 ± 0.02 4.0 ± 0.00 4.6 ± 0.06 
VEVGRLGPSDYFGE (311-324) (762.87) 2 12 3.7 ± 0.06 3.1 ± 0.00 1.8 ± 0.03 
FGEIAL (322-327) (649.36) 1 5 2.1 ± 0.03 1.1 ± 0.10 0.2 ± 0.11 
LMNRPRAAT (328-336) (515.28) 2 7 3.9 ± 0.02 2.9 ± 0.10 1.6 ± 0.05 
VARGPLKC (338-345) (422.25) 2 5 0.7 ± 0.02 0.6 ± 0.00 0.4 ± 0.13 
VKLDRPRF (346-353) (515.81) 2 6 0.7 ± 0.00 1.0 ± 0.10 1.3 ± 0.03 
ERVLGPCSD (354-362) (975.45) 1 7 2.3 ± 0.03 3.1 ± 0.00 3.2 ± 0.04 
ILKRNIQQYNSF (363-374) (762.42) 2 11 9.0 ± 0.09 8.5 ± 0.00 6.8 ± 0.03 
         
Values reported are the mean and standard error calculated from two independent experiments. All deuterium exchange 







Table 1 .2 : Effect of cAMP binding on the C-subunit peptides from RIα(92-379)R209K:C holoenzyme measured by amide 
HDX. 
    Maximum  Maximum Deuterons 
C- subunit pepsin digest fragments Charge  Exchangeable Exchanged after 10 min 
(Sequence) (m/z) (Z) Amides RIα(92-379) RIα(92-379) 
      R209K:C R209K:C + cAMP 
FLAKAKED (18-25) (461.25) 2 7 4.5 ± 0.48 4.7 ± 0.04 
LKKWETPSQNTAQL (27-40) (822.44) 2 12 8.1 ± 0.07 7.8 ± 0.06 
TPSQNTAQLDQFDRIKTLGTG-     
SFGRVMLVKHKESGNHYAMK (32-72) (919.08) 5 39 12.7 ± 0.14 13.2 ± 0.10 
IEHTLNE (85-91) (428.22) 2 6 0.2 ± 0.04 0.4 ± 0.01 
KRILQAVNFPFL (92-103) (723.44) 2 10 2.2 ± 0.00 2.0 ± 0.00 
VKLEFSFKDNSNL (104-116) (770.91) 2 12 2.5 ± 0.01 2.2 ± 0.05 
VMEYVAGGEMFSH (119-131) (728.84) 2 12 0.3 ± 0.02 0.4 ± 0.09 
EMFSHLRRIGR (127-137) (701.38) 2 10 6.4 ± 0.29 6.3 ± 0.21 
RRIGRFSEPHARF (133-145) (427.97) 4 11 1.4 ± 0.00 1.3 ± 0.02 
IVLTF (150-154) (592.37) 1 4 0.1 ± 0.05 0.1 ± 0.06 
FEYLHSLDLI (154-163) (625.33) 2 9 0.2 ± 0.01 0.3 ± 0.01 
IYRDLKPENLL (163-173) (687.40) 2 9 0.5 ± 0.00 0.6 ± 0.01 





YIQVTDFGF (179-187) (942.46) 1 8 0.3 ± 0.00 0.3 ± 0.00 
AKRVKGRTWTLCGTPEYLAPEIIL (188-211) (932.50) 3 21 3.0 ± 0.05 3.5 ± 0.02 
SKGYNKAVDWWALGVL (212-227) (903.98) 2 15 1.9 ± 0.01 1.9 ± 0.04 
IYEMAAGYPPFFADQPIQ (228-245) (1029.49) 2 14 6.1 ± 0.08 6.2 ± 0.09 
YEKIVSGKVRFPSHFSSDLKDLLRNLL (247-273) (633.16) 5 25 4.5 ± 0.02 4.5 ± 0.00 
QVDLTKRFGNLKNGVNDIKNHKW (274-296) (681.88) 4 22 7.5 ± 0.07 8.5 ± 0.20 
FATTDW (297-302) (740.33) 1 5 3.4 ± 0.05 2.9 ± 0.02 
IAIYQRKVEAPFIPKFKGPGDTSN (303-326) (669.87) 4 20 10.0 ± 0.16 9.5 ± 0.03 
FDDYEE (327-332) (817.29) 1 4 2.6 ± 0.01 2.5 ± 0.05 
DDYEEE (328-333) (799.27) 1 5 3.4 ± 0.09 3.0 ± 0.02 
IRVSINEKCGKE (335-346) (485.91) 3 11 7.1 ± 0.13 6.9 ± 0.02 
Values reported are the mean and standard error calculated from two independent experiments. All deuterium exchange 








1.3.2. Evidence that cAMP binding to RIα(92-379)R209K:C holoenzyme does not lead to 
dissociation of the complex  
Binding of cAMP to the RIα(92-379)R209K:C holoenzyme complex under our 
deuterium exchange reaction conditions did not lead to dissociation of the holoenzyme. 
This was confirmed by comparing the deuterium exchange of our results with earlier 
studies on free RIα and holoenzyme complexes (Hamuro et al., 2004). In the 
holoenzyme, the N-terminal pseudosubstrate regions were completely shielded from 
solvent in contrast to the free, unbound state.  We observed the same effects in the N-
terminal pseudosubstrate region from our samples of the cAMP-bound RIα(92-
379)R209K:C holoenzyme. This is consistent with previous studies that showed cAMP 
binding to CNB-B in the RIα(92-379)R209K:C holoenzyme failed to dissociate the C and 
R-subunits (Herberg et al., 1996). 
1.3.3. cAMP binding to RIα(92-379) R209K:C holoenzyme decreases deuterium 
exchange in PBC:B  
The regions from R- subunit includes, (271-289), (275-290), (311-324), (322-327), (328-
336) and (363-374) within CNB-B, showed decreased exchange upon binding of cAMP. 
This is a direct result of binding interactions of these residues with cAMP. From the 
crystal structure of cAMP-bound RIα(113-379) (Su et al., 1995), it can be seen that the 
residues which form part of CNB-B include Arg 333, Glu 289, Tyr 371 and Glu 324. Arg 
333 in PBC:B hydrogen bonds directly with the equatorial exocyclic oxygen of the 
cAMP phosphate and also forms salt bridges with Glu 289. Further, Tyr 371 stacks 
against adenine ring of cAMP in the CNB-B and forms hydrogen bonds with Glu 324 to 
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stabilize cAMP binding to PBC:B. The decreased exchange observed in our experiments 
reflects binding of 1 molecule of cAMP to PBC:B (Figure: 1.4 and 1.5 - peptides, 
RIα(322-327) and RIα(275-290)). Comparison of the amide exchange in the cAMP-
bound RIα(92-379)R209K:C holoenzyme and cAMP-bound RIα(92-379)R209K showed 
some differences. While the exchange measured was similar in certain regions, the 
magnitude of amide exchange protection seen upon cAMP binding in the free R-subunit 
was significantly different from that in the cAMP-bound holoenzyme (Figure: 1.4 and 1.5 
– peptide RIα(322-327)). This presumably reflected the C-subunit- induced long-range 












Figure 1.5: Time course of deuterium exchange for peptides from RIα(92-379)R209K. Open 
circle (○), RIα(92-379)R209K:C in the absence of cAMP; Close circle (●), RIα(92-
379)R209K:C in the presence of cAMP. The solid lines denote the best fit of the data to a one-









1.3.4. cAMP binding to CNB-B increases deuterium exchange at interface between CNB-
B and C-subunit 
Even though the C-subunit does not dissociate upon binding of 1 cAMP molecule to 
RIα(92-379) R209K:C holoenzyme complex, the R-C interface shows increased 
deuterium exchange at peptide fragment C(274-296). In the C-subunit, this region 
corresponds to αH-αI region (site 4 of R-C interface contacts) which contacts the αB:B-
αC:B helix (residues 354-362) (Kim et al., 2007). Interestingly, the above region from the 
C-subunit and CNB-B of the R-subunit showed increased exchange (Tables 1.1, 1.2, 
Figure: 1.6) suggesting detachment of CNB-B from the C-subunit. These results reflect 
cAMP-induced conformational changes within the CNB-B domain leading to partial 










Figure 1.6:  cAMP binding to the CNB-B domain shows increased exchange at the CNB-B:C-
subunit interface, amide HDX data mapped onto the crystal structure of holoenzyme, RIα(92-
379)R333K:C (the only available type I holoenzyme structure with both CNB-Α and CNB-B 
domains , PDB ID: 2QCS) (Kim et al., 2007). The R- subunit and the C- subunit are shown in 
green and gray respectively. Regions showing increased exchange upon binding cAMP are in 
red and suggest disruption of the specific intersubunit contacts mediated by the CNB-B domain 
with the C-subunit (yellow arrow), (site 4 of R-C intersubunit interactions, (Kim et al., 2007)). 
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1.3.5. Effects of cAMP binding to RIα(92-379)R209K:C holoenzyme: Changes in PBC:A 
of RIα  
Upon binding of cAMP, 1 region in PBC:A spanning residues 198-204 (Figure: 1.4 and 
1.5 - peptide RIα(198-204)) showed decreased exchange while another region, RIα(202-
212) and RIα(202-217) showed increased exchange upon cAMP binding to PBC:B. We 
believe there are two possible explanations for this observation. 1) This indicates that 
cAMP binding to the CNB-B induces long-range conformational changes within PBC:A 
and the altered amide exchange is reflective of that. 2) An alternative intriguing 
explanation could be that a second molecule of cAMP interacts with Glu 200 via the 
2‟OH moiety leading to protection at the RIα (198-204) peptide. A similar effect seen in 
peptide RIα (322-327) can be attributed to cAMP binding to PBC:B. In contrast, 
increased exchange around residues RIα (202-217) is likely due to lack of the anchoring 
Arg 209 residue. This alternative explanation would suggest that a second molecule of 
cAMP is capable of partially binding with CNB-A through the ribose 2‟OH group, but is 
unable to stably occupy the site as it lacks the critical Arg 209 anchoring residue. As 
mentioned earlier, cAMP interacting with the Arg 209 residue is highly important for the 
dissociation and activation of PKA. 
 Comparison of cAMP-bound RIα(92-379)R209K:C holoenzyme and cAMP-
bound RIα(92-379)R209K subunit (Table 1.1) showed higher exchange in cAMP-bound 
RIα(92-379)R209K subunit within the PBC:A also reflecting the long-range allosteric 
and direct binding effects of C-subunit on the dynamics of CNB-A (Anand et al., 2002; 
Hamuro et al., 2004). 
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1.3.6. Global conformational changes in RIα 
In the process of activation of holoenzyme, cAMP binds to CNB-B first followed by 
CNB-A leading to dissociation of the C-subunit (Herberg et al., 1996). Addition of cAMP 
to the RIα (92-379)R209K:C showed extensive changes in amide exchange throughout 
the molecule, beyond the cAMP binding sites in the two domains. These are summarized 
below: 
1.3.6.1. Pseudosubstrate region: The N-terminal pseudosubstrate region fragments, (101-
106), (111-125) and αA:Α region fragment, (136-149) in RIα(92-379)R209K:C 
holoenzyme  showed lower deuterium exchange when compared to the cAMP bound 
RIα(92-379)R209K.  And these regions in holoenzyme did not show any difference in 
deuterium exchange upon cAMP binding to the CNB-B. This reflects maintenance of 
integrity of the holoenzyme in the absence of a second molecule of cAMP stably binding 
CNB-A.  
1.3.6.2. αB/C:Α, αC’:A  and αA:B helix: The αB/C:Α and αC‟:A helices connect CNB-A 
and B of R-subunit and undergoes a huge conformational change between the C- subunit 
bound H-form and the cAMP bound B-form (Kim et al., 2007). The fragments, (230-
238), (239-247) and (248-254) which cover αB/C:A and αC‟:A helices show greatly 
increased amide exchange in the holoenzyme complex bound to a single molecule of 
cAMP at CNB-B (Figure: 1.4 and 1.5 - peptides, RIα(230-238), RIα(239-247)). We 
believe that this increased exchange that is seen only in the single cAMP-bound 
intermediate is reflective of greater conformational mobility (Popovych et al., 2006). The 






















RIα(248-270)) upon addition of 1 molecule of cAMP and spans helices αC:Α, αC‟:Α and 
αA:B (Figure: 1.7). Interestingly, αA:B helix forms the bridge that communicates binding 
of cAMP to CNB-B to CNB-A. The positioning of this helix is greatly shifted in 
structures of the cAMP-bound and C-subunit-bound states (Figure: 1.8 A and B). Several 
key residues including Trp 260, a hydrophobic capping residue for cAMP bound to PBC-
A, are part of αA:B (Berman et al., 2005; Kim et al., 2007). It is to be noted that 6 amides 
out of a total of 10 exchangeable amides spanning this helix are completely exchanged 












Figure 1.7: Increased exchange upon binding of a single molecule of cAMP to RIα(92-379) 
R209K:C holoenzyme, within residues 230-270 (spanning α:B/C and α:A of CNB-B) region of 
the R-subunit reflects increased dynamics and is shown  in red. This region reflects the large 
conformational changes between the H (green) and B (gray) -conformations shown by 
superposition of PBC:A of cAMP-bound RIα (113-379) (PDB ID: 1RGS) and PBC:A of C-
subunit-bound RIα (92-379) (PDB ID: 2QCS). The yellow arrow shows alternate positioning of 
α:B/C helix between the H and the B forms.  Regions spanning PBC:B show decreased 
exchange upon binding of cAMP (blue). The inset figure shows residues that are critical for 
cAMP binding to PBC:B. 
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Interestingly, the cAMP-bound R-subunit showed lower exchange in this region 
comparable to C-subunit-bound holoenzyme complex. This suggests that binding of a 
single cAMP molecule at CNB-B domain shows increased protein mobilities at this 
region. This contributes to a large difference in conformational entropy as seen in cAMP-
bound intermediates in Catabolite Activator Protein (CAP) (Popovych et al., 2006). In 
such a model, the end-point B and H-conformations show reduced conformational 
dynamics compared to the single cAMP-bound intermediate, clearly highlighting the high 
conformational entropic penalty that accompanies binding of the second molecule of 
cAMP to CNB-A of wild-type RIα (Hamuro et al., 2004). The increased dynamics in this 
region reflected by the high amide exchange seen in this segment of the single cAMP-
bound intermediate clearly defines the basis for the contribution of the CNB-B domain to 
cooperativity in the cAMP-dependent activation of PKA. Higher exchange at this region 
is also consistent with loss of a salt bridge between Glu 261- Arg 366 of RIα - subunit in 




















































Our study has highlighted a powerful application of amide HDXMS in characterizing 
transient intermediates in the activation cycles of large protein complexes not easily 
amenable by other structural biology tools such as NMR and X-ray crystallography. Our 
results on the cAMP-dependent activation of type I PKA clearly demonstrate the 
important role of the CNB-B domain in mediating the cooperative and allosteric cAMP-
dependent activation of PKA. By using a point mutant that abolishes high affinity binding 
of cAMP to the CNB-A site, we demonstrate the conformational properties of an 
Figure 1.8: Importance of CNB-B α:A in mediating allosteric cooperativity in the cAMP-
activation of PKA. Crystal structure of RIα(92-379) in C-subunit bound, H-conformation (A) 
(PDB ID: 2QCS) is compared with the crystal structure of RIα(113-379) in cAMP bound 
conformation, B-form (B) (PDB ID: 1RGS). Regions showing salt bridges between Q370-E255, 
E261-R366, R241-D267 and E143-K240 are critical when the R- subunit is in the H-
conformation. Binding of a single molecule of cAMP to CNB-B leads to disruption of these 
critical salt bridges and increases the mobilities of α:A and α B/C helices facilitating binding of 
a second molecule of cAMP at CNB-A and leading to activation of PKA. 
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intermediate containing a single cAMP. Binding of cAMP to CNB-B increases amide 
exchange at one of the four sites of R-C intersubunit interactions, suggesting that 
conformational changes associated with cAMP binding at the CNB-B domain partially 
disrupt intersubunit interactions without leading to dissociation of the C-subunit. Another 
important result is the increased exchange seen upon cAMP binding at two key regions, 
the αC/C‟:A helix and the αA:B  helix. Both these regions are critical in relaying the 
effects of cAMP-binding to CNB-B to CNB-A. The increased exchange in these two 
regions exclusively in the cAMP-bound to the RIα(92-379)R209K:C holoenzyme but not 
cAMP-bound to RIα(92-379)R209K specifically highlights the role of CNB-B domain in 
facilitating the cooperative cAMP-dependent activation of PKA by potentially enhancing 
affinity of binding of a second molecule of cAMP to CNB-A domain. Our results provide 
unique insights into the role of CNB-B domain and its communication with CNB-A 
domain to allow a coordinated and cooperative regulation of PKA where the two domains 
function as closely coupled rather than individual isolated domains.   
 Our results highlight the unique capabilities of amide HDXMS in structural 
biology in understanding regulatory cycles of enzyme complexes. It is uniquely poised to 
probe conformational dynamics of transient reaction intermediates and presents a 



















Phosphodiesterases Catalyze Hydrolysis of cAMP-bound to 












In eukaryotes, the main intracellular target for cAMP is PKA (Beebe, 1986; 
Johnson et al., 2001; Shabb, 2001). Binding of cAMP to the R-subunit of the holoenzyme 
induces conformational changes leading to its dissociation and unleashes the active C-
subunit. The synthesis and degradation of cAMP are catalyzed by two classes of 
enzymes, adenylyl cyclases which facilitate cAMP synthesis from ATP upon hormonal 
stimulation of G-protein-coupled receptors (Kamenetsky et al., 2006) and PDEs which 
catalyze the conversion of cAMP to 5‟AMP and mediate signal termination (Conti and 
Beavo, 2007) (Figure: 2.1).  The superfamily of PDEs comprises 5 cAMP-specific PDE 
families and numerous isoforms which are directly involved in maintaining the duration 
and intensity of the cAMP response (Conti and Beavo, 2007). While extensive 
biochemical studies and structural biology of PDEs and PKA have elucidated the 
molecular basis for PDE enzymology as well as cAMP-dependent activation of PKA, 
little is known about how reassociation of the cAMP-bound R and C-subunits occurs in 
the cell and how PDEs cross regulate PKA to accelerate signal termination in cAMP 











Figure 2.1: Overview of cAMP signaling and regulation of PKA. Adenylyl cyclases catalyze 
synthesis of cAMP from ATP while phosphodiesterases (PDEs) catalyze hydrolysis of cAMP to 5‟ 
AMP. cAMP activates PKA by mediating dissociation of the PKA holoenzyme to release R and C-
subunits via a largely well-understood mechanism. Little is known, on how cAMP-bound R-
subunits reassociate with C-subunit to generate inactive PKA, and the potential role of PDEs in 




An additional level of complexity arises from the enormous diversity in isoforms 
of PKA and PDEs in eukaryotes. Four nonredundant R-subunit isoforms (RIα, RIβ, RIIα 
and RIIβ) and three C-subunit isoforms (Cα, Cβ and Cγ) are found in eukaryotic cells. 
All the R-subunit isoforms show a common domain organization consisting of an N-
terminal dimerization/docking domain and two C-terminal cAMP-binding domains 
(CNB:A, CNB:B) (Johnson et al., 2001). Despite a conserved domain architecture, all of 
these isoforms show enormous differences in subcellular localization, tissue specificity 
and function (McKnight, 1991). Of these, RIα and Cα are the two isoforms that are 
distributed across all cell-types (Amieux et al., 1997; Amieux and McKnight, 2002). 
Furthermore, gene knockout studies have shown obligatory requirement for both RIα and 
Cα for normal growth and development of all cells (Amieux and McKnight, 2002). The 
superfamily of PDEs also shows wide differences in catalytic activity, tissue specificity 
and subcellular localization (Conti and Beavo, 2007). It is evident that the subcellular 
localization of specific PDE and PKA families/isoforms must govern the duration and 
intensity of the cAMP signaling response across various subcellular compartments. 
The discovery of A-kinase anchoring proteins (AKAPs) (Wong and Scott, 2004), 
a class of anchoring proteins that tether the PKA R-subunits to different classes of 
signaling and target proteins, further underscore the importance of compartmentalization 
in cAMP signaling. AKAPs interact with the N-terminal dimerization domains of the R-
subunits and function to bring elements of the cAMP signaling pathway in close 
proximity and to enable targeting to specific organelles. mAKAP (AKAP 450) is one 
AKAP that has been shown to bind both the RII isoform of the PKA R-subunit and 
PDE4D3 (Baillie et al., 2005; Dodge et al., 2001) where the proximity of PDEs with 
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PKA would generate a single functional unit with tight regulation of cAMP signaling. It 
must be noted that nearly all the AKAPs discovered thus far preferentially interact with 
the RII isoforms of the R-subunit (Gold et al., 2006). Even the dual-specificity AKAPs 
(D-AKAPs) bind the RII isoform with a higher affinity than the RI isoform (Burns et al., 
2003; Huang et al., 1999).  
There have also been a few examples of AKAP-independent colocalization of 
PDEs and PKA. PDE7A and its interactions with the PKA C-subunit (Han et al., 2006) is 
one example. Another example describes interactions between the cAMP-binding 
domains of PKA RIα and a PDE, RegA from the eukaryote Dictyostelium discoideum 
(Shaulsky et al., 1998). This species contains only a single RIα isoform of the PKA R-
subunit. Furthermore, D. discoideum RIα is monomeric as it lacks the N-terminal third of 
the mammalian RIα sequence, including the N-terminal dimerization/docking domain, 
while the sequences of the cAMP-binding domains (CNB:A and CNB:B) are highly 
invariant amongst RIα across species (Canaves and Taylor, 2002). These indicate that the 
PDE-RIα interactions must involve the cAMP-binding domains and would therefore be 
independent of AKAPs. Earlier studies also showed that RegA was capable of interacting 
not only with RIα from D. discoideum but also with the monomeric N-terminal truncation 
mutant of mammalian (Bos taurus) RIα (RIα(91-379)) (Shaulsky et al., 1998).  
Our study characterizing RIα-RegA PDE interactions reveals a novel mechanism 
highlighting an active role for PDEs in signal termination. Our comprehensive 
enzymological analysis of PDE-R-subunit complexes shows that PDEs are capable of 
hydrolyzing cAMP-bound to the R-subunit in addition to free soluble cAMP. This is 
achieved by two processes: a) PDEs mediate active dissociation of cAMP from R-
45 
 
subunits, b) Binding of the R-subunits activates PDE catalysis. This establishes a 
previously unknown function of RIα as an activator for PDEs, underscoring the 
importance of PDE-R-subunit cross talk in cAMP signaling. We have used amide 
HDXMS to map the interactions between RIα and RegA. This chapter describes the 
mechanism for RegA-RIα interactions and the subsequent release and hydrolysis of 
bound cAMP. Our results have enabled identification of residues critical for RIα-RegA 
interactions and show that RIα uses overlapping but distinct surfaces for mediating 
interactions with the C-subunit and PDEs. By catalyzing hydrolysis of cAMP-bound to 
the RIα, PDEs actively prime RIα for reassociation with the C-subunit and thus are 
critical for signal termination in cAMP signaling. 
2.2 Materials and Methods 
2.2.1. Materials 
 Unless otherwise mentioned all reagents were from Sigma Aldrich (St. Louis, 
MO). The expression vector pGEX-4T-1 was from General Electric (Chicago, IL); 
restriction endonucleases and DNA modifying enzymes were from New England Biolabs 
(Beverly, MA); CIAP (calf intestinal alkaline phosphatase) was from Fermentas 
(Burlington, Canada).  BL21 (DE3) E.coli strains were from Novagen (Madison, WI). 
Glutathione sepharose 4B and NHS-activated sepharose 4 Fast Flow were obtained from 
GE (Chicago, IL). TALON metal affinity resin was from Clontech Laboratories 
(Mountain view, CA), 8-AEA-cAMP and 8-Fluo-cAMP, a fluoresceine-modified analog 
of cAMP with the dye linked at position 8 of the adenine base spacer were from Biolog 
Life Science Institute (Bremen, Germany), Fluorescein-5-maleimide was from Invitrogen 
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(Carlsbad, CA), cyclic nucleotide phosphodiesterase assay kit was from BIOMOL 
(Plymouth Meeting, PA), TFA protein sequence analysis grade was from Fluka 
BioChemika (Buchs, Switzerland), Poroszyme immobilized pepsin cartridge was from 
Applied Biosystems (Foster city, CA),  Immobilized pepsin bead slurry was from 
Thermoscientific Pierce (Rockford, IL).  
2.2.2. Cloning and Expression of a C-terminal deletion domain mutant of RegA 
 Recombinant clones for expression of B. taurus PKA RIα and M. musculus PKA 
C-subunit in E. coli were from Dr. Susan S. Taylor, Howard Hughes Medical Institute, 
University of California San Diego. The clones for RegA and RegA (127-335) were a gift 
from Dr. William Loomis, Center for Molecular Genetics, Department of Biology, 
University of California San Diego. A fragment of regA encoding the conserved PDE 
catalytic domain from residues 385-780 was sub-cloned into vector pGEX-4T-1 by 
standard molecular biology methods. A pair of forward and reverse oligonucleotide 
primers: 5‟CGGGATCCAAGTTGATAAAGAATGA-TTCAGT-3‟ and 5‟-
CGCGCTCGAGTAAAGGAGCGGTCGAAGAAGAT-3' were synthesized for 
amplification of regA encoding amino acid residues 385-780 by PCR. The amplified 
DNA and the expression vector were digested separately by restriction endonucleases 
BamHI and XhoI, purified from agarose gel, and ligated by T4 DNA ligase. The 






2.2.3. Protein Expression and Purification 
 cAMP affinity chromatography resin for R-subunit purification was synthesized 
by coupling 8-AEA-cAMP to the NHS-activated sepharose 4 Fast Flow ®  beads 
according to manufacturer specifications (GE Life Sciences Singapore) (Diller et al., 
2000). Both cAMP-bound and cAMP-free RIα(91-379) and RIα(91-244) were expressed 
and purified as described previously (Anand et al., 2007). The C-subunit of PKA was 
expressed and purified as described previously (Herberg et al., 1993). Full length RegA 
and the response regulator (RR) domain construct RegA (127-335) were expressed as 
hexahistidine tagged proteins and purified according to manufacturer specifications 
(Talon, Clontech laboratories). RegA (385-780) was expressed as a GST fusion protein in 
E. coli BL21*(DE3). The protein was purified using glutathione sepharose 4B (GE Life 
Sciences) according to manufacturer specifications followed by size exclusion-gel 
filtration chromatography on an AKTA system (GE Life Sciences). 
2.2.4. Pull-Down Assays 
 GST- tagged RegA (385-780) (10 nmol) was incubated with 50μL bed volume of 
glutathione sepharose beads for 30 min at room temperature (23ºC). The beads were then 
washed with binding buffer (20mM Tris.HCl, pH 7.5, 50mM NaCl, 10 mM MgCl2, 5mM 
β-mercaptoethanol (BME)) to remove any unbound protein and proteins nonspecifically 
bound to the beads. Glutathione-immobilized GST-RegA (385-780) was subsequently 
incubated with 50 nmol of cAMP-free RIα(91-379) and cAMP-free RIα(91-244) in 
separate experiments. The beads were then agitated gently at room temperature (23ºC) for 
1 h and rapidly washed 3-4 times with binding buffer. Protein was then eluted with 
elution buffer (10mM reduced glutathione, 20mM Tris HCl, pH 7.5, 50mM NaCl, 10 mM 
48 
 
MgCl2, 5mM BME) and analyzed by SDS-PAGE (12%) and stained with Coomassie 
blue to test for co-elution of PKA R-subunit fragments with deletion domain fragments of 
RegA. A control experiment with GST alone was carried out in parallel. Hexahistidine 
tagged RegA (127-335) was immobilized on cobalt beads ( Talon resin, Clontech 
Laboratories) and similar amounts of protein samples, beads and the same experimental 
conditions as above were used except that the elution buffer contained 150 mM imidazole 
pH 7.5 instead of glutathione.  
2.2.5. Fluorescence Spectroscopy 
 In order to test the effect of RegA binding to fluorescein labeled R-subunit, we 
chose mutant RIα (91-244) R239C and labeled with fluorescein maleimide (FM) as 
described earlier (Anand et al., 2007). The percentage of R-subunit labeled was 
determined spectrophotometrically using the following equation: 
Percentage labeled =  Concentration of Fluorescein-labeled protein   X 100 (2.1) 
Concentration of Total protein 
Concentration of fluorescein-labeled protein was calculated by measuring the absorbance 
at 497 nm (ε487= 83 000 for Fluorescein maleimide) and the total protein concentration 
was estimated by the Bradford assay. The fluorescence quenching studies was carried out 
using the lowest possible concentrations of FM-labeled protein that could be effectively 
measured under our experimental conditions. FM-labeled RIα(91-244) R239C which 
showed labeling of 62.5%, was used at lower concentrations (0.5 μM) to monitor changes 
in fluorescence upon addition of GST-RegA(385-780) (1-128 μM). All fluorescence 
measurements were made on an LS 55 luminescence spectrophotometer, (Perkin Elmer). 
An excitation wavelength of 490 nm was used and changes in the intensity of emission of 
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fluorescein at 518 nm were monitored. The experiment was carried out by setting both 
the excitation and emission slits at 2.5 nm with a scan speed of 100 nm/min. Plots of 
normalized relative fluorescence (F0/F) versus concentration of RegA (385-780) where, 
F0 and F are the fluorescence intensities at the emission maxima in the absence and 
presence of GST-RegA (385-780) respectively, best fit to an equation for one site-
specific binding (Graph Pad Prism software version 5 (San Diego, CA)). Values for KD 
obtained were 1.6 ± 0.4 and 1.7 ± 0.7 μM for cAMP-bound and cAMP-free RIα(91-244) 
respectively. For accurate determination of dissociation constants it is necessary for the 
total concentration of one of the reactants to ideally be 10-100X lower than the measured 
dissociation constants (Goodrich, 2007), but here the concentration of FM-labeled 
RIα(91-244) is only 3X lower than our measured KD. The values we obtained therefore 
represent higher estimates of the dissociation constant. Calculation of a more accurate 
dissociation constant would require higher sensitivity of labeled probes and/or detection 
or labeling of both RegA and RIα.  
2.2.6. Phosphodiesterase Assay 
 Full-length RegA and GST RegA(385-780) were assayed for cAMP hydrolytic 
activity using a colorimetric cyclic nucleotide phosphodiesterase assay (BIOMOL, 
Plymouth Meeting, PA). Full-length RegA and GST RegA(385-780) (200nM) were each 
separately incubated with 200 μM cAMP at room temperature (23 ˚C) over a time course 
spanning 10 - 60 min in assay buffer (20 mM Tris.HCl, pH 7.5, 50 mM NaCl, 10 mM 
MgCl2 and 5 mM BME) in a total reaction volume of 50 μL. The linked PDE assay used, 
measures PDE activity by monitoring the amount of product, 5' AMP indirectly, where 
free inorganic phosphate generated by CIAP (Calf Intestinal Alkaline Phosphatase) by 
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hydrolysis of 5‟ AMP is detected by BIOMOL green reagent (malachite green) which 
interacts with free phosphate which in turn increases absorbance at 620nm. PDE 
reactions were quenched by addition of TCA to a final concentration of 7%. The samples 
were then centrifuged to remove denatured protein; phosphate in the supernatant was 
quantitated by adding 100μL of BIOMOL green reagent and by measurement of the 
absorbance at 620 nm. A control experiment with GST in the presence of RIα(91-244) 
was carried out in parallel and showed no PDE activity. 
 To measure  RIα(91-244)-mediated activation of RegA, GST RegA(385-780) (50 
nM) was incubated with a range of cAMP- free RIα(91-244) concentrations (1 nM – 30 
μM) and assayed for PDE activity. The maximal activity was seen under these conditions 
in the presence of 3µM or greater cAMP-free RIα(91-244) with an EC50 for the activation 
equal to 0.13 µM. GST RegA(385-780) alone (50nM) and in the presence of 3µM 
cAMP-free RIα(91-244) was then used to determine the kinetic parameters (KM and Kcat)  
by measuring activity at cAMP concentrations ranging from10 μM to 250 μM. 
 To test the ability of RegA to hydrolyze cAMP bound to RIα(91-244) rather than 
cAMP in solution, we used cAMP-bound RIα(91-244) as a sole substrate for RegA. 50 
μM cAMP-bound RIα(91-244)  was incubated for 30 min at 30 ºC with different 
concentrations of GST- RegA (385-780) (0-120 μM) in assay buffer with added CIAP 
(1u, Fermentas) to a final volume of 50μL. The reaction was quenched by addition of 
TCA to a final concentration of 7%. The samples were then centrifuged to remove 
denatured protein; phosphate in the supernatant was quantitated by adding 100μL of 
BIOMOL green reagent and by measurement of the absorbance at 620 nm. 
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2.2.7. Fluorescence Polarization (FP) Assay for cAMP Dissociation 
 To determine if RegA interactions facilitate dissociation of cAMP from RIα, we 
carried out a fluorescence polarization (FP) assay using 8-Fluo-cAMP saturated RIα(91-
244) as described (Kool et al., 2007). This assay allows measurement of the rate of 
dissociation/ competitive displacement of 8-Fluo-cAMP from RIα by cAMP, since FP of 
bound fluorescent analog is greater than for analog free in solution.  FP was calculated by 
the equation: 
        
      –        
              
          (2.2) 
FP (mP) is the Fluorescence Polarization measured in milli polarization units,    is the 
intensity with polarizers parallel,    is the intensity with polarizers perpendicular and G 
is the G-factor or correction factor. A Biotek Synergy 4 Multi-Detection microplate 
reader (Winooski, VT) was used in FP mode for the plate reader assays. The excitation 
and emission wavelengths used were 485 nm and 528 nm, respectively with a bandwidth 
of 20 nm with an instrument G-factor of 0.87. 96-well black plates were from Greiner 
(Germany). The FP signals for 7.2 μM of 8-Fluo-cAMP bound RIα(91-244) in buffer A 
(20 mM Tris-HCl, pH 7.5, 50 mM NaCl, 10 mM MgCl2, 5 mM BME) were monitored 
with and without (i) unlabeled cAMP (1 mM), (ii) C- subunit with 0.2 mM ATP (36 μM) 
and (iii) GST-RegA (385-780)(36 μM). FP measurements were taken at time intervals of 
2 min for 30 min. In all samples 36 μM of GST-RegA (385-780) was added at 30 min, 
and FP measurements were obtained till 40 min. Data from early time points (0 – 18 min) 
were fit to a one phase exponential decay equation using Graph Pad Prism software 
version 5 (San Diego, CA). 
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2.2.8. Amide HDXMS – (LC-ESI-QTOF-MS) 
 cAMP-free RIα(91-244): GST-RegA (385-780) complex eluted from the pull-
down experiment described above was purified and concentrated to 6.9 mg/mL protein, 
based on Bradford assay, using vivaspin concentrators (Sartorius Stedim Biotech GmbH, 
Goettingen, Germany). We believe that in this sample containing a molar excess of GST-
RegA (385-780), all the RIα(91-244) would be fully saturated with GST-RegA(385-780) 
and enable mapping of RegA-RIα(91-244) interactions.  
 Deuterium exchange was carried out by mixing 2 μL of the samples in storage 
buffer (20 mM Tris.HCl, pH 7.5, 50 mM NaCl, 10 mM MgCl2, 5 mM BME) with 28 μL 
of D2O (99.90%) resulting in a final concentration of 93.3% deuterated buffer A (20 mM 
Tris.HCl, pHread 7.5, 50 mM NaCl, 10 mM MgCl2, 5 mM BME). Exchange was carried 
out at 20ºC for various times (0.5, 1, 2, 5 and 10min). The exchange reaction was 
quenched by adding 30 μL of pre-chilled 0.1% TFA to get a final pHread of 2.5. 50 μL of 
the quenched sample (~ 14 μg protein sample) was then injected on to a chilled nano-
UPLC sample manager (beta test version, Waters, Milford, MA) as previously described 
(Wales et al., 2008). The sample was washed through a 2.1 x 30mm immobilized pepsin 
column (Porozyme, ABI, Foster City, CA) using 100 μL/min 0.05% formic acid in water.  
The digest peptides were trapped on a 2.1 x 5 mm C18 trap (ACQUITY BEH C18 
VanGuard Pre-column, 1.7 μm, Waters, Milford, MA). Peptides were eluted using an 8-
40% gradient of acetonitrile in 0.1% formic acid at 40 μL/min, supplied by a 
nanoACQUITY Binary Solvent Manager (Waters, Milford, MA), on to a reverse phase 
column (ACQUITY UPLC BEH C18 Column, 1.0 x 100 mm, 1.7 μm, Waters, Milford, 
MA) for resolution. Peptides were detected and mass measured on a SYNAPT HDMS 
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mass spectrometer (Waters, Manchester, UK) acquiring in MS
E
 mode (Bateman et al., 
2002; Silva et al., 2005). 
 Peptides were identified from MS
E
 data of undeuterated samples using 
ProteinLynx Global Server (PLGS 2.4 (beta test version))(Waters, Milford, MA) 
(Geromanos et al., 2009; Li et al., 2009). Identifications were only considered if they 
appeared at least twice out of three replicate runs.  These identifications were mapped on 
to subsequent deuteration experiments using prototype custom software (HDX browser, 
Waters, Milford).  Data on each individual peptide at all time points were extracted using 
this software, and exported to the HX-Express program (Weis et al., 2006).  
 Continuous instrument calibration was carried out with Glu-Fibrinogen peptide 
(GFP) at 100fmol/μL. We also visually analyzed the data to ensure only well-resolved 
peptide isotopic envelopes were subjected to quantitative analysis. The lowest signal to 
noise ratio among all peptides analyzed was 6. HX-express generated centroid values for 
the isotopic envelopes of all the peptides analyzed which reflected the average mass of 
the peptide. The difference between the average masses of the deuterated and 
undeuterated peptide gave the average number of deuterons exchanged. The N-terminal 
amide of all the peptide fragments exchanged too rapidly to measure and was not 
included in calculation of average deuterons exchanged (Weis et al., 2006). A control 
experiment was carried out to calculate the deuterium back exchange loss during the 
experiment by incubating cAMP-free RIα (91-244) with deuterated buffer A for 24 h at 
room temperature (20ºC). Even after extended deuteration, RIα(91-244) still showed 
some solvent inaccessible and ordered regions that were not completely deuterated. For 
an accurate measurement of back exchange loss, we therefore focused only on peptides 
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from within highly solvent exchangeable regions of the protein, identified as those 
regions that show the greatest relative exchange at shorter time points (10 min exchange). 
The region in RIα(91-244) spanning residues 111-130 is a highly solvent exchangeable 
region  and all 3 overlapping peptides used for calculations of back exchange span this 
region and showed nearly maximal exchange in ligand-free RIα(91-244) following 10 
min deuterium exchange and would represent fully deuterated samples following 24 h 
exchange. An average deuteration back exchange of 32.8 ± 1.0 % was calculated from 
average back exchange values for 3 peptides: RIα(111-123) (m/z = 547.65) (back 
exchange - 34.4%), RIα(111-119) (m/z = 559.34) (back exchange =  33.7%) and 
RIα(111-126) (m/z = 632.701) (back exchange = 30.4%). All deuterium exchange values 
reported were corrected for a 32.8%  back exchange by multiplying the raw centroid 
values by a multiplication factor of 1.49 (Anand et al., 2010). Kinetic plots of deuteration 
for all peptides from RIα(91-244) alone and bound to RegA were made and these fit best 
to a one phase association model accounting for deuterons exchanging at a rapid rate 
(mainly solvent-accessible amides) (Mandell et al., 1998). Parallel amide HDX 
experiments were carried out and measured by MALDI-TOF mass spectrometry to 
provide additional sequence coverage.  
2.2.9. Amide HDXMS  – (MALDI-TOF-MS) 
Samples of 2 μL of cAMP-free RIα (91-244) alone and in complex with RegA were 
diluted and incubated with 18 μL of D2O (99.90%) resulting in a final concentration of 
90.0% deuterated buffer (20 mM Tris.HCl, pHread 7.5, 50 mM NaCl, 10 mM MgCl2, 5 
mM BME). Exchange was carried out at 20ºC for various time points (0.5, 1, 2, 5 and 
10min). The exchange reaction was quenched by adding 180 μL of pre-chilled 0.1% TFA 
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to get a final pHread of 2.5. Quenched reactions were digested for 5 min in ice with 
immobilized pepsin slurry (Thermo Scientific Pierce, Rockford, IL). Solutions were spun 
down for 15 s at 13 000 rpm and 20 μL aliquots of digested solutions were flash-frozen in 
liquid nitrogen and stored at -80 °C until MALDI-TOF MS analysis. Undeuterated 
samples were included as a negative control. One sample was allowed to exchange with 
deuterated buffer for 24 hrs to allow complete deuteration of solvent exposed regions of 
the protein. This was used to calculate back exchange under our experimental conditions. 
For MALDI-TOF MS analysis, aliquots were thawed and 0.5 μL pepsin digest samples 
were mixed with 0.5 μL of matrix (15 mg/ml α-cyano-4-hydroxycinnamic acid in 1:1:1 
ethanol: acetonitrile: 0.2% TFA, (pH 2.5). An aliquot of 0.5 μL was spotted on the 
MALDI plate and quickly dried under vacuum and analyzed on a MALDI-TOF mass 
spectrometer (4800 MALDI-TOF/TOF, Applied Biosystems). Spectra were calibrated 
using Data Explorer (Applied Biosystems) with internal peptide masses of RIα (91-244),  
m/z = 1011.4609 (residues 222-229) and m/z = 1594.7138 (residues 136-148) pepsin 
proteolytic fragments (Anand et al., 2002). The centroid of the peptide envelopes were 
measured using Decapp Mass Spec Isotope Analyzer computer program (Mandell et al., 
1998). Back exchange was found to be ~55%, so all centroid values were multiplied by a 







2.3.1. Deletion Mutagenesis Indicates that the Catalytic Domain of RegA Mediates 
AKAP-independent Interactions with the CNB:A Domain   
 To further characterize interactions between RIα and RegA (Shaulsky et al., 
1998), we set out to define the specific domains involved in mediating these interactions 
by deletion mutagenesis of both RegA and RIα. RIα(91-244), containing a single cAMP 
binding domain (CNB:A), is a minimal module that has been used to examine the 
molecular details of the R-C interface (Kim et al., 2005) as well as to probe cAMP 
interactions with RIα (Su et al., 1995). This minimal construct consists of two sub-
domains: an α- subdomain composed entirely of α- helices, which forms the interface 
with the C-subunit (Kim et al., 2005) and a β-subdomain that contains a conserved 
cAMP-binding pocket (Berman et al., 2005; Su et al., 1995). We therefore set out to 







At least two domains are predicted from the amino acid sequence of RegA, i) an N-
terminal regulatory receiver domain (RR)  bearing high homology to response regulators 
Figure 2.2: Domain organization of RegA showing an N-terminal receiver domain (RegA(127-





























GST-RegA (385-780) (Lane 1)




(Stock et al., 2000) and  ii) a C-terminal catalytic domain  highly homologous to catalytic 
domains of all PDEs (Conti and Beavo, 2007)(Figure: 2.2). We were interested in testing 
which of these two conserved domains mediated interactions with RIα and so generated 
deletion domain constructs of RegA; RegA (127-335) to span the receiver domain and 
RegA (385-780) to span the catalytic domain. Each of these domain constructs were 
tested for their ability to interact with the larger deletion mutant of R-subunit, RIα(91-
379) containing both CNB:A and CNB:B by a pull-down assay. We found that GST 
RegA (385-780) alone but not RegA (127-335) interacted with cAMP-free RIα(91-379) 











Figure 2.3: GST pull down of cAMP-free RIα(91-379) with the PDE catalytic domain, GST 
RegA (385-780) shows direct binding to cAMP-free RIα(91-379) (Lane 1). GST was used as 
control (Lane 3). Hexahistidine pull down of cAMP-free RIα(91-379) with hexahistidine tagged 























We additionally carried out pull-down assays with cAMP-free RIα(91-244) and observed 













Our results indicate that the CNB:A domain is sufficient for mediating interactions with 
the catalytic domain of RegA. GST alone did not bind to either RIα construct. For clarity, 
all future references to RegA in the text denote GST-tagged RegA(385-780) and all 
future references to PKA RIα denote RIα(91-244) unless otherwise stated. 
Figure 2.4: GST pull down of cAMP-free RIα(91-244) with GST RegA(385-780) (Lane1). GST 
was used as control (Lane 2). (MW: Molecular weight marker). For clarity, all future references 
to RegA in the figure legends denote the GST-tagged RegA(385-780) and all future references 
to RIα denote RIα(91-244) unless otherwise stated. 
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2.3.2. Measurement of Binding Affinity of RIα to RegA by Fluorescence Quenching 
 In order to test the effect of RegA binding to fluorescein-labeled RIα, we chose  
single site cysteine point mutant in RIα (91-244) R239C and labeled them with 
fluorescein maleimide (FM) as described earlier (Anand et al., 2007). Quenching of 
fluorescence signal upon addition of RegA seen with RIα (91-244) (R239C) was 
followed to calculate estimated dissociation constants (KD) as described in materials and 
methods. Plots of fluorescence quenching of cAMP-free and cAMP-bound FM-labeled 
RIα (91-244) R239C by RegA were nearly identical with dissociation constants, KD= 1.7 
μM ± 0.7 and KD= 1.6 μM ± 0.4 for cAMP-bound and cAMP-free RIα determined by non 
linear curve fitting to equation for one site-specific binding (Graph Pad Prism software 










Figure 2.5: cAMP-bound and cAMP-free RIα bind RegA with identical affinities. Plot of 
relative fluorescence of fluorescein-labeled RIα(91-244) R239C (0.5 μM)  and concentrations of 
RegA (0.5 - 10 μM) (Excitation wavelength: 490 nm, Emission wavelength: 520 nm). Y-axis 
shows normalized values of relative fluorescence where 100% represents the maximum value 
for F0/F. Open triangle (∆), cAMP-free RIα and inverted open triangle (∇), cAMP-bound RIα. 
The curves were fit to the equation for one-site specific binding (Graph Pad Prism software 




Since the concentration of labeled RIα (91-244) R239C is only 3X fold lower than our 
measured value for the KD , when it should ideally be between 10 and 100-fold lower than 
the KD, the calculated KD values represent upper limits for the true affinities of the 
cAMP-bound and cAMP-free RIα complexes (Goodrich, 2007).  
2.3.3. RIα Binding Induces a 13X Increase in RegA Phosphodiesterase Activity 
 We next set out to measure the functional effects of RIα binding on PDE activity 
of RegA. The catalytic domain of RegA retained the same level of PDE activity as full-
length RegA (Figure: 2.6). This is consistent with previous studies showing deletion of 
the N-terminal receiver domain and generation of a GST-fusion catalytic domain did not 









Figure 2.6: Deletion of the N-terminal domain of RegA does not affect PDE activity. 




We then tested the effects of cAMP-free RIα binding on PDE activity of RegA, by 
measuring the activity of RegA (50 nM) alone and with a range of concentrations of RIα 











Maximal activity was seen in the presence of 3µM or greater RIα with an EC50 for the 
activation to be 0.13 µM. While the dissociation constant for RegA-RIα by fluorescence 
quenching was estimated to be less than 1.5 µM, the EC50 values obtained from the 
reaction provide a more accurate measurement of the affinity as it pertains to the RIα-
dependent activation of RegA PDE catalysis. These results showed further that RIα 
binding induces a ~13X fold enhancement in PDE catalysis of RegA.  There was a linear 
Figure 2.7: cAMP-free RIα is an activator of PDE catalysis. Figure 4A, EC50 for cAMP-free RIα-
mediated activation of RegA. Concentrations of RegA and cAMP were 50 nM and 200 μM 
respectively. Triplicate reactions were carried out at 30˚C for 15 min with a range of 
concentrations of cAMP-free RIα (1 nM – 30 μM). The plot was fit to an equation describing a 
sigmoidal dose response curve (Activity vs. Log Agonist) (Graphpad Prism version 5 (San 
Diego, CA)) and an EC50 of 132 nM was calculated. These results indicate that a maximal 
increase (~ 13 X) in activity is seen when RegA is fully saturated with RIα. Inset shows PDE-
mediated 5‟AMP synthesis over time for free RegA and in the presence of RIα (3 µM). 
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relationship between the activity of RegA in the presence of excess RIα, with the total 
concentrations of RegA used, and this enabled us to carry out cAMP saturation kinetics 
of RegA alone and in the presence of 3 µM RIα. The plots were fit to the Michaelis-
Menten equation (Graph Pad Prism version 5) as described in Materials and Methods. 
These showed that the basis for the ~13-X fold enhancement of PDE catalysis by RIα 
was through direct effects on the catalytic turnover rates (kcat = 3.2 min
-1
 for RegA and 
43.0 min
-1
 for the RegA-RIα complex) while the Michaelis constants (KMcAMP= 35.0 












Figure 2.8: RIα activates RegA by increasing the Vmax of the phosphodiesterase reaction. PDE 
assays of RegA (50 nM) were carried out in the absence (○) or presence (●) of cAMP-free RIα 
(3 μM).  Rates of 5‟-AMP product formed were plotted versus a range of cAMP concentrations 
and fitted to the Michaelis-Menten equation (Graph Pad Prism software version 5 (San Diego, 
CA)). The Vmax for the PDE reactions catalyzed by RegA was 8.1±0.5 pmol 5‟AMP released/ 
min (kcat = 3.2 min
-1) and that for RegA + RIα is 107.6±1.3 pmol 5‟AMP released/min (kcat= 43.0 
min
-1
); The KM for RegA was calculated to be 35.0 μM and for RegA + RIα, 32.5 μM. Data are 
average measurements from three replicate experiments. Error bars indicating standard deviation 




2.3.4. Mapping RIα-RegA Interactions by Amide HDXMS 
 Amide HDXMS is an ideal method to monitor protein-protein interactions in 
solution and is especially suitable for mapping protein interfaces (Hoofnagle et al., 2003). 
In this study, we used amide HDX coupled to pepsin digestion and LC-ESI-QTOF mass 
spectrometry to specifically probe the solvent accessibility (Mandell et al., 2001) of the 
RIα surface in the free state and in complex with RegA,  by monitoring amide HDX over 
a 0.5 -10 min time period. In the ESI-QTOF MS experiments, the identities of the pepsin 
digest fragments of RIα were determined by PLGS v.2.4 program (Waters Corporation, 
Milford, MA) and a total number of 36 peptides corresponding to 90% of the sequence of 
RIα(91-244) were identified (Figure: 2.9) and centroid analysis on all the peptides was 
carried out by the program HX-express as described in  materials and methods. The 
variability in centroid values between replicate measurements was less than 1% for most 
peptides and less than 10% for all peptides. 
 Table 2.1 summarizes the extent of deuteration for all the 36 peptides from which 
quantitative data were obtained. The data are reported as the average number of deuterons 
incorporated after ten minutes for three independent determinations. Kinetic plots of 
deuteration for all peptides from RIα(91-244) alone and bound to RegA were generated 
and these fit best to a one phase association model (Graph Pad Prism software version 5) 
accounting for deuterons exchanging at a rapid rate (mainly solvent-accessible amides) 
(Mandell et al., 1998). For two of the peptides that showed large differences between 
cAMP-free RIα and RegA-bound RIα, the plots along with isotopic envelopes are shown 
in Figure: 2.10. There was no significant difference observed between the exchange after 
ten minutes of deuterium exchange or from calculation of the maximum number of 
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deuterons exchanged determined from fitting plots of the time course of deuteration, 
either method of data presentation resulting in the same conclusion (Anand et al., 2002; 
Hughes et al., 2001). 
Table 2.1:  Summary of HDX data for cAMP-free RIα(91-244) and cAMP-free RIα(91-
244):RegA 
        Maximum Deuterons  
Pepsin digest fragments  Charge Residue   Maximum Exchanged after 10 min 






(m/z)     amides (Mean ± SD) (Mean ± SD) 
AEVYTEE (840.36) 1 100-106 6 4.6 ± 0.12 4.6 ± 0.15 
AEVYTEEDAA (1097.51) 1 100-109 9 5.5 ± 0.21 5.3 ± 0.17 
VYTEE (640.28) 1 102-106 4 2.3 ± 0.06 2.3 ± 0.06 
YVRKVIPKDYKTM (547.65) 3 111-123 11 8.6 ± 0.28 8.3 ± 0.21 
YVRKVIPKDYKTMAA (595.01) 3 111-125 13 9.8 ± 0.38 10.2 ± 0.21 
YKTMAA (684.34) 1 120-125 5 4.2 ± 0.12 3.9 ± 0.09 
LAKAIEKNV (493.31) 2 126-134 8 4.4 ± 0.12 4.1 ± 0.12 
AKAIEKNVL (493.31) 2 127-135 8 4.4 ± 0.12 4.1 ± 0.12 
FSHLDDNERSDIF (797.86) 2 136-148 12 3.1 ± 0.06 2.9 ± 0.12 
NERSDIF (880.41) 1 142-148 6 1.8 ± 0.07 1.4 ± 0.23 
ERSDIF (766.37) 1 143-148 5 0.8 ± 0.06 0.8 ± 0.07 
RSDIFD (752.36) 1 144-149 5 0.5 ± 0.03 0.5 ± 0.06 
DAMFPVSF (913.41) 1 149-156 6 1.1 ± 0.03 1.0 ± 0.00 
AMFPVSF (798.39) 1 150-156 5 1.2 ± 0.07 1.1 ± 0.03 
FIAGET (637.33) 1 156-161 5 0.4 ± 0.03 0.3 ± 0.07 
TVIQQGDEGDN (1175.54) 1 161-171 10 6.0 ± 0.07 4.5 ± 0.07* 
TVIQQGDEGDNF (661.80) 2 161-172 11 5.4 ± 0.10 3.7 ± 0.15* 
VIQQGDEGDNF (1221.58) 1 162-172 10 5.4 ± 0.09 4.2 ± 0.15* 
QQGDEGDN (862.32) 1 164-171 7 4.6 ± 0.03 3.7 ± 0.09* 
QQGDEGDNF (1009.39) 1 164-172 8 4.7 ± 0.10 3.4 ± 0.09* 
FYVIDQ (784.39) 1 172-177 5 0.4 ± 0.03 0.3 ± 0.03 
FYVIDQGEM (1101.50) 1 172-180 8 1.5 ± 0.07 1.2 ± 0.10 
DVYVNNE (852.37) 1 181-187 6 2.3 ± 0.09 1.9 ± 0.09 
VYVNNE (737.35) 1 182-187 5 2.5 ± 0.20 2.1 ± 0.03 
YVNNEW (824.36) 1 183-188 5 3.0 ± 0.12 2.5 ± 0.07 
NEWATSVGEG (525.22) 2 186-195 9 4.3 ± 0.12 4.2 ± 0.09  
GELAL (502.29) 1 199-203 4 3.0 ± 0.09 1.0 ± 0.09* 
ALIYGTPRAATVKAKT (554.33) 3 202-217 14 7.9 ± 0.25 4.0 ± 0.03* 













91 101 111 121 131
141 151 161 171 181
191 201 211 221
231 241 244
IYGTPRAATVKAKTNVK (606.70) 3 204-220 15 7.0 ± 0.15 3.2 ± 0.12* 
IYGTPRAATVKAKTNVKL (644.39) 3 204-221 16 7.9 ± 0.24 3.7 ± 0.09* 
VKAKTNVKL (500.83) 2 213-221 8 1.3 ± 0.06 0.9 ± 0.00 
AKTNVKLWG (508.80) 2 215-223 8 1.7 ± 0.03 1.7 ± 0.03 
WGIDRDS (424.70) 2 222-228 6 1.8 ± 0.03 1.9 ± 0.26 
RDSYRRILMGSTLRKRKM (1134.10) 2 226-243 17 10.1 ± 0.03 7.4 ± 0.22* 
RRILMGSTL (523.81) 2 230-238 8 3.3 ± 0.12 3.0 ± 0.00 
            
 
a
Averages and standard deviations were calculated with measurements from three 
independent experiments. * Peptides showing significant differences in exchange 



















Figure 2.9: Amino acid sequence of RIα(91-244) showing secondary structure elements with 
boundaries. Solid lines indicate the 36 pepsin digest fragments analyzed in the study with a total 




Table 2.2: Peptides detected and analyzed from MALDI-TOF for RIα (91-244) both in 
free and in complex with RegA. 









YVRKVIPKDYKTMAA 111-125 10.1 9.8 
    
VRKVIPKDYKTMAAL   112-126 11.6 11.3 
    
FSHLDDNE 136-143 3.4 3.4 
    
LIYGTPRAATVKAKTNVK 203-220 7.9 3.9 
    
WGIDRDSY 222-229 3.5 3.4 
    
RKRKMY 239-244 2.3 1.2 
 
Parallel amide exchange experiments were also carried out and measured by 
MALDI-TOF MS (Table: 2.2). Although the primary sequence coverage obtained was 
lower than from the ESI-QTOF MS analysis, there was one peptide in the MALDI-TOF 
MS analysis (Figure: 2.11), that provided information on the C-terminus of RIα (91-244) 
(residues 239-244), missing in coverage from the ESI-QTOF MS analysis. Results from 








































































RIα (202 – 217) RIα (162 – 172) 
Figure 2.10: ESI-QTOF mass spectra for a peptides spanning RIα(202-217) (A) and 
RIα(162-172) (B) in the top showing decreased exchange in the RIα–RegA complex. (i) 
The isotopic envelope for the same peptides from RIα alone after 10 min deuteration (ii) 
The isotopic envelope for the same peptides from RIα:RegA after 10 min deuteration; (iii) 
Undeuterated sample. Time course of deuterium exchange for same peptides (bottom) fit to 
an equation for one-phase association (Graph Pad Prism software version 5 (San Diego, 




















































From a combination of the ESI-QTOF MS and MALDI-TOF MS data, three 
clusters of overlapping peptides showing significantly decreased exchange in the 
complex compared to unbound RIα were identified and these regions are further 
discussed below.  













Figure 2.11: Matrix-assisted laser-desorption/ionization time-of-flight (MALDI-TOF) spectra of 
one of the peptides spanning the PBC residues 204-221 (m/z = 1931.15) (A) and residues 239-244 
(m/z = 881.51) (B) in RIα (91-244). The spectra are expanded to show the isotopic distribution for 
the same peptides (top). (i) Isotopic envelope of undeuterated sample. The isotopic envelope for 
the same peptide after 10 min of deuteration from RIα (91-244) (ii) in the absence of RegA, (iii) 
bound to RegA. Time course of deuterium incorporation into backbone amides of the same 
peptides (bottom). (○) Peptide from RIα (91-244) alone, () Peptide from RIα (91-244) in 
complex with RegA. The solid lines denote the best fit of the data to a single exponential equation. 
204 - 221 239 - 244 
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2.3.5. Three Regions on RIα showed Decreased Solvent Accessibility in the RegA-RIα 
Complex: Phosphate Binding Cassette, β-strands 1-2 and aB/C:A helices 
 An important region of the protein where RegA binding caused decreased 
deuterium exchange was the region spanning the phosphate binding cassette (PBC) 
(Figure: 2.10). Interestingly, this region is the binding site for cAMP and contains critical 
and invariant cAMP interaction residues including Glu200 and Arg209 (Canaves et al., 
2000). Subtractive analysis of peptides with residues 202-217, 204-212, 204-220 and 
204-221 spanning the PBC showed decreased solvent accessibility corresponding to 
protection of 3 backbone amide deuterons that can be localized to residues 205-212. 
Peptide with residues 199-203 showed decreased solvent accessibility corresponding to 
protection of 2 backbone amide deuterons.  
 A second region spans the β-strands 1, 2 and the loop connecting them. 
Subtractive analysis of overlapping peptides with residues 161-171, 161-172, 162-172, 
164-171 and 164-172 showed protection of nearly 1.5 backbone amides that are localized 
to residues 162-172 (Figure: 2.10).  
 A third region where we observed decreased exchange in the RegA-RIα complex 
is the C-terminal end of the C-helix spanning residues 226-243. Subtractive analysis of 3 
overlapping peptides with residues 226-243, 222-228 and 230-238 allowed us to localize 
the changes to segments within these peptides. Since there were no observable 
differences in exchange in the peptides, 222-228 and 230-238, the observed 2.7 deuterons 
protected in residues 227-243 is localized to residues 229,230 and/or residues 239-243. 
















regions map onto a contiguous surface on the structure of RIα and highlight the regions 

















Figure 2.12: Amide HDXMS data mapped on to the crystal structure (surface representation) of 
cAMP-bound RIα(113-379) (PDB ID: 1RGS), CNB:A is in green and CNB:B is in gray (Su et 
al., 1995). The phosphate binding cassette (PBC-A) (residues 199-212), B-helix (residues 229, 
230), C-helix (residues 239-244) (From subtractive analysis and with amide exchange MALDI-
TOF MS data) and 1 segment from the β-subdomain (residues 162-172) showed decreased 
exchange in the RIα:RegA complex. cAMP is yellow and protected regions are blue.  Structure 




2.3.6. RegA Catalyzes Hydrolysis of cAMP-bound to RIα 
 The crystal structure of cAMP-bound RIα (PDB:1RGS) shows that the highly 
conserved PBC provides an important hydrophobic environment for cAMP, shielding it 
from intracellular phosphodiesterases (Diller et al., 2000; Wu et al., 2004). Since we 
identified the PBC as one of the regions mediating interactions with RegA, we set out to 
test if the catalytic domain of RegA could hydrolyze cAMP bound to RIα. We carried out 
PDE assays with variable concentrations of RegA (0 to 120 μM) with constant 
concentrations (50 μM) of cAMP-bound RIα (Figure: 2.13). We observed that RegA is 
able to hydrolyze bound cAMP at a rate far slower than the rate of RegA hydrolysis of 
cAMP in solution (an average rate of 0.015 per min for bound cAMP compared to kcat 










Figure 2.13:  RegA catalyzes hydrolysis of cAMP-bound to RIα. Phosphodiesterase activity of 
RegA was measured by a colorimetric assay described in materials and methods using cAMP-
bound RIα as substrate. 50 μM cAMP-bound RIα was incubated with different concentrations of 
RegA (0-120 μM). Plot shows PDE activity as a function of concentration of RegA (□). The plots 
were fit to an equation describing a sigmoidal dose response curve (Activity vs. Log Agonist) 
(Graphpad Prism version 5 (San Diego, CA)). 
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Furthermore, a plot of PDE activity and variable concentrations of RegA catalytic 
domain fit best to a sigmoidal curve. This together with the slower activity seen with 
bound cAMP suggested that RegA-mediated hydrolysis of bound cAMP proceeded as a 
two-step reaction. Binding of RegA leads to dissociation of bound cAMP first followed 
by PDE-dependent cAMP hydrolysis. To test this further we used a fluorescent analog of 
cAMP, 8-Fluo-cAMP which has been shown to have similar binding affinities to RIα as 
cAMP (Schwede et al., 2000) and is highly resistant to PDEs as well (manufacturer‟s 
sheet, Biolog, Bremen, Germany) in a fluorescence polarization (FP) assay for measuring 
cAMP dissociation as described in Materials and Methods (Kool et al., 2007) (Figure: 
2.14 A).  










Figure 2.14: (A), RegA mediates dissociation of cAMP from RIα. Dissociation of 8-Fluo-cAMP 
from RIα (7.2 μM) was monitored by measuring the fluorescence polarization (FP) under different 
conditions, (○) control: Buffer A (20 mM Tris-HCl, pH 7.5, 50 mM NaCl, 10 mM MgCl2, 5 mM 
BME), (●) presence of unlabeled cAMP (Buffer A, 1 mM cAMP), (▲) presence of C- subunit (36 
μM), (Buffer A, 0.2 mM ATP), (X) presence of RegA (36 μM) (Buffer A). FP measurements were 
as described in materials and methods. FP values are plotted versus time, arrow indicates the time 
point (30 min) of addition of RegA (36 μM) to all samples. (B), RegA increases dissociation rates of 
8-Fluo-cAMP from RIα. Dissociation rates were calculated by fitting the data for the early time 
points (0-18 min) to an equation describing  one phase exponential decay using Graph Pad Prism 
software version 5 (San Diego, CA). Data are average measurements from three independent 




There was no spontaneous dissociation of 8-Fluo-cAMP from RIα over the 
duration of the experiment consistent with the high affinity of cAMP to RIα (Dao et al., 
2006). Addition of RegA after 30 min incubation showed a drop in FP indicative of 
RegA-mediated dissociation of bound 8-Fluo-cAMP. Any effect of addition of RegA 
must only be due to dissociation of 8-Fluo-cAMP since this analog is resistant to PDE 
hydrolysis (Biolog Inc., specification). We additionally verified that RegA was unable to 
hydrolyze 8-Fluo-cAMP under the conditions of our experiment. In the presence of 1 mM 
unlabelled cAMP, we calculated the intrinsic off-rate for cAMP to be 0.18 min
-1
(Figure: 
2.14 B). RegA increases the rate of cAMP dissociation even in the absence of excess 
cAMP (koff = 0.50 min
-1
). The rate of RegA-mediated dissociation of cAMP is thus 2.8-
fold greater than the intrinsic off-rate of cAMP seen only in the presence of excess 
cAMP. We also compared the kinetic off-rates in the presence of C-subunit. Under the 
conditions of the assay, the C-subunit would be predicted to be bound to cAMP-RIα in a 
ternary complex (KD= 0.2 µM for R-cAMP:C (Anand et al., 2007; Kopperud et al., 2002) 
and KD= 2.9 µM of cAMP for holoenzyme (Dao et al., 2006) so what we observed here is 
a decrease in FP that potentially reflects increased dynamics of cAMP while still bound 
to the regulatory subunit in a ternary complex (Dao et al., 2006) rather than dissociation. 
This is confirmed by our observation that the FP signal dropped upon further addition of 
RegA to our sample (Figure: 2.14 B). Thus the C-subunit primarily weakens the binding 
of cAMP to RIα and stays bound to it in a ternary complex (KD= 0.2 µM,(Anand et al., 
2007; Kopperud et al., 2002) while RegA mediated active dissociation of cAMP and 

























Figure 2.15: (A), Proposed mechanism for RegA mediated hydrolysis of cAMP-bound to RIα. 
Figure 10A, Structure of cAMP-bound RIα is shown (from PDB ID: 1RGS) highlighting the 
cAMP binding site and αC:A helix which are part of the three regions showing decreased 
exchange upon interactions with the catalytic PDE domain of RegA (red cartoon). Binding of 
RegA induces release of cAMP which is consequently hydrolyzed to 5‟ AMP. (B), RegA 
binding disrupts conserved electrostatic charge relays anchoring cAMP to RIα at binding site 





 The cAMP-PKA signaling pathway is highly conserved across all eukaryotes 
from yeast to humans. Although the individual elements of the pathway, namely PKA R 
and C-subunits and PDEs are conserved, higher eukaryotes show an enormous 
complexity in isoforms and splice variants for each of the proteins involved in this 
pathway (Conti and Beavo, 2007). Sophisticated regulatory networks modulate the 
activity of the cAMP signaling pathway wherein intracellular levels of cAMP are 
controlled not only by hormonal stimulation of ACs but also by PDE-mediated hydrolysis 
of cAMP to 5‟ AMP. In order to study interactions between PDEs and PKA we have 
chosen the elements of a simple eukaryotic model- Dictyostelium discoideum which 
presents a simple model for cAMP-PKA signaling with single isoforms of the PKA R 
(RIα) and C-subunit (Cα) that both show high homology to mammalian PKA subunits 
(Canaves and Taylor, 2002). Extensive studies have shown that an N-terminal deletion 
mutant of B. taurus RIα interacts with and activates the D. discoideum PDE, RegA to the 
same extent as the cognate D. discoideum R-subunit (Shaulsky et al., 1998). Our results 
further localize the interactions of RegA to a shorter double truncation mutant lacking the 
N-terminal domain as well as the CNB-B domain, RIα(91-244) which encompasses the 
CNB-A domain. All of the residues involved in cAMP binding and allostery are invariant 
between D. discoideum RIα and mammalian (B. taurus) RIα (Figure: 2.16, (Canaves and 
Taylor, 2002)). Given the strong homology and functional equivalence of mammalian 
and D. discoideum PKA subunits, we have used the mammalian PKA R and C-subunits 
and D. discoideum PDE, RegA to examine direct protein interactions between the two 
groups of proteins. Even though the cAMP signaling proteins used are from separate 
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species, our studies on regulatory interactions have shed light on the mechanism of signal 
termination that is likely to be conserved across all species. Our evidence of allosteric 
communication between PKA and PDEs is thus relevant for cAMP signaling in general 
and cAMP signaling in D. discoideum in particular.  
 
bRIα         91 RRRRGAISAEVYTEEDAASYVRKVIPKDYKTMAALAKAIEKNVLFSHLDDNERSDIFDAM  
DictR           RKRRGAISSEPLGDKPATPLPN--IPKTVETQQRLEQALSNNIMFSHLEEEERNVVFLAM  
rRIα            RRRRGAISAEVYTEEDAASYVRKVIPKDYKTMAALAKAIEKNVLFSHLDDNERSDIFDAM                                
hRIα            RRRRGAISAEVYTEEDAASYVRKVIPKDYKTMAALAKAIEKNVLFSHLDDNERSDIFDAM  
                *:******:*   :: *:.  .  *** :* **. * : **: :*:****** *****.* 
 
 
bRIa            FPVSFIAGETVIQQGDEGDNFYVIDQGEMDVYVNN-----EWATSVGEGGSFGELALIYG  
DictR           VEVLYKAGDIIIKQGDEGDLFYVIDSGICDIYVCQNGGSPTLVMEVFEGGSFGELALIYG  
rRIa            FPVSFIAGETVIQQGDEGDNFYVIDQGEMDVYVNN-----EWATSVGEGGSFGELALIYG  
hRIa            FSVSFIAGETVIQQGDEGDNFYVIDQGETDVYVNN-----EWATSVGEGGSFGELALIYG  
                  :*   * :*:.:*::****:::**.  *:** :       . .* *************  
bRIa            TPRAATVKAKTNVKLWGIDRDSYRRILMGSTLRKRKMYEEFLSKVSILESLDKWERLTVA  
DictR           SPRAATVIARTDVRLWALNGATYRRILMDQTIKKRKLYEEFLEKVSILRHIDKYERVSLA  
rRIa            TPRAATVKAKTNVKLWGIDRDSYRRILMGSTLRKRKMYEEFLSKVSILESLDKWERLTVA  
hRIa            TPRAATVKAKTNVKLWGIDRDSYRRILMGSTLRKRKMYEEFLSKVSILESLDKWERLTVA  
                :****** *:*:*:**.::  :******..*::***:*****.*****. :**:**:::* 
 
bRIa            DALEPVQFEDGQKIVVQGEPGDEFFIILEGSAAVLQRRS--ENEEFVEVGRLGPSDYFGE  
DictR           DALEPVNFQDGEVIVRQGDPGDRFYIIVEGKVVVTQETVPGDHSTSHVVSELHPSDYFGE  
rRIa            DALEPVQFEDGQKIVVQGEPGDEFFIILEGTAAVLQRRS--ENEEFVEVGRLGPSDYFGE  
hRIa            DALEPVQFEDGQKIVVQGEPGDEFFIILEGSAAVLQRRS--ENEEFVEVGRLGPSDYFGE  
                ******:*:**: ** **:***.*:**:**...* *.    ::.    *..* ******* 
 
bRIa            IALLMNRPRAATVVARGPLKCVKLDRPRFERVLGPCSDILKRNIQQYNSFVSLSV-----  
DictR           IALLTDRPRAATVTSIGYTKCVELDRQRFNRLCGPIDQMLRRNMETYNQFLNRPPSSPNL  
rRIa            IALLMNRPRAATVVARGPLKCVKLDRPRFERVLGPCSDILKRNIQQYNSFVSLSV-----  
hRIa            IALLMNRPRAATVVARGPLKCVKLDRPRFERVLGPCSDILKRNIQQYNSFVSLSV-----  
                **** :*******.: *  ***:*** **:*: ** .::*:**:: **.*:. . 
 
bRIa            ----- 381  
DictR           TSQKS  
rRIa            -----  
hRIa            ----- 
 






Figure 2.16: Multiple Sequence Alignment for RIα; Partial multiple sequence alignment of 
RIα sequences. The RIα from species along with the accession number are, Bos taurus (bRIα, 
P00514); Dictyostelium discoideum (DictR, P05987); Rattus norvegicus (rRIα, P09456); 
Homo sapiens (hRIα, P10644). Highlighted residues (D170, E200, R209, and R241) are 
critical for cAMP binding or allosteric activation of PKA. Regions around these residues are 




2.4.1. RegA Phosphodiesterase is capable of Hydrolyzing cAMP-bound to RIα 
 In the cAMP-dependent activation/termination cycle of PKA, cAMP generated by 
the activation of adenylyl cyclases binds PKA leading to dissociation of the C and R-
subunits. Signal termination is assumed to occur through the reverse process of 
reassociation of the subunits and release of cAMP. However two aspects of the signaling 
process remain unclear. How is the cAMP that binds the free R-subunit with high affinity 
(low nM) released before it can reassociate with the C-subunit? It has been demonstrated 
in several studies with [3H]-labeled cAMP (Abu-Abed et al., 2007; Diller et al., 2001) 
that the intrinsic dissociation rate of cAMP from the R-subunit is low as measured by 
dialysis (t ½ > 5 days) (Diller et al., 2001). When excess unlabeled cAMP is included the 
dissociation rates are faster but the important question remains that in the absence of 
excess cAMP, how is the bound cAMP released and signal termination achieved? A 
related aspect is how PKA is better suited to respond to a flux of cAMP rather than to 
fixed levels of cAMP (Abu-Abed et al., 2007)? Our present study underscores the role of 
PDEs in mediating dissociation and hydrolysis of cAMP bound to the R-subunits and is 
critical for signal termination in cAMP signaling.  
The cAMP binding A-domain (CNB:A) of RIα is sufficient for mediating 
interactions with the catalytic PDE domain of RegA. Interaction of RegA with cAMP-
bound RIα catalyzes hydrolysis of cAMP to generate 5‟ AMP and cAMP-free RIα: RegA 
complex as products. Amide HDXMS show that RegA interactions with RIα at a surface 
spanning the PBC. Examination of the structure of the cAMP-binding pocket suggests 
two possibilities of how RegA might mediate hydrolysis of bound cAMP. It could 
recognize bound cAMP and hydrolyze it directly or alternatively RegA binding to the R-
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subunit might induce the active dissociation of cAMP from its high affinity binding site 
with subsequent hydrolysis to 5' AMP. Our PDE activity and fluorescence polarization 
experiments with a PDE-resistant cAMP analog support the latter mechanism (Figure: 
2.15 A). The two steps involved in cAMP release are summarized in Figure: 2.15 B are: 
i)  Binding to cAMP-bound RIα leading to dissociation of cAMP from RIa,   
ii) Activation of PDE catalysis and hydrolysis of the dissociated cAMP generating 
the cAMP-free RIα-RegA complex.  
 
These are described in additional detail below, 
i) Binding to cAMP-bound RIα which weakens interactions between cAMP and RIα: 
Our studies for the first time highlight an important aspect of signal termination in cAMP 
Signaling, namely to understand how cAMP bound to RIα is released. Till now it was 
assumed that this occurred solely through competitive binding of the C-subunit which 
weakens the affinity of cAMP to the R-subunit.  Our FP studies with 8-Fluo-cAMP, a 
fluorescent cAMP analog have been very useful in elaborating a role for PDEs in 
facilitating the dissociation of bound cAMP. Monitoring the dissociation rates of cAMP 
from the R-subunit under various conditions show that RegA is capable of facilitating a 
faster dissociation of cAMP from the R-subunit even in the presence of unlabelled cAMP 
or the C-subunit (Figure: 2.14).   
     ii) Activation of PDE catalysis and hydrolysis of the dissociated cAMP generating the 
cAMP-   free RIα-RegA complex: 
RIα binding results in a 13-X fold activation of PDE catalysis through an effect solely on 
the catalytic rate for the reaction (Figure: 2.7 and 2.8). This enhanced catalysis is 
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observed with cAMP in solution while a significantly lower activity was seen when 
bound cAMP was used as a sole substrate for RegA (Figure: 2.13). A possible 
explanation for this would be that RegA mediates dissociation of bound cAMP at a 
slower rate followed by rapid hydrolysis of the released cAMP. We confirmed this by 
measuring the rates of dissociation of cAMP bound to RIα in the absence and presence of 
RegA (Figure: 2.14 A and B). Our results support a step-wise model whereby RegA 
binds RIα leading to dissociation first followed by hydrolysis of cAMP to 5‟AMP. The 
rate of PDE activity of the RIα-bound protein (kcat = 43.0 min-1) is greater than the rate 
of dissociation of cAMP from RIα (cAMP-off rate = 0.5 min-1). RegA binding mediates 
dissociation of cAMP from PBC of the R-subunit followed by its hydrolysis. RegA thus 
is capable of hydrolyzing both cAMP, free in solution as well as cAMP-bound to the R- 
subunit, the latter via a two-step process. This represents the first known instance of a 
phosphodiesterase actively mediating hydrolysis of cAMP-bound to PKA R-subunits or 
any other CNB domain-containing protein. It is interesting to note the difference in 
affinities of cAMP for the CNB domains in RIα compared to that with the guanine 
exchange factor Epac. The affinity of cAMP to free RIα is in the nanomolar range but is 
1000X weaker for the holoenzyme as well as for the CNB domains of Epac. Thus cAMP 
binds to the PKA R- subunit (KD = 0.2 nM) with ~10000X higher affinity than to Epac1 
(KD = 2.9 μM) (Dao et al., 2006). The ability of PDEs to hydrolyze cAMP-bound to RIα 
through a two-step process might thus be uniquely relevant to it given the higher affinity 
of cAMP to RIα relative to other CNB domain-containing proteins such as Epac, given 




2.4.2. Dual Function of RIα as Inhibitor of C-subunit and Activator of PDEs 
 Our results on the affinities of RegA for both cAMP-bound and cAMP-free forms 
of RIα being nearly identical are not surprising as cAMP is hydrolyzed during the course 
of fluorescence experiments, generating cAMP-free RIα-RegA complex. It should be 
noted that RIα would exist in the cell predominantly in the cAMP-bound or C-subunit-
bound states but only transiently in the cAMP-free state given the high affinity of RIα for 
both cAMP and the C-subunit. We predict that the cAMP-free RIα-RegA complex is thus 
an important intermediate in the signal termination step of cAMP signaling where it 
activates PDE catalysis. This enables adaptation to steady state levels of cAMP and 
ensures reactivation of PKA only upon large fluxes of cAMP levels in the cell (Abu-
Abed et al., 2007). Significantly, cAMP-bound RIα is a substrate for PDEs and an 
activator of PDE catalysis in addition to its well-known role as a cAMP-dependent 
inhibitor of PKA C-subunit. 
2.4.3. RIα Mediates Distinct but Overlapping Interactions with PKA C- subunit and 
RegA-PDE 
 The crystal structure of cAMP-bound RIα (PDB:1RGS) shows that the highly 
conserved PBC provides an important hydrophobic environment for cAMP, shielding it 
from intracellular phosphodiesterases (Diller et al., 2001; Wu et al., 2004). Three regions 
on RIα showed decreased solvent accessibility upon binding to RegA. The first region 
includes the PBC with two sets of fragments spanning residues 205-212 and 199-203 
respectively. The first fragment includes Arg 209 and Ala 210, conserved residues critical 
for anchoring the cyclic phosphate moiety of cAMP (Canaves et al., 2000). The second 
fragment peptide contains two important residues Glu 200 and Ala 202 which are 
81 
 
important for interacting with the 2' OH of the ribose moiety of cAMP (Su et al., 1995). 
A second region spanning β strands 1-2 showed decreased solvent accessibility. 
Interestingly, this region contains residues that are involved in mediating an important 
relay coupling cAMP binding to PKA activation (Abu-Abed et al., 2007; Gibson et al., 
1997). A third region showing decreased solvent accessibility in the RegA-RIα complex 
spans αB:A and αC:A helices, critical for coupling C-subunit and cAMP binding to the 
PBC as well as integrating signals from cAMP:B domain (Anand et al., 2002).  Any of 
these regions alone or together might form the RegA-RIα interaction interface since 
reduced solvent accessibility seen upon RegA binding can be due to shielding of solvent 
as a consequence of direct binding interactions between RIα and RegA or due to binding-
induced conformational changes. It is interesting that the 3 regions we identified on RIα 
as being important for RegA interactions are equally important either for cAMP binding 
or for relaying the allosteric effects of cAMP binding to the rest of the protein. 
Furthermore the solvent protected regions form a contiguous surface distinct from the 
RIα(91-244):C interface (Anand et al., 2002; Kim et al., 2005). None of the other regions 
including the helical subdomain: αX:N helix, A helix, and the B/C helix in the cAMP 
binding A domain that form the interaction interface with C- subunit  showed any 
difference in deuterium exchange in the RegA-RIα complex suggesting that the modes of 
RegA and C-subunit binding to RIα might be different.  Whereas the C-subunit interacts 
with the pseudosubstrate site and helices in the α:subdomain, RegA mainly interacts with 
residues involved in binding cAMP and enabling allosteric effects of cAMP binding 
across the entire molecule. Amide HDXMS data has provided insights into the regions of 
RIα important for interactions with RegA. These include PBC, β-subdomain region (β1-
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β2) and α:B-C-helices, all nearly invariant across R-subunits from all species with a very 












































In humans, there are 11 families of PDEs currently identified and classified with 
more than 60 isoforms distributed specifically to various tissues (Bender and Beavo, 
2006; Conti and Beavo, 2007). Among them PDEs 4, 7 and 8 are cAMP specific, PDEs 
5, 6 and 9 are cGMP specific and all others can hydrolyze both cAMP and cGMP. All 
PDEs possess highly conserved C- terminal catalytic domain, which catalyzes the 
hydrolysis of cyclic nucleotides, but the N- terminal regulatory domains are not 
conserved and possess different structural motifs. One such regulatory domain includes 
the cyclic nucleotide binding domain called the GAF (cGMP specific PDE, Adenylyl 
cyclase, and Fh1A) domain. The GAF domains are mostly found within the cGMP 
specific or the dual specific PDEs (PDE 2, 5, 6, 10 and 11) where binding of 
cGMP/cAMP regulates the activity of enzyme. Unlike the GAF domain containing PDEs 
the cAMP specific PDEs does not possess any nucleotide binding domains to control the 
PDE activation. PDE4 is controlled by PKA and ERK phosphorylation (Conti et al., 
2003); PDE7 is known to be interacting with PKA catalytic subunit (Han et al., 2006) and 
PDE8 is shown to be activated upon interacting with Iκ B (Wu and Wang, 2004).  
The type I cAMP specific PDE, RegA from Dictyostelium discoideum is an 
intracellular PDE which plays critical function as controlling the development of cell 
under starvation condition. The regA null mutant is found to develop faster and produce 
premature spores (Thomason et al., 1999). The PDE domain of RegA has good homology 





binding and substrate binding are highly conserved. We have recently demonstrated 
(chapter 2) that RegA PDE activity is controlled through direct interactions with the 
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regulatory (R) subunit of PKA, where the R- subunit directly interacts with the catalytic 
domain of RegA and increases its PDE activity (Moorthy et al., 2011b). The R-subunit 
consists of two tandem cAMP binding domains, cAMP binding domain A (CNB-A) and 
B (CNB-B). cAMP binding to the R-subunit of the inactive holoenzyme PKA leads to the 
dissociation of active catalytic (C) subunit. Thus a cAMP binding R-subunit is shown to 
negatively regulate a kinase and positively regulate a PDE in terminating the cAMP 
mediated cycle. Here in this chapter the mechanism by which RIα activates RegA and the 
key role of RegA in signal termination are studied.  
3.2 Materials and Methods 
3.2.1. Materials 
 Unless otherwise mentioned all reagents were from Sigma Aldrich (St. Louis, 
MO).  BL21 (DE3) E.coli strains were from Novagen (Madison, WI). Glutathione 
sepharose 4B and NHS-activated sepharose 4 Fast Flow were obtained from GE 
(Chicago, IL). 8-AEA-cAMP is from Biolog Life Science Institute (Bremen, Germany), 
TFA protein sequence analysis grade was from Fluka BioChemika (Buchs, Switzerland), 
Poroszyme immobilized pepsin cartridge was from Applied Biosystems (Foster city, 
CA). EZ-link maleimide PEG2-Biotin reagent were from Thermoscientific Pierce 
(Rockford, IL) and Streptavidin-agarose was from Novagen (Madison, WI). 
3.2.2. Protein Expression and Purification 
 cAMP affinity chromatography resin for R-subunit purification was synthesized 
by coupling 8-AEA-cAMP to the NHS-activated sepharose 4 Fast Flow ®  beads 
according to manufacturer specifications (GE Life Sciences Singapore) (Diller et al., 
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2000). Both cAMP-bound and cAMP-free RIα(91-244) were expressed and purified as 
described previously (Anand et al., 2007). The C-subunit of PKA was expressed and 
purified as described previously (Herberg et al., 1993). RegA (385-780) was expressed as 
a GST fusion protein in E. coli BL21*(DE3). The protein was purified using glutathione 
sepharose 4B (GE Life Sciences) according to manufacturer specifications followed by 
size exclusion-gel filtration chromatography on an AKTA system (GE Life Sciences). 
3.2.3. Amide HDXMS 
 50 μL of 20 μM GST-RegA (385-780) and 60 μM cAMP free RIα (91-244) final 
concentration sample was incubated at room temperature for 30 min. Deuterium 
exchange was carried out by mixing 2 μL of the samples in storage buffer (20 mM 
Tris.HCl, pH 7.5, 50 mM NaCl, 10 mM MgCl2, 5 mM BME) with 28 μL of D2O 
(99.90%) resulting in a final concentration of 93.3% deuterated buffer A (20 mM 
Tris.HCl, pHread 7.5, 50 mM NaCl, 10 mM MgCl2, 5 mM BME). Exchange was carried 
out at 20ºC for various times (0.5, 1, 2, 5 and 10min). The exchange reaction was 
quenched by adding 30 μL of pre-chilled 0.1% TFA to get a final pHread of 2.5. 50 μL of 
the quenched sample was then injected on to a chilled nano-UPLC sample manager (beta 
test version, Waters, Milford, MA) as previously described (Wales et al., 2008). The 
sample was washed through a 2.1 x 30mm immobilized pepsin column (Porozyme, ABI, 
Foster City, CA) using 100 μL/min 0.05% formic acid in water.  The digest peptides were 
trapped on a 2.1 x 5 mm C18 trap (ACQUITY BEH C18 VanGuard Pre-column, 1.7 μm, 
Waters, Milford, MA). Peptides were eluted using an 8-40% gradient of acetonitrile in 
0.1% formic acid at 40 μL/min, supplied by a nanoACQUITY Binary Solvent Manager 
(Waters, Milford, MA), on to a reverse phase column (ACQUITY UPLC BEH C18 
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Column, 1.0 x 100 mm, 1.7 μm, Waters, Milford, MA) for resolution. Peptides were 
detected and mass measured on a SYNAPT HDMS mass spectrometer (Waters, 
Manchester, UK) acquiring in MS
E
 mode (Bateman et al., 2002; Silva et al., 2005). 
 Peptides were identified from MS
E
 data of undeuterated samples using 
ProteinLynx Global Server (PLGS 2.4 (beta test version))(Waters, Milford, MA) 
(Geromanos et al., 2009; Li et al., 2009). Identifications were only considered if they 
appeared at least twice out of three replicate runs.  These identifications were mapped on 
to subsequent deuteration experiments using prototype custom software (DynamX, 
Waters, Milford).  Data from each individual peptide at all time points were extracted and 
analyzed using this software. Instrument calibration and the back exchange calculations 
were carried out as explained before (Anand et al., 2010).  
3.2.4. Pull down assay with immobilized cAMP-bound RIα(91-244) 
To test if RegA primed RIα for reassociation with C- subunit, immobilized 
cAMP-bound RIα(91-244)(R92C) alone and incubated with RegA was used in a pull 
down assay. Immobilized RIα(91-244)(R92C) was prepared by reacting it with EZ-Link 
Maleimide-PEG2-Biotin (spacer arm of 29.1 Ǻ) as per manufacturer‟s instructions 
(Thermo scientific). 10 nmol of maleimide-PEG2-Biotin modified cAMP-bound RIα(91-
244)(R92C) was bound to streptavidin-agarose beads (50 µL) (Novagen) by incubation 
for 20 min at room temperature (23ºC) to yield RIα(91-244) immobilized on agarose 
beads. The beads were then washed 3 times with Buffer B (20 mM Tris-HCl, pH 7.5, 50 
mM NaCl, 10 mM MgCl2 and 0.2 mM ATP) to remove any unbound protein. Two 25 μL 
aliquots of RIα(91-244)(R92C) bound beads were  incubated with 50 nmol of C-subunit 
in buffer B and 50 nmol of C-subunit plus 50 nmol of GST-RegA (385-780) in buffer B 
88 
 
separately for 30 min at room temperature (23ºC). The beads were then collected by 
centrifugation and washed 4 times with buffer B. 15 μL of 1X SDS-PAGE loading dye 
was added to the beads, boiled at 95ºC for 10 min and analyzed on 12 % SDS-PAGE. 
3. 3 Results 
3.3.1. Peptide Array Analysis for RegA:RIα Interactions 
To narrow down the binding site for RIα on RegA, we used peptide array analysis. The 
peptide array analysis serves as one of the powerful techniques to study protein-protein 
interactions. The assay was performed in collaboration with Dr Susan S. Taylor, 
University of California, San Diego. A library of overlapping peptides of 15-mers, each 
with 5 amino acid overhangs based on the sequence of full length RegA was synthesized 
on a cellulose membrane.  Membrane having peptides immobilized from region within 




  (spot A
2
 → 301-315 
residues, spot A
3
 → 306-320 residues and so on). The membrane was then incubated 
overnight with cAMP free full length RIα at 4°C. Subsequently, the membrane was 
washed numerous times and any bound RIα was probed with RIα specific antibodies 
followed by secondary antibodies as like with other immunoblotting assays (Bolger et al., 
2006). Dark spots shown in Figure 3.1 indicate positive interactions of RIα with peptides 
from RegA and are listed in Table 3.1 (Katz et al., 2011). Overlapping peptides which 







 respectively. This region significantly is important for divalent 
metal binding necessary for PDE catalysis. The other region which include overlapping 






. Analysis of 
the modeled 3D structure of RegA shows that these regions are close to each other and 
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form a contiguous structural motif important for interaction with RIα. The structure of 
RegA was modeled using SWISS-MODEL based on the crystal structure of PDE8A 










Table 3.1: Peptides detected and analyzed from peptide array data. RegA peptide 









B7 VNALYRKNNRYHNFT 476-490 
B11 TQTVYTFLTSFNAAQ 496-510 
B15 DIFALLISCMCHDLN 516-530 
B16 LISCMCHDLNHPGFN 521-535 
B17 CHDLNHPGFNNTFQV 526-540 
B23 LENHHAMLTFKILRN 556-570 
B24 AMLTFKILRNSECNI 561-575 
B25 KILRNSECNILEGLN 566-580 
C17 TPFMDKTKTTRARIA 676-690 
D1 MEDPTILVKSKLPKI 746-760 
D5 RDKVSSSSSSSTAPL 766-780 
    
Figure 3.1: Peptide array data shows interaction of RIα with RegA. Peptide libraries were made 
on cellulose membrane as 15-mer peptides each shifted along by five amino acids to the entire 
RegA sequence and probed for interaction with cAMP free RIα. The interactions are detected by 
immunoblotting. Peptides interacts positively with RIα generate dark spots whereas non-
interacting peptide leave white (blank) spots and peptides interacts specifically with RIα are 
shown in red box. Spot numbers (A2 to D8) relate to peptides in the scanned array (A2 to D8,  
spot A2 → 301-315 residues, spot A3 → 306-320 residues and so on to D8→ 781-793) and 




























































Figure 3.2: (A) Homology model (SWISS-MODEL) of RegA (418-731) (green) based on the 
crystal structure of PDE8A (PDB ID: 3ECM) (orange). Yellow and purple spheres represent the 
divalent metal ions, which plays key role in the hydrolysis of substrate. (B) Peptide array data was 
mapped on to the homology model of RegA (418-731). Regions highlighted in blue are the 















3.3.2. Pepsin digestion and peptide identification for RegA 
To further localize the interaction interfaces and accompanying conformational changes, 
amide HDX experiments were carried out as described in materials and methods.  
Undeuterated samples of RegA alone and in complex with RIα were subjected to mass 
spectrometry analysis as described in materials and methods to sequence the pepsin 
digest fragments generated. Overall 32 peptides were detected and analyzed, which 
covers ~ 83% of the RegA (385-780) sequence (Figure: 3.3). Spectra from both 
undeuterated and deuterated samples were visually analyzed to identify the peptides and 











Figure 3.3: Sequence coverage (83%) map for RegA (385-780). Amino acid sequence of RegA 
(385-780) with solid lines denotes the pepsin digest fragments analyzed in the study of RegA (385-




3.3.3. Amide HDXMS 
Based on the KD (1.6 μM, upper limit) for RegA interactions with cAMP free RIα 
(Moorthy et al., 2011b), excess cAMP free RIα  (91-244) (60 μM) was incubated with 
RegA (385-780) (20 μM) and the exchange reactions carried out as described in materials 
and methods. Under such conditions ≥ 75% of RegA (385-780) would be expected to be 
saturated with RIα (91-244) during deuterium exchange and allowed us to monitor the 
changes in RegA upon interactions with RIα. ESI-QTOF spectra for some of the peptides 
from RegA (385-780) which show significant difference in deuterium exchange (10 min) 
upon interactions with RIα (91-244) are shown in Figure 3.4. The results from the amide 
HDXMS experiment correlate with peptide array results. A decrease in average 
deuterium exchange was observed for pepsin digest peptides, 404-425, 424-446, 525-538, 
547-552, 549-556, 557-565, 643-651, 656-661, 668-693 and 715-726 from three different 
and functionally important regions of RegA in the presence of RIα. The data from our 
HDXMS experiment were mapped on to the modeled structure of RegA (Figure: 3.5) and 
is also plotted as butterfly plot for an overview of changes across the entire protein 












































































Figure 3.4: (A) ESI-QTOF mass spectra of pepsin digest fragments from different regions of 
RegA (385-780) that showed significant changes in amide H/D exchange upon interactions 
with RIα (91-244). (i) The isotopic envelope for the peptides from RegA (385-780) in the 
presence of RIα (91-244) after 10 min deuteration (ii) The isotopic envelope for the peptides 
from RegA (385-780) in the absence of RIα (91-244) after 10 min deuteration; (iii) 
undeuterated isotopic envelope  of peptides from RegA (385-780). (B): Time course (1 - 10 
min) of deuterium exchange for peptides from RegA (385-780). Open circle (○), RegA (385-















































3.3.4. RegA-Rα interactions alter regions within metal binding site 
The PDE catalytic domain is composed of 16 α-helices and is divided into three 
subdomains, the N-terminal cyclin-fold region, the linker region and the C-terminal 
helical bundle. The hydrophobic pocket of these sub-domains comprises of four subsites, 
the metal binding M site, and the substrate binding core Q pocket, a hydrophobic H 
pocket, and a lid region (Sung et al., 2003 106). Within RegA, regions containing 
residues H491, H527, D528 and D639 from the M site are shown to be protected from 
Figure 3.5: The metal ions binding sites are critical for RIα-RegA interactions. The amide HDX 
and mass spectrometry data was mapped on to the homology model of RegA (418-731). Regions 
showing decreased deuterium exchange in the presence of RIα (91-244) are labeled blue, regions 
with no difference are in green and regions missing in the analysis are grey. The inset figure 
shows residues that are critical for metal ions binding; purple and yellow spheres represent the 







deuteration upon interactions with RIα. From the multiple sequence analysis, these 
residues are highly conserved across species and are critical for the coordination of two 




 (Figure: 3.9). Crystal structure analysis of homologous 
PDEs explains that Zn
2+
 forms six coordinations with H491, H527, D528, D639 and two 
water molecules, thus this metal forms an integral component of PDEs. Whereas Mg
2+
 is 
coordinated by D528 along with five water molecules and thus it is a weak binder 
compared to Zn
2+
. Results from our deuterium exchange experiment shows that pepsin 
digest fragment 525-538, which span residues H527 and D528, are protected from 
deuteration. In correlation with peptide array result, the other region which shows 
protection in deuteriation is 557-565. These two regions are close to each other and might 
form a contiguous structural motif important for interaction with RIα 
3.3.5. Substrate binding pocket is stabilized during RegA- RIα interactions 
Comparative analysis of ligand bound and unbound crystal structures of homologous 
PDEs have enabled the identification of residues playing key role in the substrate 
binding. Residues, Y486, H487, H491, H527, D528, H531, M600, D639, I640, N642, 
S654, V657, F661, and F693 in RegA are highly conserved across different PDE families 
and are important for the substrate binding (Ke and Wang, 2007). From the modeled 
RegA structure, region spanning residues 535-550 form helices α8 and α9 is called the H-
loop and residues 671-686 which span and connect α14 and α15 is called the M-loop. 
Both H- and M-loops are involved in the substrate binding. These loops are highly 
dynamic and exist in different conformations with different PDEs in different liganded 
states (Huai et al., 2004). The different conformations of the loops determine the 
architecture of the active site and specificity for substrate/inhibitor. Peptic peptides, 
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which span some of these regions along with residues critical for substrate binding, 
include 525-538, 656-661 and 668-693 showed decreased exchange upon interactions 
with RIα. The protection seen within these regions reflect the stabilization of substrate 
binding pocket and may be one of the possible mechanisms for facilitating increased 






























































































































































































































































































































































































































































































































































































































































































































































































Figure 3.6: (A) Butterfly plot showing the relative fractional exchange (y-axis) for all the peptic 
peptides (x-axis) from RegA (385-780) during amide HDXMS. The data for RegA (385-780) alone 
(top) and in complex with RIα (91-244) (bottom) are plotted in different colors, orange, red, cyan, 
blue and black for 0.5, 1, 2 5 and 10 min respectively. (B) Differences in HDX levels between 
RegA (385-780) alone and in complex with RIα (91-244) are plotted in different colors as in Figure 
3.6A.  Blue dashed boxes highlight regions within RegA showing decreased deuterium exchange 
upon complexation with RIα. Plots are the average from two independent HDXMS experiment 




3.3.6. RegA primes RIα for reassociation with C-subunit 
Our earlier work on RegA-RIα interactions clearly showed that RegA binding to cAMP-
bound RIα mediates dissociation of bound cAMP followed by hydrolysis, generating 
cAMP-free RIα bound to RegA (Chapter 2). Here, we then set out to test the effects of C-
subunit on this complex. We immobilized RIα using a specific biotin-maleimide tag 
covalently attached to RIα at residue 92 bound to streptavidin-agarose beads as described 
in materials and methods. We next compared the effects of RegA binding and hydrolysis 
of cAMP-bound to RIα on the ability of the C-subunit to reassociate with the R-subunit. 
Our results indicate that the C-subunit binds strongly to cAMP-free RIα and displaces 
RegA while it binds poorly to the cAMP-bound RIα that is not hydrolyzed by RegA 
(Figure: 3.7). These results together with our previous studies (Chapter 2) show that 
RegA binding to RIα facilitates dissociation of cAMP followed by subsequent hydrolysis 
to 5‟AMP, generating the cAMP-free RIα. This is now poised to reassociate with the free 
C-subunit in the presence of Mg
2+
 and ATP. Thus, RegA primes RIα for reassociation 
















































3. 4 Discussion 
Previous studies on the regulation of PDEs reveal several mechanisms; these 
include phosphorylation (Baillie et al., 2000; MacKenzie et al., 2002), ligand interaction 
(Okada and Asakawa, 2002) and protein interaction (Shaulsky et al., 1998; Wu and 
Wang, 2004). Such regulatory mechanisms are carried out by molecules within the 
pathway, PKA (phosphorylation and interactions), cAMP/cGMP (interactions) and 
AKAPs (interactions). The most novel and important regulatory feedback between the 
RIα of PKA and PDE, RegA shows that PDEs actively dissociate and catalyze the 
Figure 3.7: RegA primes RIα for reassociation with C-subunit; Biotinylated cAMP-bound RIα 
(91-244)(R92C) was bound to Streptavidin-agarose and incubated with C-subunit in the presence 
and absence of RegA as described in materials and methods, the samples were then analyzed by 
SDS-PAGE. Lane 1: C-subunit and immobilized RIα in the absence of RegA; Lane 2: C-subunit 
and immobilized RIα in the presence of RegA; Lane 3: C-subunit and Maleimide-PEG2-Biotin-
Streptavidin agarose beads (control). 
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hydrolysis of cAMP bound to RIα (Moorthy et al., 2011b). Also in turn RIα activates 
PDE via this interactions. The mechanism by which RIα activates PDE was not answered 
in our earlier study (Chapter 2), here we proposed to identify the key regions in PDE 
which are important for interactions with RIα followed by activation.  
Amide HDXMS is a widely used technique in the study of macromolecular 
interactions. Although contribution of this method is significant in the field of structural 
biology, mapping interfaces for protein-protein interactions and differentiating interfaces 
from interaction mediated conformational changes are highly challenging. Here in this 
work we first performed peptide array analysis for RegA-RIα interactions to identify 
regions important for interactions. Peptides from different regions which show high 
intensity are the indication of specific binding, than the one which binds randomly with 
sequences.   In addition to mapping the interface for the complex we further used amide 
HDXMS to monitor the conformational changes in RegA upon interactions with RIα. 
Results from our peptide array data reveals that the binding sites for RIα on RegA 
in RegA-RIα interactions are critical for divalent metal binding. The metals play key role 
in catalyzing hydrolysis of cAMP substrate. These results are highly consistent with our 
amide HDXMS data. Functionally 2 important regions in RegA which include, divalent 
metal binding site and region within substrate binding pocket are shown to have 
significant protection against deuteration. We believe that regions that are consistent in 
our peptide array and the amide HDXMS data are binding interface for RegA-RIα 
interactions. In such case RIα binding to these sites on RegA stabilizes the Zn2+ and Mg2+ 
metal binding. Our amide HDXMS data analysis also underscores the mechanism behind 
RegA activation, where direct interaction of RIα with RegA increases the catalytic 
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turnover rate for cAMP. The decreased deuterium exchange seen within the substrate 
binding pocket in RegA suggests a mechanism, where RIα binding to RegA stabilizes the 
pocket allosterically and increases the rate of cAMP hydrolysis. 
Results from our pull down experiments show that RegA binding primes cAMP-
bound RIα for reassociation with the C-subunit. C-subunit predictably associates weakly 
with cAMP-bound RIα but preincubation/addition of RegA leads to strong binding to 
cAMP-free apo RIα. This also indicates that the C-subunit is capable of displacing RegA 
from the cAMP free RegA-RIα complex leading to signal termination. We propose a 
model for this mechanism below. 
3. 5 Conclusion 
It has been assumed until now that reassociation of the PKA holoenzyme occurs 
through a reversal of the activation process where C-subunit binding to cAMP-bound 
RIα, facilitates dissociation of cAMP, leading to regeneration of the holoenzyme (Ogreid 
and Doskeland, 1983). This is supported by evidence showing affinity of cAMP for the 
holoenzyme being significantly lower than that for free RIα (Dao et al., 2006). In such a 
process, PDEs would only play a passive role in hydrolyzing the cAMP released upon C-
























We describe for the first time an alternate mechanism where RIα activates PDE 
catalysis several fold, leading to hydrolysis of bound cAMP. These studies highlight a 
universal model for cross-talk between R-subunits and PDE catalytic domains which 
plays important roles in signal termination of second messenger cAMP signaling (Figure: 
3.8). Given that the PDE catalytic domains across species are highly conserved (Conti 
and Beavo, 2007),(Berman et al., 2005; Canaves and Taylor, 2002), We strongly believe 
that these interactions are also likely to be conserved among mammalian PDEs as well 
(Figure: 3.9). 
 
Figure 3.8: Proposed model for the role of PDEs in signal termination of PKA. cAMP activates 
PKA by facilitating dissociation of the holoenzyme into cAMP-bound R-subunit and free C-
subunit which then catalyzes the phosphorylation of numerous intracellular substrates. PDEs bind 
the cAMP-bound R-subunit, induce cAMP dissociation and parallel hydrolysis of cAMP. The 
cAMP-free R subunit generated enhanced activity of the associated PDE and is primed to re-
associate with the C-subunit regenerating the PKA holoenzyme. 
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RegA        385 KLIKNDSVDPVTKSFLVSEFSSTTSRRNSIPTFPQTTYNRDTKEVIKGWEFDVFKYSEDD 
PDE9A           AARSSRTNCPCKYSFLDNHKKLTP--RRDVPTYPKYLLSPETIEALRKPTFDVWLWEPNE 
PDE8A           RLSGNEYVLSTKNTQMVSSNIITPISLDDVPPRIARAMENEEYWDFDIFELEAATHN-RP 
PDE7A           RLLSFQRYLRSSRFFRGTAVSNSLNILDDDYNGQAKCMLEKVGNWNFDIFLFDRLTNGNS 
PDE4A           PMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRS 
PDE10A          RIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVR------LCKEIELFHFDIGPFE 
PDE11A          QVKKSWAKQSVALDVLSYHATCSKAEVDKFK---AANIPLVSELAIDDIHFDDFSLDVDA 
PDE6A           VKCDNEEIQKILKTREVYGKEPWECEEEELAEILQAELPDADKYEINKFHFSDLPLTELE 
PDE5A           AVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLE 
PDE3A           RKASACSTYAPETMMFLDKPILAPEPLVMDNLDSIMEQLNTWNFPIFDLVENIGRKCGRI 
PDE2A           KVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDS-NFASFTYTPRSLPEDD 
PDE1A           PKFRSIVHAVQAGIFVERMYRKTYHMVGLAYPAAVIVTLKDVDKWSFDVFALNEASGEHS 
                                                                                       
 
RegA            LMPLLVDMFENFQLPEIFKIPIEKLQRFIMTVNALYRKNN-RYHNFTHAFDVTQTVYTFL 
PDE9A           MLSCLEHMYHDLGLVRDFSINPVTLRRWLFCVHDNYR-NN-PFHNFRHCFCVAQMMYSMV 
PDE8A           LIYLGLKMFARFGICEFLHCSESTLRSWLQIIEANYHSSN-PYHNSTHSADVLHATAYFL 
PDE7A           LVSLTFHLFSLHGLIEYFHLDMMKLRRFLVMIQEDYHSQN-PYHNAVHAADVTQAMHCYL 
PDE4A           LTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADV-AYHNSLHAADVLQSTHVLL 
PDE10A          NMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYR-RV-PYHNWKHAVTVAHCMYAIL 
PDE11A          MITAALRMFMELGMVQKFKIDYETLCRWLLTVRKNYR-MV-LYHNWRHAFNVCQLMFAML 
PDE6A           LVKCGIQMYYELKVVDKFHIPQEALVRFMYSLSKGYR-KI-TYHNWRHGFNVGQTMFSLL 
PDE5A           TALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNV-AYHNWRHAFNTAQCMFAAL 
PDE3A           LSQVSYRLFEDMGLFEAFKIPIREFMNYFHALEIGYRDIP--YHNRIHATDVLHAVWYLT 
PDE2A           TSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYR-DP-PYHNWMHAFSVSHFCYLLY 
PDE1A           LKFMIYELFTRYDLINRFKIPVSCLITFAEALEVGYSKYKNPYHNLIHAADVTQTVHYIM 
                       :                :  :   :   *      :**  *   . :       
 
RegA            TS--------------------------------------------FNAAQYLTHLDIFA 
PDE9A           WL--------------------------------------------CSLQEKFSQTDILI 
PDE8A           SK--------------------------------------------ERIKETLDPIDEVA 
PDE7A           KE--------------------------------------------PKLANSVTPWDILL 
PDE4A           AT--------------------------------------------PALDAVFTDLEILA 
PDE10A          QN--------------------------------------------N--HTLFTDLERKG 
PDE11A          TT--------------------------------------------AGFQDILTEVEILA 
PDE6A           VT--------------------------------------------GKLKRYFTDLEALA 
PDE5A           KA--------------------------------------------GKIQNKLTDLEILA 
PDE3A           TQPIPGLSTVINDHGSTSDSDSDSGFTHGHMGYVFSKTYNVTDDKYGCLSGNIPALELMA 
PDE2A           KN--------------------------------------------LELTNYLEDIEIFA 
PDE1A           LH--------------------------------------------TGIMHWLTELEILA 
                                                                    .   :    
 
RegA            LLISCMCHDLNHPGFNNTFQVNAQTELSLEYN-DISVLENHHAMLTFKILR-NSECNILE 
PDE9A           LMTAAICHDLDHPGYNNTYQINARTELAVRYN-DISPLENHHCAVAFQILA-EPECNIFS 
PDE8A           ALIAATIHDVDHPGRTNSFLCNAGSELAILYN-DTAVLESHHAALAFQLTTGDDKCNIFK 
PDE7A           SLIAAATHDLDHPGVNQPFLIKTNHYLATLYK-NTSVLENHHWRSAVGLLR---ESGLFS 
PDE4A           ALFAAAIHDVDHPGVSNQFLINTNSELALMYN-DESVLENHHLAVGFKLLQ-EDNCDIFQ 
PDE10A          LLIACLCHDLDHRGFSNSYLQKFDHPLAALY--STSTMEQHHFSQTVSILQ-LEGHNIFS 
PDE11A          VIVGCLCHDLDHRGTNNAFQAKSGSALAQLYG-TSATLEHHHFNHAVMILQ-SEGHNIFA 
PDE6A           MVTAAFCHDIDHRGTNNLYQMKSQNPLAKLH--GSSILERHHLEFGKTLLR-DESLNIFQ 
PDE5A           LLIAALSHDLDHRGVNNSYIQRSEHPLAQLY--CHSIMEHHHFDQCLMILN-SPGNQILS 
PDE3A           LYVAAAMHDYDHPGRTNAFLVATSAPQAVLYN-DRSVLENHHAAAAWNLFMSRPEYNFLI 
PDE2A           LFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILN-THGCNIFD 
PDE1A           MVFAAAIHDYEHTGTTNNFHIQTRSDVAILYN-DRSVLENHHVSAAYRLMQ-EEEMNILI 
                   ..  ** :* * .: :        :  :    : :* **      :        ::   
 
RegA            GLNEDQYKELRRSVVQLILATDMQNHFEHTNKFQHHLNNL-----------------PFD 
PDE9A           NIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEKMEN-------------------FD 
PDE8A           NMERNDYRTLRQGIIDMVLATEMTKHFEHVNKFVNSINKPLATLEENGETDKNQEVINTM 
PDE7A           HLPLESRQQMETQIGALILATDISRQNEYLSLFRSHLDRG-----------------DLC 
PDE4A           NLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSG-----------VLL 
PDE10A          TLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTG-----------------SLN 
PDE11A          NLSSKEYSDLMQLLKQSILATDLTLYFERRTEFFELVSKG-----------------EYD 
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PDE6A           NLNRRQHEHAIHMMDIAIIATDLALYFKKRTMFQKIVDQSKTYESE-------QEWTQYM 
PDE5A           GLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKN-----------------QFN 
PDE3A           NLDHVEFKHFRFLVIEAILATDLKKHFDFVAKFNGKVNDDVG----------------ID 
PDE2A           HFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVG------------------YD 
PDE1A           NLSKDDWRDLRNLVIEMVLSTDMSGHFQQIKNIRNSLQQP-------------------- 
                 :           :   :::*::         :                  
 
RegA            RNKKEDRQMILNFLIKCGDISNIARPWHLNFEWSLRVSDEFFQQSHYETICG--YPVTPF 
PDE9A           YSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEG--LPVAPF 
PDE8A           LRTPENRTLIKRMLIKCADVSNPCRPLQYCIEWAARISEEYFSQTDEEKQQGLPVVMPVF 
PDE7A           LEDTRHRHLVLQMALKCADICNPCRTWELSKQWSEKVTEEFFHQGDIEKKY--HLGVSPL 
PDE4A           LDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERG--MEISPM 
PDE10A          LNNQSHRDRVISLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGD-EMKKLGIQPIPMM 
PDE11A          WNIKNHRDIFRSMLMTACDLGAVTKPWEISRQVAELVTSEFFEQGDRERLELKLTPSAIF 
PDE6A           MLEQTRKEIVMAMMMTACDLSAITKPWEVQSQVALLVAAEFWEQGDLERTVLQQNPIPMM 
PDE5A           LEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLM 
PDE3A           WTNENDRLLVCQMCIKLADINGPAKCKELHLQWTDGIVNEFYEQGDEEASLG--LPISPF 
PDE2A           RNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNR-PMEMM 
PDE1A           --EGIDRAKTMSLILHAADISHPAKSWKLHYRWTMALMEEFFLQGDKEAELG--LPFSPL 
                              :   *:    :           :  *:: : . *   
 
RegA            MDKTKTTRARIAADFIDFVASPLFQSMAKFLK--ESQFLLKVISKNRENWQAYMELQKEG 
PDE9A           MDRDKVTKATAQIGFIKFVLIPMFETVTKLFP----MVEEIMLQPLWESRDRYEELKR-- 
PDE8A           DRNTCS-IPKSQISFIDYFITDMFDAWDAFVD--LP-DLMQHLDNNFKYWKGLDEMKLRN 
PDE7A           CDRHTESIANIQIGFMTYLVEPLFTEWARFSNTRLSQTMLGHVGLNKASWKGLQREQSSS 
PDE4A           CDKHTASVEKSQVGFIDYIVHPLWETWADLVHP-DAQEILDTLEDNRDWYYSAIRQSPSP 
PDE10A          DRDKKDEVPQGQLGFYNAVAIPCYTTLTQILP--PTEPLLKACRDNLSQWEKVIRGEETA 
PDE11A          DRNRKDELPRLQLEWIDSICMPLYQALVKVNV--KLKPMLDSVATNRSKWEELHQKRLLA 
PDE6A           DRNKADELPKLQVGFIDFVCTFVYKEFSRFHE--EITPMLDGITNNRKEWKALADEYDAK 
PDE5A           NREKKNKIPSMQVGFIDAICLQLYEALTHVSE--DCFPLLDGCRKNRQKWQALAEQQEKM 
PDE3A           MDRSAPQLANLQESFISHIVGPLCNSYDSAGLMPGKWVEDSDESGDTDDPEEEEEEAPAP 
PDE2A           DRE-KAYIPELQISFMEHIAMPIYKLLQDLFP--KAAELYERVASNREHWTKVSHKFTIR 
PDE1A           CDRKSTMVAQSQIGFIDFIVEPTFSLLTDSTEKIVIPLIEEASKAETSSYVASSSTTIVG 
                              :   .                                
 
RegA            KCNDDDLQFMEDPTILVKSKLPKIDEEENRDKVSSSSSSSTAPL 780 
PDE9A           --IDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA---- 
PDE8A           LRPPPE-------------------------------------- 
PDE7A           EDTDAAFELNSQLLPQENRLS----------------------- 
PDE4A           PPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEA 
PDE10A          TWISSPSVAQKAAASED--------------------------- 
PDE11A          STASSSPASVMVAKEDRN-------------------------- 
PDE6A           MKVQEEKKQKQQSAKSAAAGNQPGGNPSPGGATTSKSCCIQ--- 
PDE5A           LINGESGQAKRN-------------------------------- 
PDE3A           NEEETCENNESPKKKTFKRRKIYCQITQHLLQNHKMWKKVIEEE 
PDE2A           GLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE-------- 






Figure 3.9: Partial multiple sequence alignment of human (Homo sapiens) phosphodiesterases 
with RegA(385-780), The PDEs along with the accession number are, RegA (AAB03508); PDE9A 
(AAC39778); PDE8A (AAC39763); PDE7A (AAI26361); PDE4A (AAC35015); PDE10A 
(AAI04861); PDE11A (AAI14432); PDE6A (AAH35909); PDE5A (AAP21809); PDE3A 
(AAI17372); PDE2A (AAH40974); PDE1A (AAH22480). Highlighted residues in yellow are 
critical for interactions with substrate or cAMP while highlighted residues in green are important 
for coordination of divalent metal ions required for catalysis. (*) denotes invariant, (:), conserved 














Multi-State Allostery in Response Regulators: Phosphorylation and 











The ability of signaling proteins to toggle between „inactive‟ and „active‟ states 
constitutes the molecular basis of signal transduction. Phosphorylation plays a central 
role in signaling pathways, serving to promote the switching in signaling proteins. 
Histidine-Aspartate phosphorelays function to regulate Two-component signaling (TCS) 
pathways, which play a role in stimulus-response coupling in bacteria and lower 
eukaryotes (Stock et al., 2000). In this mode of signaling, diverse stimuli are detected by 
a sensory domain attached to a Histidine Kinase (HK) which forms the first component. 
Sensory domain activation leads to enhanced autophosphorylation of a conserved His 
within the HK. This phosphate is then transferred to a conserved aspartyl residue on the 
second component, the response regulator (RR) either directly or through an intermediary 
phosphotransfer protein (HPt) (Egger et al., 1997; Mizuno, 1998) Phosphorylation of RRs 
results in modulation of the activity of an associated effector domain leading to 
generation of a response (Galperin, 2010).  
RRs consist of highly conserved Receiver domains connected to diverse effector domains 
ranging from transcription factors to enzymes (Stock et al., 2000). Some RRs, like CheY 
and Spo0F only consist of Receiver domains and completely lack effector domains. X-
ray crystallography and NMR of individual Receiver domains have provided high 
resolution snapshots of the Receiver domain fold and the position of the conserved 
aspartate, site of phosphorylation and the Mg
2+
 binding site. All RR Receiver domains 
are α/β proteins consisting of a central five-stranded parallel β-sheet surrounded by five 
α-helices. In CheY, several residues in addition to the aspartate site of phosphorylation 
are conserved across all RRs, such as Asp 12 and 13, required for Mg
2+
 binding, Thr 87 
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and Lys 109 are clustered around the site of phosphorylation (reviewed in (Stock et al., 
2000)).  While various effects of phosphorylation have been identified in different RRs, 
such as promotion of protein-protein or protein-DNA interactions, relief of inhibition or 
rearrangement of catalytic core residues, a major riddle remains on how phosphorylation 
of a conserved Receiver domain leads to activation of diverse effector domains. It is 
equally intriguing how despite having similar architectures and clusters of conserved 
residues, RRs show a range of half-lives for the phosphorylated states from seconds to 
hours (Robinson et al., 2000; Stewart, 1993; Zapf et al., 1996).Original models to 
describe this fundamental problem were based on the premise that phosphorylation 
induced changes in the active site are propagated across the entire molecule (Hurley et 
al., 1990). More recently, these have given way to models that assume signaling proteins 
exist in ensembles of multiple conformational states in equilibrium, with phosphorylation 
functioning to alter the equilibrium. These have been variously referred to as „allosteric 
activation‟(Volkman et al., 2001), Conformational Selection (Badireddy et al., 2011; 
Boehr et al., 2009) or population shift (Dyer and Dahlquist). For consistency, we refer to 
this model as „Conformational Selection‟ throughout the rest of the manuscript. 
Previous structural studies by X-ray crystallography on the phosphorylated and 
unphosphorylated states of RRs have attempted to unravel the effects of phosphorylation 
by comparisons of the unphosphorylated and phosphorylated states (Bourret, 2010). 
Readily identifiable differences are found to be the orientation of side chains of two 
highly conserved residues, Ser/Thr and Phe/Tyr (Thr 87 and Tyr 106 in CheY)(Robinson 
et al., 2000). An aromatic switch hypothesis, which postulates that the positioning of the 
aromatic residue correlates with function (Y-T coupling), has been considered to be the 
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basis for the phosphorylation-dependent activation of RRs (Birck et al., 1999; Lee et al., 
2001; Lewis et al., 1999). Mutation of the conserved Tyr to Trp in CheY was found to 
exhibit increased activity, comparable to phosphorylated CheY, where activation of 
CheY results in reduced swimming and increased tumbling of E. coli (Zhu et al., 1997; 
Zhu et al., 1996). Comparison of structures of unphosphorylated wild type CheY and the 
constitutively active mutant CheY Y106W have provided a basis for the aromatic switch 
hypothesis (Simonovic and Volz, 2001; Zhu et al., 1997).  This has however been proven 
inadequate in explaining the mechanistic basis for phosphorylation of RRs (Dyer and 
Dahlquist, 2006; Volkman et al., 2001). X-ray crystallography provides valuable high 
resolution structures of proteins but these remain snapshots of endpoint conformations 
that are influenced by crystallization conditions. Morphing of the two endstates provides 
an explanation for the molecular effects of phosphorylation that can be equally explained 
by „Induced-Fit‟ or „Conformational Selection‟. NMR studies have provided a clearer 
picture of the timescales of domain movements in RRs and indicate dynamics in the 
millisecond to second timeframe (Feher and Cavanagh, 1999; Henzler-Wildman and 
Kern, 2007; Volkman et al., 2001). These further provide stronger support for 
„Conformational Selection‟ and suggest intrinsic switching of RRs between two endpoint, 
inactive and active states.  
Despite extensive X-ray crystallography and NMR, detailed correlation between 
structure, dynamics and function are not clear. There have been no structures of 
phosphorylated states of multidomain RRs. Some of these larger RRs are also not 
amenable to NMR studies. This has limited understanding of the molecular details of how 
the effects of phosphorylation of the Receiver domain are transmitted across to the 
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effector domain in multidomain RRs. In this study, we report structure and dynamics of 
the phosphorylation-mediated regulation of the multidomain RR, RegA 
phosphodiesterase from the soil amoeba, Dictyostelium discoideum which serves to 
regulate intracellular levels of the second messenger cAMP, and plays an important role 
in development (Bagorda et al., 2009; Kim et al., 1998). RegA is one of few RRs, where 
the effector domain is a cAMP phosphodiesterase (PDE) whose activity is controlled by 
phosphorylation of the Receiver domain. This makes it an ideal model to quantitate and 
correlate enzyme activity with phosphorylation of the Receiver domain. Amide HDXMS 
is a powerful method to monitor conformational changes of proteins in solution 
(Konermann et al., 2011; Moorthy et al., 2011a; Tsutsui and Wintrode, 2007; Wales and 
Engen, 2006) and has been applied to probing effects of phosphorylation of RRs (Hughes 
et al., 2001; Liu et al., 2009). In this study, we have compared the amide HDX of 
unphosphorylated, phosphorylated and a constitutively active aromatic switch residue 
mutant, RegA F262W. Our results support coupling of the aromatic switch residue with 
the Aspartate site of phosphorylation but indicate that there are more than one „active‟ 
states, since the effects of the mutation do not match those of phosphorylation. We also 
report evidence for phosphorylation leading to large-scale reductions in dynamics of the 







4.2 Materials and Methods: 
4.2.1. Reagents 
The expression vector pQE-30, E.coli M15 and BL21 (DE3) cells were from QIAGEN 
(Valencia, CA); restriction endonucleases and DNA modifying enzymes were from New 
England Biolabs (Beverly, MA); calf intestinal alkaline phosphatase was from Fermentas 
(Burlington, Canada). TALON metal affinity resin was from Clontech Laboratories 
(Mountain view, CA), cyclic nucleotide phosphodiesterase assay kit was from BIOMOL 
(Plymouth Meeting, PA), trifluoroacetic acid, protein sequence analysis grade, was from 
Fluka BioChemika (Buchs, Switzerland). All other reagents were from Sigma Aldrich 
(St. Louis, MO). 
4.2.2. Cloning, expression and purification of RegA and mutants 
A bacterial expression vector for RegA was a gift from Dr. William Loomis, Center for 
Molecular Genetics, Department of Biology, University of California San Diego. regA 
mutant (F262W and D212N) plasmids were obtained from wild type pQE-10-regA 
plasmid by site directed mutagenesis using overlap PCR technique. The plasmids were 
transformed into E.coli M15 strain for the overexpression of protein. Both wild type 
RegA and mutants were expressed as hexahistidine proteins and purified as per 
manufacturer‟s specifications (Talon, Clontech Laboratories) followed by size exclusion-
gel filtration chromatography on an AKTA system (GE Life Sciences). RegA (385-780) 
(RegAC) was expressed and purified as described (Moorthy et al., 2011b). The domain 
organization of RegA has been previously described to contain a Receiver domain (163-
280) and a catalytic PDE domain (486-723) connected by a linker (Thomason et al., 
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1998). A summary of all the samples, including mutants and fragments analyzed in the 
study are shown in Figure 4.1. 
4.2.3. Phosphodiesterase activity assay 
RegA and RegA F262W were assayed for PDE activity using a colorimetric cyclic 
nucleotide phosphodiesterase assay (BIOMOL, Plymouth Meeting, PA). To measure the 
activity difference, 50 nM of RegA or RegA F262W are incubated with different 
concentrations (10-400 μM) of cAMP separately at room temperature (23°C) for 15 min. 
Assays were carried out in  20 mM Tris-HCl, pH 7.5, 50 mM NaCl, 10 mM MgCl2, and 5 
mM BME in a total reaction volume of 50 μL. The reactions were then quenched by 
addition of 100 μL of BIOMOL green reagent (malachite green) and the levels of 
phosphate in the supernatant were quantitated based on absorbance at 620 nm. This 
linked PDE assay measures PDE activity by monitoring the amount of product, 5‟ AMP 
indirectly, where free inorganic phosphate generated by calf intestinal alkaline 
phosphatase by hydrolysis of 5‟ AMP is detected by BIOMOL green reagent that 
interacts with free phosphate, which in turn increases absorbance at 620 nm. The 
calculated values were then used to determine the kinetic parameters, Km and kcat through 
the curve-fit program for Michaelis-Menten Kinetics (GraphPad Prism 5.0). 
4.2.4. Amide HDXMS studies 
The protein samples RegA, RegA F262W and RegAC were concentrated to ~50 μM. Sample 
RegA was preincubated with 50 mM final concentration of phosphoramidate to generate  
phosphorylated RegA. Deuterium exchange was carried out by mixing 2 μL of the samples in 
storage buffer (20 mM Tris-HCl, pH 7.5, 50 mM NaCl, 10 mM MgCl2, 5 mM BME (buffer 
A) for RegA, RegA F262W and RegAC and 20 mM Tris-HCl, pH 7.5, 50 mM NaCl, 10 mM 
MgCl2, 50 mM phosphoramidate, 5 mM BME (buffer B) for phosphorylated RegA with 18 
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μL of D2O (99.90%) resulting in a final concentration of 90.0% deuterated buffer A for 
RegA, RegA F262W and RegAC and deuterated buffer B for phosphorylated RegA. 
Deuterium on exchange was carried out at 20ºC for various times (0.5, 1, 2, 5 and 10 min). 
Single time point (10 min) deuterium exchange for a control sample (RegA D212N) was 
carried out with buffer B. The exchange reaction was quenched by addition of 40 μL of pre-
chilled 0.1% TFA to get a final pHread of 2.5. 50 μL from the quenched sample (~ 90 pmol 
protein sample) was then injected on to a chilled nano-UPLC sample manager (beta test 
version, Waters, Milford, MA) as previously described. The sample was washed through a 
2.1 x 30mm immobilized pepsin column (Porozyme, ABI, Foster City, CA) using 100 
μL/min 0.05% formic acid in water. The digest peptides were trapped on a 2.1 x 5 mm C18 
trap (ACQUITY BEH C18 VanGuard Pre-column, 1.7 μm, Waters, Milford, MA). Peptides 
were eluted using an 8-40% gradient of acetonitrile in 0.1% formic acid at 40 μL/min, 
supplied by a nanoACQUITY Binary Solvent Manager (Waters, Milford, MA), on to a 
reverse phase column (ACQUITY UPLC BEH C18 Column, 1.0 x 100 mm, 1.7 μm, Waters, 
Milford, MA) for resolution. Peptides were detected and mass measured on a SYNAPT 
HDMS mass spectrometer (Waters, Manchester, UK) acquiring in MSE mode (Bateman et al., 
2002).  
Peptides were identified from MSE data of undeuterated samples using ProteinLynx Global 
Server (PLGS 2.4 (beta test version))(Waters, Milford, MA) (Geromanos et al., 2009) and 
searched against sequence of RegA (1-793) with no enzyme specified and no 
modifications of amino acids. Identifications were only considered if they appeared at least 
twice out of three replicate runs. The precursor ion mass tolerance was set at <10 ppm and 
fragment ion tolerance was set at <20 ppm. Only those peptides that satisfied the above 
criteria through database search pass 1 were selected and are listed in Table 4.1. These 
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identifications were mapped on to subsequent deuteration experiments using prototype 
custom software (HDX browser, Waters, Milford). Data on each individual peptide at all time 
points were extracted using this software, and exported to the HX-Express program (Weis et 
al., 2006). Continuous instrument calibration was carried out with Glu-fibrinogen peptide 
at 100 fmol/μl. We also visually analyzed the data to ensure only well-resolved peptide 
isotopic envelopes were subjected to quantitative analysis. The lowest signal to noise 
ratio among all analyzed peptides was four. A control experiment was carried out to 
calculate the deuterium back exchange loss during the experiment by incubating RegA 
with deuterated buffer A for 24 h at room temperature. All reported deuterium exchange 
values were corrected for a 34.3% back exchange by multiplying the raw centroid values 
by a multiplication factor of 1.56. Plots of the relative deuteration levels across the 
primary sequence of RegA were generated in Microsoft Office Excel (2007). 
 Results from amide exchange analysis experiments were mapped onto homology 
models of the Receiver domain and PDE catalytic domains, generated by SWISS-
MODEL (Arnold et al., 2006) using the structure of CheY (PDB ID: 3GWG) (Lam et al., 
2010) as a template model for the Receiver domain and structure of the PDE8 catalytic 
domain (PDB ID: 3ECM) (Wang et al., 2008) as a template model for the 
phosphodiesterase catalytic domain of RegA(385-785). Receiver domains show high 
sequence homology across the entire family of RRs. The structure of known RRs have 
been used extensively for homology modeling of several RRs (Liu et al., 2009). PDE 
catalytic domains show high homology across the entire PDE superfamily. The PDE 
catalytic domain of RegA shows highest homology to PDEs 8 and 9 (Conti and Beavo, 
2007) and these have therefore been used for structural modeling. Color coded 
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representation of the relative deuteration levels mapped onto the structural models were 
as described in figure legends. 
4.3 Results 
4.3.1. Mutation of the aromatic switch residue enhances phosphodiesterase catalysis of 
RegA: 
We first set out to observe if there existed a correlation between the conserved aromatic 
switch residue and conformation of the active state as observed in CheY(Zhu et al., 1997) 
and test if the activating mutation indeed represented an intermediate conformation in the 
phosphorylation-dependent activation mechanism of RegA as inferred before(Zhu et al., 
1997). We therefore generated the equivalent mutant of RegA, RegA F262W, where the 
conserved aromatic switch residue in RegA was substituted with a Trp (Zhu et al., 1997). 
This mutant showed ~8-fold greater PDE activity compared to the wild-type protein. The 
enhanced PDE catalysis was accounted for entirely by an increase in catalytic rates for 
the reaction (Figure 4.2), kcat = 4.45 ± 0.15   min
-1
 for RegA and kcat = 36.18 ± 0.90 min
- 1
 
for RegA F262W without changes in Km cAMP, Km cAMP = 33.0 ± 6.0 μM for RegA 
and Km cAMP = 35.0 ± 5.0 μM for RegA F262W.  Phosphorylation of RegA with 
saturating concentrations of phosphoramidate (10 mM) have been previously shown to 
yield up to 10-fold activation (Thomason et al., 1998) and 20-fold activation, when 
phosphorylated RdeA was used as a phosphodonor (Thomason et al., 1999), that were 





















































Figure 4.1: Domain organization of RegA and mutants showing Receiver domain in light gray 
and the effector PDE domain in dark gray. 
Figure 4.2: The increase in PDE activity of RegA F262W is via increases in the catalytic turnover 
rates (kcat) for the cAMP hydrolysis reaction. RegA F262W (closed square, ■) is ~ 8 fold more 
active than RegA (open square, □). Rates of 5‟ AMP product formed were plotted versus a range 
of cAMP concentrations (10 – 400 μM) and fitted to the Michaelis-Menten equation (Graph Pad 
Prism software version 5). The Vmax for the PDE reactions catalyzed by RegA was 11.14 ± 0.38 
pmol 5‟ AMP released/min (kcat  = 4.45 ± 0.15 min
-1
) and that for RegA F262W was 90.45 ± 2.25 
pmol 5‟ AMP released/min (kcat = 36.18 ± 0.90 min
-1
); The Km for RegA was calculated to be 




4.3.2. Phosphorylation causes decreased exchange across the Receiver Domain which 
reflects large scale stabilization and reduction in backbone dynamics: 
To monitor phosphorylation-dependent activation and effects of the activating mutation, 
RegA F262W, on conformational dynamics, we used amide HDX measured by ESI-
QTOF mass spectrometry as described in materials and methods. We specifically focused 
on the fast exchanging backbone amides as conformational probes since amide HDXMS 
is an ideal technique that can report on changes in the millisecond-sec timescales 
(Henzler-Wildman and Kern, 2007), which are relevant for correlation with catalysis in 
general and  in  particular for RRs where prominent changes have been observed upon 
phosphorylation (Volkman et al., 2001).  HDXMS kinetics of RegA and RegA F262W 
were compared with phosphorylated RegA. Phosphorylation of RegA was carried out 
using phosphoramidate as a phosphodonor in the presence of MgCl2 (Anand et al., 1998; 
Hughes et al., 2001; Lukat et al., 1992; Thomason et al., 1998). RegA is reported to have 
low intrinsic autophosphatase activity (Thomason et al., 1998) and shows a relatively 
long half-life for its phosphorylated state compared to labile phosphorylated states of RRs 
such as CheB (Stewart). We specifically selected concentrations of phosphoramidate and 
Mg
2+
 (50 mM, 10 mM respectively) above those used previously  to generate stably 
phosphorylated RegA (Thomason et al., 1999) to ensure complete phosphorylation of 
RegA throughout the duration of the deuterium exchange experiments.  
Prior to deuterium exchange analysis, pepsin digest fragments of undeuterated RegA and 
mutants were identified using ProteinLynx Global Server 2.4 (beta test version) (Waters, 
Milford, MA). A total of 72 pepsin digest fragments, covering ~ 73 % of RegA sequence 
were identified, and sequenced in this study (Figure 4.3).  It is to be noted that the 
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sequence coverage is greater (~83%) if the polythreonine and polyasparagine stretches in 
the N-terminus are excluded. In total, pepsin digest fragments common to all samples 
which included 64 fragments for RegA, 63 fragments for RegA F262W and 59 fragments 
for RegA D212N were analyzed with a sequence coverage of ~ 70 % respectively. The 
average number of deuterons exchanged for each of the peptides were calculated as 
described in materials and methods section and the results for 10 minute Deuterium-on 
experiments are summarized in Table 4.1.  
HDXMS results were mapped onto the homology modeled Receiver and PDE domain 
structures generated on the basis of the crystal structures of CheY (PDB ID: 3GWG) 
(Lam et al., 2010) and PDE8 (PDB ID: 3ECM) (Wang et al., 2008) respectively using 
SWISS-MODEL (Arnold et al., 2006), (Figure 4.4 and 4.6). Overall, the Receiver 
domain showed decreased exchange throughout the entire domain upon phosphorylation. 
This reflects decreased dynamics of the domain in the phosphorylated state.  Within the 
Receiver domain, one peptic fragment (211-223) spanning the conserved Asp 212 site of 
phosphorylation, showed ~66% deuteration in unphosphorylated RegA. Additional 
peptides, 164-178, 241-247 and 262-280 spanning key conserved residues in all response 
regulators, namely: Asp 166, Asp 167, Ser 242, Phe 262 and Lys 265, each showed high 
levels of deuterium exchange (> 50%, 10 min Don) in unphosphorylated RegA (Table 
4.1, Figure 4.5A). All of these regions showed significant decreases in deuterium 
exchange upon phosphorylation. This is reflective of Mg
2+
 dependent, phosphoramidate 
mediated phosphorylation at Asp 212, where residues Asp 166 and Asp 167 coordinate 
Mg
2+
 and the phosphate moiety. There were changes associated with sites required for 
allosteric propagation of phosphorylation where the phosphate forms hydrogen bonds 
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with conserved Ser 242 and an anchoring salt bridge with Lys 265. This has been 
proposed to create an internal pocket for the aromatic switch residue Phe 262 (Liu et al., 
2009; Robinson et al., 2000; Volz, 1993).  Isotopic envelopes of deuterium exchange 
together with kinetic time plots for peptides within the Receiver domain which showed 
the most significant differences in deuterium exchange between RegA and 
phosphorylated RegA are shown in Figure 4.5 and Table 4.1. Along with residues which 
participate in Mg
2+
 coordination and phosphate binding, adjacent regions showed 
decreased deuterium exchange (Table 4.1, Fig 4.4B).  
Interestingly, the functionally important α4-β5-α5 regions showed the largest decreases in 
exchange in phosphorylated RegA which were not observed in the activating mutant 
(Figure 4.4).  The α5 helix in particular, spanned by a single large peptide spanning 
residues 262-280 and mapping onto the important helix α5 in the Receiver domain 
showed nearly complete deuterium exchange in all unphosphorylated states including in 
the activating mutant (Figure 4.5A, B, Table 4.1) and large decreases upon 
phosphorylation (~ 7.4 Deuterons protected from exchange). This highlights that the 
entire Receiver domain is highly dynamic accompanied by a complete lack of helical 
structure for α5. Phosphorylation likely results in and increased ordering of this region. 
No differences in exchange were observed between  RegA D212N and RegA in the 
unphosphorylated state as well as under conditions for  phosphorylation, consistent with 
Asp 212 being the sole site for phosphorylation and confirming no nonspecific effects of 





















































4.3.3. Interdomain linker and catalytic loop residues also show decreased deuterium 
exchange upon phosphorylation: 
Most of the peptic digest fragments within the catalytic PDE domain of RegA in contrast 
with Receiver domain showed reduced exchange compared to the Receiver domain (< 30 
%, 10 min Don) (Table 4.1). This is also lower than the exchange observable across all 
Figure 4.3: Pepsin digest fragments and sequence coverage for RegA. Solid lines indicate peptic 




other regions outside the Receiver domain including the linker  (281-485) and the C-
terminus (723-793) which each show more than 50% deuterium exchange after 10 min of 
deuteration (Table 4.1). Some regions from PDE domain, which includes peptic digest 
fragments, 526-537, 539-546, 564-573, 565-573, 574-593, 605-628 and 697-705 in 
phosphorylated RegA showed a slight decrease (~ 0.5-1.0 Deuterons) in deuterium 
exchange compared to RegA (Table 4.1, Figure 4.6A).  Within the linker, peptides 320-
333, 334-342, 350-358, 349-361, 371-377, 404-425, 436-445, 454-462 and 453-472 
showed small decreases in deuterium exchange upon phosphorylation (Table 4.1, Figure 
4.7A). 
4.3.4. Receiver domain of activating mutant (RegA F262W) is more dynamic compared to 
phosphorylated as well as unphosphorylated RegA: 
Comparison of deuterium exchange of Receiver domain of RegA F262W with RegA and 
phosphorylated RegA showed large differences. There was no decrease in deuterium 
exchange seen across the entire Receiver domain of RegA F262W and in fact, 
interestingly there were increases in deuterium exchange  observed within peptides 164-
178, 179-193, 198-210, 211-223, 222-240 and 262-280 when compared to RegA  (Table 
4.1, Figure 4.4C and 4.5). 
4.3.5. Deuterium exchange of the linker and catalytic domains in activating mutant, RegA 
F262W are distinct but overlap with phosphorylated RegA: 
The peptic digest fragments, 480-493, 526-537, 539-546, 564-573, 565-573, 574-593 and 
605-628 from the catalytic PDE domain  and peptides 342-349, 343-348, 350-358, 349-
361, 362-370, 404-425, 429-435, 453-472 and 454-462 from the linker  in RegA F262W 
121 
 
showed a small (~0.5-1 Deuteron) decrease in deuterium exchange when compared to 
RegA (Table 4.1, Figure 4.6B, 4.7B). Peptide 393-400 from RegA F262W showed a 
small increase in deuterium exchange than RegA (Table 4.1). The level of difference in 
deuterium exchange and the regions within RegA F262W overlap but are completely 
distinct from phosphorylated RegA. This was a surprising result as we expected the 
aromatic switch mutant to assume an intermediate conformation to phosphorylation but 
our results show that this mutant activates RegA either through stabilization or induction 
of an alternate conformation to that of the phosphorylated, fully active state. 
4.3.6. Receiver domain decreases deuterium exchange within the catalytic PDE domain 
without altering activity: 
To examine the effect of Receiver domain on conformation of the catalytic domain, we 
compared the dynamics of PDE domain in RegA with RegAC. Amide HDXMS for 
RegAC was carried out in conditions similar to RegA as described in materials and 
methods. A total of 29 pepsin digest fragments with a sequence coverage of 83% were 
identified and analyzed for RegAC. Several regions within the catalytic domain of RegAC  
spanned by  peptic digest fragments, 387-396, 427-446, 504-510, 526-537, 557-563, 564-
573, 608-626, 643-651, 656-661, 668-693, 697-702, 722-733 from RegAC showed 
increased deuterium exchange when compared with peptides from the same region of 
RegA (Figure 4.8). Peptic digest fragments, 536-546 and 767-780 from RegAC showed 
decreased deuterium exchange compared to RegA. These results indicate that the 
presence of the Receiver domain decreases deuterium exchange in most regions of the 
catalytic domain without a change in activity (Moorthy et al., 2011b; Thomason et al., 
1998). Phosphorylation and activating mutant alike result in further decreases in 
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deuterium exchange within the catalytic PDE domain excluding any possibility of solvent 











Table 4.1: Summary of HDXMS data for RegA, phosphorylated RegA (RegA~P), RegA F262W and RegA D212N under 
phosphorylation conditions (RegA D212N+P). 
No. Peptide
b
 (m/z) (+z) 
Residue 
Nos. Amides 












1 SSSPSNNDSTSL (1195.50)(+1) 23-35 10 5.9 ± 0.03 5.0 ± 0.09 5.6 ± 0.01 5.4 ± 0.10 N - Terminal 
2 PSNNDSTSL (934.41)(+1) 27-35 7 4.2 ± 0.01 3.5 ± 0.04 4.1 ± 0.05 NA N - Terminal 
3 KSMISGIENL (546.29)(+2) 36-45 9 6.8 ± 0.06 6.4 ± 0.03 6.3 ± 0.00 7.1 ± 0.03 N - Terminal 
4 NDQPSPSSHRVSDF (786.86)(+2) 138-151 11 5.7 ± 0.18 5.0 ± 0.07 5.2 ± 0.09 5.4 ± 0.13 N - Terminal 
5 VADDDDVQRKILNNL (864.45, 576.64*)(+2, +3*) 164-178 14 8.3 ± 0.08 2.7 ± 0.07 9.4 ± 0.05 8.4 ± 0.01 Receiver 
6 LKKFHYNVTLVPNGE (879.98)(+2) 179-193 13 7.3 ± 0.01 4.4 ± 0.04 8.0 ± 0.02 7.5 ± 0.01 Receiver 
7 NVTLVPNGE (942.48)(+1) 185-193 7 4.3 ± 0.01 2.1 ± 0.11 4.4 ± 0.02 4.6 ± 0.08 Receiver 
8 VPNGEIAWE (1014.49)(+1) 189-197 7 5.0 ± 0.03 NA 5.5 ± 0.05 NA Receiver 
9 YINKGQQKYDLVL (791.43)(+2) 198-210 12 5.1 ± 0.03 2.3 ± 0.09 6.1 ± 0.01 NA Receiver 
10 TDVMMPHITGFDL (738.84)(+2) 211-223 11 7.3 ± 0.02 2.7 ± 0.03 8.1 ± 0.05 NA Receiver 
 
TNVMMPHITGFDL (738.36)(+2) 211-223 11 NA NA NA 7.7 ± 0.08 Receiver 
11 VMMPHITGFDL (630.81)(+2) 213-223 9 6.0 ± 0.05 3.1 ± 0.24 6.0 ± 0.01 NA Receiver 
12 DLLQRINDHPVHRHIPVIL (572.08)(+4) 222-240 16 7.9 ± 0.07 3.4 ± 0.07 9.0 ± 0.01 8.5 ± 0.27 Receiver 
13 MSGTAVD (680.29)(+1) 241-247 6 4.6 ± 0.05 1.0 ± 0.16 4.9 ± 0.04 4.6 ± 0.02 Receiver 
14 YKYAND (773.34)(+1) 248-253 5 3.8 ± 0.03 0.9 ± 0.23 4.0 ± 0.00 3.8 ± 0.40 Receiver 
15 FLTKPIAKELLKKKIDTVL (733.47)(+3) 262-280 17 13.6 ± 0.14 6.7 ± 0.11 NA 14.1 ± 0.13 Receiver 
 
WLTKPIAKELLKKKIDTVL (560.11)(+4) 262-280 17 NA NA 14.6 ± 0.04 NA Receiver 
16 QSIWQRRKEEE (744.88)(+2) 281-291 10 7.0 ± 0.02 NA 7.2 ± 0.01 NA linker 
17 SIWQRRKEEE (680.86)(+2) 282-291 9 7.0 ± 0.02 6.7 ± 0.09 NA 6.8 ± 0.08 linker 
18 AQEREKGNKL (586.82)(+2) 297-306 9 5.2 ± 0.07 NA 5.5 ± 0.01 NA linker 
19 EMELKEHEIE (643.80)(+2) 309-318 9 5.3 ± 0.04 5.1 ± 0.04 NA 5.6 ± 0.03 linker 
20 LKEHEIEE (513.76)(+2) 312-319 7 3.4 ± 0.03 NA 3.3 ± 0.06 NA linker 
21 LTKKVSKMSS (554.82)(+2) 320-329 9 5.0 ± 0.06 NA 5.2 ± 0.00 NA linker 
22 LTKKVSKMSSISKE (522.64)(+2) 320-333 13 8.4 ± 0.07 7.3 ± 0.09 NA 8.5 ± 0.03 linker 
23 AMESPLVSV (932.47)(+1) 334-342 7 6.2 ± 0.08 5.3 ± 0.17 5.9 ± 0.06 6.3 ± 0.12 linker 






25 TRNIEE (761.38)(+1) 343-348 5 2.2 ± 0.02 2.2 ± 0.02 1.8 ± 0.02 NA linker 
26 LKQSSWSHY (568.28, 1135.56*)(+2, +1*) 350-358 8 3.4 ± 0.01 3.0 ± 0.09 2.5 ± 0.02 3.4 ± 0.09 linker 
27 LLKQSSWSHYESE (797.38)(+2) 349-361 12 7.0 ± 0.06 6.3 ± 0.22 6.4 ± 0.01 6.8 ± 0.03 linker 
28 IKEKLSSIL (515.83, 1030.67*)(+2, +1*) 362-370 8 2.7 ± 0.02 2.6 ± 0.04 2.2 ± 0.01 3.1 ± 0.01 linker 
29 KELGSSN (734.37)(+1) 371-377 17 3.5 ± 0.01 2.9 ± 0.06 NA 3.2 ± 0.07 linker 
30 IKNDSVDPVT (544.29)(+2) 387-396 8 5.3 ± 0.00 NA 5.1 ± 0.00 NA linker 
31 EKLIKNDSVDPVTKSFL (645.03)(+3) 384-400 15 11.1 ± 0.12 10.7 ± 0.07 NA 10.9 ± 0.05 linker 
32 DPVTKSFL (453.75)(+2) 393-400 6 4.0 ± 0.02 3.9 ± 0.11 4.5 ± 0.03 NA linker 
33 FSSTTSRRNSIPTFPQTTYNRD (859.42)(+3) 404-425 19 12.7 ± 0.19 11.1 ± 0.23 12.2 ± 0.03 12.5 ± 0.34 linker 
34 VIKGWEF (439.74, 878.48*)(+2, +1*) 429-435 6 4.8 ± 0.02 4.6 ± 0.03 4.3 ± 0.02 5.1 ± 0.02 linker 
35 DVFKYSEDDL  (615.78, 1230.57*)(+2, +1*) 436-445 9 4.5 ± 0.02 3.9 ± 0.12 4.6 ± 0.01 4.5 ± 0.06 linker 
36 FENFQLPEIFKIPIEKLQRF (634.85)(+4) 453-472 17 6.6 ± 0.02 6.2 ± 0.06 6.1 ± 0.03 7.1 ± 0.10 linker 
37 ENFQLPEIF (1136.56)(+1) 454-462 7 3.1 ± 0.02 2.6 ± 0.01 2.3 ± 0.02 3.5 ± 0.05 linker 
38 IMTVNAL (761.42)(+1) 473-479 6 0.3 ± 0.02 0.2 ± 0.00 0.1 ± 0.00 0.5 ± 0.02 linker 
39 YRKNNRYHNFTHAF (623.31)(+3) 480-493 13 2.1 ± 0.06 1.8 ± 0.08 1.3 ± 0.02 1.9 ± 0.03 PDE 
40 FDVTQTVY (972.46)(+1) 493-500 7 0.3 ± 0.00 0.2 ± 0.01 0.3 ± 0.01 0.3 ± 0.03 PDE 
41 DVTQTVY (825.39)(+1) 494-500 6 0.5 ± 0.01 0.4 ± 0.02 0.3 ± 0.03 0.3 ± 0.11 PDE 
42 DVTQTVYTF (1073.51)(+1) 494-502 8 0.4 ± 0.02 0.3 ± 0.01 0.2 ± 0.00 0.2 ± 0.02 PDE 
43 TVYTFL (743.39)(+1) 498-503 5 0.2 ± 0.02 0.1 ± 0.01 0.1 ± 0.01 0.0 ± 0.05 PDE 
44 FLTSF (614.32)(+1) 502-506 4 1.3 ± 0.05 1.2 ± 0.01 0.9 ± 0.00 NA PDE 
45 TSFNAAQYLTHL (683.34)(+2) 504-515 11 3.7 ± 0.00 3.3 ± 0.12 NA 3.3 ± 0.02 PDE 
46 YLTHLDI (437.74, 874.48*)(+2, +1*) 511-517 6 1.0 ± 0.00 0.8 ± 0.10 1.1 ± 0.01 0.7 ± 0.44 PDE 
47 LLISCM (679.35)(+1) 520-525 5 0.1 ± 0.00 0.0 ± 0.01 0.2 ± 0.03 0.1 ± 0.02 PDE 
48 CHDLNHPGFNNT (684.79)(+2) 526-537 10 2.9 ± 0.08 2.5 ± 0.02 2.4 ± 0.02 2.8 ± 0.06 PDE 
49 QVNAQTEL (902.45)(+1) 539-546 7 3.4 ± 0.04 3.0 ± 0.07 2.9 ± 0.00 3.6 ±0.02 PDE 
50 EYNDISVL (952.46)(+1) 549-556 7 1.3 ± 0.04 1.2 ± 0.01 1.3 ± 0.02 1.6 ± 0.02 PDE 
51 ENHHAMLTF (550.25, 1099.51*)(+2, +1*) 557-565 8 0.6 ± 0.00 0.6 ± 0.01 0.2 ± 0.00 0.6 ± 0.05 PDE 
52 TFKILRNSEC (605.82, 1210.63*)(+2, +1*) 564-573 9 2.9 ± 0.01 2.5 ± 0.03 2.3 ± 0.03 2.9 ± 0.08 PDE 
53 FKILRNSEC (555.29, 1109.59*)(+2, +1*) 565-573 8 2.8 ± 0.02 2.3 ± 0.06 2.1 ± 0.05 2.6 ± 0.03 PDE 
54 NILEGLNEDQYKELRRSVVQ (801.76)(+3) 574-593 19 5.9 ± 0.01 5.4 ± 0.00 5.1 ± 0.03 6.2 ± 0.02 PDE 
55 EHTNKFQHHLNNLPFDRNKKEDRQ (609.91)(+5) 605-628 22 7.4 ± 0.07 6.2 ± 0.09 6.0 ± 0.41 7.4 ± 0.03 PDE 
56 MILNF (637.34)(+1) 629-633 4 0.2 ± 0.02 0.1 ± 0.00 0.1 ± 0.01 0.4 ± 0.02 PDE 
57 LIKCGDISNIARPWHL (612.67)(+3) 634-649 14 2.3 ± 0.01 2.4 ± 0.05 NA 2.0 ± 0.08 PDE 






59 NFEWSL (795.36)(+1) 650-655 5 0.7 ± 0.01 0.5 ± 0.02 0.3 ± 0.08 0.4 ± 0.15 PDE 
60 RVSDEF (752.36)(+1) 656-661 5 0.5 ± 0.01 0.5 ± 0.01 0.6 ± 0.00 0.6 ± 0.04 PDE 
61 ETICGYPVTPFM (1357.61)(+1) 668-678 9 5.4 ± 0.00 5.2 ± 0.02 5.6 ± 0.06 5.8 ± 0.07 PDE 
62 ETICGYPVTPFMDKTKTTRARIAADF (733.88)(+4) 668-693 23 10.9 ± 0.02 10.3 ± 0.10 10.4 ± 0.10 10.2 ± 0.13 PDE 
63 FVASPLF (780.43)(+1) 696-702 5 1.4 ± 0.02 1.0 ± 0.12 1.3 ± 0.00 1.5 ± 0.03 PDE 
64 VASPLFQSM (979.50)(+1) 697-705 7 2.9 ± 0.03 2.3 ± 0.08 NA 3.2 ± 0.08 PDE 
65 LLKVISKNRENWQA (566.99)(+3) 715-728 13 1.7 ± 0.01 1.4 ± 0.00 1.1 ± 0.01 1.7 ± 0.02 C - Terminal 
66 LKVISKNRENWQA (529.30)(+3) 716-728 12 1.7 ± 0.05 1.5 ± 0.01 1.1 ± 0.07 1.8 ± 0.20 C - Terminal 
67 MELQKEGKCNDDDLQF (956.94)(+2) 730-745 15 9.5 ± 0.02 8.9 ± 0.21 NA 9.5 ± 0.12 C - Terminal 
68 LQKEGKCNDDDLQFME (956.92)(+2) 732-747 15 8.4 ± 0.07 NA 8.8 ± 0.02 NA C - Terminal 
69 FMEDPTIL (965.46)(+1) 745-752 6 4.7 ± 0.02 4.3 ± 0.05 4.5 ± 0.05 4.8 ± 0.05 C - Terminal 
70 MEDPTIL (818.40)(+1) 746-752 5 3.5 ± 0.02 3.2 ± 0.14 3.5 ± 0.17 3.6 ± 0.06 C - Terminal 
71 VKSKLPKIDE (578.85)(+2) 753-762 8 5.3 ± 0.03 4.7 ± 0.06 4.8 ± 0.01 5.0 ± 0.03 C - Terminal 
72 EENRDKVSSSSSSSTAPLTS (690.33)(+3) 763-782 18 12.2 ± 0.04 12.3 ± 0.02  12.8 ± 0.03 12.5 ± 0.03 C - Terminal 
                  
 
a 
Averages and standard deviations were calculated with measurements from two independent experiments. 
b
 Sequence identifications 
of pepsin-digest fragments of RegA were obtained with MSE data searched with Protein Lynx Global Server (PLGS, v. 2.4). Peptide 
mass tolerance: 10 ppm, fragment ion mass tolerance: 20 ppm with no cleavage enzyme specified and with no modifications as 
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Figure 4.4: Phosphorylation causes decreased exchange across the entire Receiver domain. A 
homology model of unphosphorylated Receiver domain of RegA was generated by SWISS-
MODEL using crystal structure of CheY (PDB ID: 3GWG) showing secondary structure 
elements and conserved residues critical for phosphorylation. The structural model represents 
the percentage of deuteration following 10 min deuterium exchange in RegA (A), 
Phosphorylated RegA (B) and RegA F262W (C). Residues that are important for hydrogen 
bond and salt bridge formation in with the phosphate oxygen are highlighted in blue sticks. 
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Figure 4.5: (A) ESI-QTOF mass spectra of pepsin digest fragments from different 
regions of the Receiver domain of RegA that showed the largest differences in 
deuterium exchange upon phosphorylation or in the mutant, RegA F262W. Isotopic 
envelopes for peptides from undeuterated RegA (i) and isotopic envelopes for 
deuterium exchanged peptides from RegA (ii), phosphorylated RegA (iii) and RegA 
F262W (iv) following 10 min of deuteration are shown. Due to the differences in charge 
state, the spectra for peptides 164-178 (m/z = 576.64, z = +3) and 262-280 (m/z = 
560.11, z = +4) of RegA F262W could not be displayed together with the others. Ratios 
of mass to charge (m/z) and charge states shown in this figure for peptides 164-178, 
179-193, 198-210, 213-223, 241-247 and 262-280 are (m/z = 864.45, z = +2), (m/z = 
879.98, z = +2), (m/z = 791.43, z = +2), (m/z = 630.81, z = +2), (m/z = 680.29, z = +1)  
and (m/z = 733.47, z = +3), respectively. (B) Time course (30 sec – 10 min) of 
deuterium exchange for the peptides; RegA, open circle (○), phosphorylated RegA, 
closed circle (●) and RegA F262W closed triangle (▲). Plots of the time course of 
deuterium exchange were fit to an equation for one-phase association (Graph Pad Prism 

























































































4.4.1 Allosteric coupling of phosphorylation and aromatic switch residue: 
Response regulators are unique regulatory switches that are regulated by phosphorylation 
at a conserved aspartate residue. Structures of the unphosphorylated state have provided 
atomic level insights into the environment of this critical aspartate residue as well as 
defined the Mg
2+
 binding site and residues that anchor the aspartyl phosphate. Structures 
of several response regulators using BeF2 to mimic the phosphorylated state have 
revealed the importance of a network of conserved residues necessary for propagation of 
phosphorylation-induced conformational changes (reviewed in (Robinson et al., 2000)). 
This relay consists of a Ser/Thr (Thr 87 in CheY) and an aromatic switch residue Phe/Tyr 
(Tyr 106 in CheY) which are highly conserved residues found across the response 
regulator family (Zhu et al., 1997; Zhu et al., 1996). The output of phosphorylation has 
been correlated with the positioning of the aromatic switch residue. In the phosphorylated 
state, this residue swings in and in the unphosphorylated state, swings „outward‟. 
Response regulator mutants with Trp at this position are fully active and 
phosphorylatable (CheY Y106W). This has been used to infer that positioning and 
Figure 4.6: Deuterium exchange within catalytic domains in activating mutant, RegA 
F262W are overlapping yet distinct with phosphorylated RegA. A structural homology 
model of catalytic PDE domain of RegA (green) showing secondary structural 
elements and loops, M and H critical for PDE action was generated by SWISS-
MODEL using the crystal structure of PDE8 (PDB ID: 3ECM). Catalytic metal ions 
are shown as yellow (Zn
2+
) and magenta (Mg
2+
) spheres. Regions that show difference 
in deuteration in phosphorylated RegA (A) and RegA F262W (B) when compared to 
RegA; regions showing decreased deuteration are blue. Regions where no coverage 
could be obtained are in gray. 
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orientation of this aromatic switch is dependent and downstream to phosphorylation at 
the conserved Aspartate. This simple linear mechanism has however been proven 
inadequate in explaining the activation mechanism of RRs (Dyer and Dahlquist, 2006; 
Stock and Guhaniyogi, 2006; Volkman et al., 2001).  
Our results show that the aromatic switch residue is indeed important in mediating 
Receiver domain function and is allosterically coupled to Aspartate phosphorylation 
across all RRs. The mutant protein showed higher PDE activity and showed increased 
deuterium exchange across the entire Receiver domain and clear increases around the 
aspartate site of phosphorylation. This is consistent with the „two-way directionality‟ of 
aspartate phosphorylation observed in other RRs such as OmpR (Ames et al., 1999; 
Buckler et al., 2000) and consistent with allosteric coupling.  
4.4.2. Dynamics of the catalytic domain in phosphorylated RegA and RegA F262W are 
overlapping yet distinct: 
Our results also show that the effects of the aromatic switch mutations are not 
comparable to phosphorylation and provide evidence to the contrary of the aromatic 
switch being an intermediate in the activation mechanism of RRs. It is particularly less 
understood how changes at the aromatic switch within the Receiver domain translate into 
regulation/activation  of diverse effector domains. There have been no structures of 
phosphorylated multidomain RRs and this has prevented understanding of how 
phosphorylation activates/regulates RRs. Our comparison of HDXMS results of the 
phosphorylated protein and the aromatic switch mutant, show overlapping yet distinct 
differences in conformational dynamics. This suggests diverse modes in activation of 
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effector domains downstream of the aromatic switch residue. On one hand 
phosphorylation, results in global stabilization of the Receiver domain, in addition to 
allosterically modulating the aromatic switch residue. This has independent consequences 
in dynamics of the linker and catalytic domains. On the other hand mutation of the 
aromatic switch residue does not lead to stabilization of the Receiver domain, but results 
in incremental changes throughout overlapping regions of the linker and catalytic 
domains, resulting in  partial activation of PDE catalysis.   
4.4.3 Phosphorylation-dependent activation of RegA through decreases in protein-wide 
dynamics: 
While we observe the largest decreases in deuterium exchange in the Receiver domain 
upon phosphorylation, smaller, yet significant effects of phosphorylation are also seen in 
other regions such as the linker and catalytic domain. Interestingly, these regions in the 
catalytic domain span the catalytically active site and provide a mechanistic basis for how 
phosphorylation enhances PDE catalysis. One such region which show decreased 
deuterium exchange upon phosphorylation spanned helices α8, α11 and α12 that form 
part of the substrate (cAMP) binding pocket (Conti and Beavo, 2007; Wang et al., 2008). 
This suggests phosphorylation results in increased stabilization/ordering of the substrate 
binding site leading to enhanced catalysis. We also observed a decrease in deuterium 
exchange in regions C-terminal to helix α7 and the loop which connects α7 and α8, 





, critical for catalysis 
41
. Another loop which spans helix α8 and α9 called 
H-loop shows decreased deuteration intake and has been identified to be important for 
substrate or inhibitor binding 
38
. The overall decreases in deuterium exchange seen upon 
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phosphorylation of RegA indicate that phosphorylation of Asp 212 within the Receiver 
domain is propagated (Induced-Fit) or allosterically coupled (Conformational Selection) 
to distal effector domain sites of RegA. These two models are discussed in further detail 
below. Thus phosphorylation results in reduced dynamics of the Receiver domain as well 
as the active site of PDE within the effector catalytic domain accompanied by changes in 
the interdomain linker. This linker has been accorded a “telephone cord” function in few 
other response regulators as well (Anand et al., 1998; Baikalov et al., 1998).  
There are three possible modes of how phosphorylation might enhance effector domain 
activity in response regulators (Robinson et al., 2000). These include a) relief of 
inhibition by the phosphorylated Receiver domain, b) facilitation of substrate binding to 
the enzyme catalytic site and c) rearrangements of residues at the phosphodiesterase 
catalytic core leading to enhancement of catalysis. Given that RegA and the truncated 
catalytic domain have the same catalytic activity, precludes relief of inhibition as a 
model. Comparison of Michaelis-Menten kinetic parameters in the RegA and RegA 
F262W states show no difference in the Km for the cAMP substrate (Figure 4.2) 
indicating that the enhanced phosphodiesterase activity is the result of an increase in the 
catalytic rate constant (kcat). This has also been demonstrated previously for 
phosphorylated RegA (Thomason et al., 1998). Based on this, it appears less likely that 
the activation is through mode b. HDXMS results show differences in deuterium 
exchange upon phosphorylation across the linker and catalytic domain, pointing to a 
model for enhanced catalysis resulting from a large-scale rearrangement of active site 
residues accompanied by changes in the linker domain (c).  Together, these results 
suggest that the basis for phosphorylation-dependent activation is via reduction in 
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dynamics across RegA through stabilization of the Receiver and linker domains. The 
stabilized phosphorylated conformation of RegA orders the catalytic loops necessary for 







































































































































Figure 4.7: (A) Comparison of relative HDXMS results for RegA and phosphorylated RegA. 
Each block represents the deuteration levels of respective peptide fragment at five time points 
(30 sec to 10 min). The deuteration levels are color coded as indicated. (B) Comparison of 
relative HDXMS results of RegA and RegA F262W. The time points and the deuteration levels 
































































































Figure 4.8: (A) Comparison of relative HDXMS results for RegA and RegAC. The time points 
and the deuteration levels are as labeled in Figure 4.7A. Structural model of the catalytic PDE 
domain displaying the extent of deuterium exchange following 10 min deuteration reaction for 




Model for RegA activation by phosphorylation on the basis of shifting equilibrium 
hypothesis: 
Our deuterium exchange analysis can be interpreted both on the basis of „Induced-Fit‟ as 
well as „Conformational Selection‟. However, there has been ever increasing evidence in 
support of „Conformational Selection‟ in describing phosphorylation-dependent 
regulation of RRs (Dyer and Dahlquist, 2006; Feher and Cavanagh, 1999; Stock and 
Guhaniyogi, 2006; Volkman et al., 2001). One of the most surprising results that we 
obtained was the high intrinsic deuterium exchange seen in the regions comprising α4-
β4-α5 that are functionally important across all RRs. More specifically, a peptide 
spanning α5, which mediates unique protein-protein interactions in response to 
phosphorylation (Stock et al., 2000), was fully deuterated after 10 min, with all the 
available backbone amides undergoing exchange in the unphosphorylated state. For 
peptide spanning residues 262-280, within the short 10 minutes of deuterium exchange, 
nearly all the (13.6 out of 17) deuterons were fully exchanged. This can be interpreted as 
fast helix-coil transitions in the unphosphorylated state in solution. This was a completely 
unexpected result as crystal structures always assume this region to adopt a helical 
conformation. However our results on deuterium exchange in dilute protein solutions 
highlights the artifactual effects of high protein concentrations and crystallization 
conditions in promoting helical structure, given that amide exchange is as much or more 
a readout of H-bonding dynamics as it is of solvent accessibility (Englander, 2006; 
Englander and Kallenbach, 1983). Our results on the dynamics of the critical α4-β5-α5 
region highlight that any assumptions of relatively subtle displacements or structural 
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perturbations (~ 1 Ǻ) in this region upon phosphorylation (Stock et al., 2000), by 
morphing crystal structures of the unphosphorylated and phosphorylated states, must 
factor in nonspecific effects of crystallization. 
While decreased exchange through stabilization of helical structure of α5 can be 
explained by „Induced-fit‟, wherein phosphorylation can be inferred to „induce‟ helix 
formation, it can equally be explained through „Conformational Selection‟ where 
phosphorylation selects and stabilizes a helical conformation.  Furthermore basal activity 
in unphosphorylated RegA is more readily explainable by conformational selection 
(Volkman et al., 2001) where the inactive and active conformational states are in 
equilibrium and the inactive states are more favored. However, phosphorylation mediates 
precise contacts at the Asp 212 and metal ion binding sites leading to increased ordering 
throughout the entire domain including the allosteric relay. We provide clear evidence 
that the aromatic switch residue functions as a critical node in converging conformational 
dynamics of the Receiver domain and coupling it to enhanced phosphodiesterase 
catalysis upon phosphorylation. However, we also demonstrate that the aromatic switch 
alone is not fully sufficient to activate RegA to the fullest extent as seen in 
phosphorylated RegA (Thomason et al., 1999). This indicates that activation of 
phosphodiesterase catalysis is governed not only by a conserved allosteric relay but also 
through ordering/stabilization of the Receiver domain that is only achievable by 
phosphorylation. To this effect the activation mechanism of the RegA F262W mutant is 
overlapping yet distinct from that of phosphorylated RegA and points to more than one 
„active‟ conformation (Stock and Guhaniyogi, 2006). In summary, our results suggest 























endpoint „inactive‟ and „active‟ states. They are consistent with a more complex 
mechanism that relies on RRs populating ensembles of interchangeable conformational 
















Figure 4.9: Model explains the conformationally dynamic, stable and different states of 
RegA. The unphosphorylated RegA is dynamic and equilibrates between the inactive (I) and 
active state (II); this dynamic nature of RegA in the presence of cAMP shows basal activity. 
Phosphorylation stabilizes the enzyme and keeps RegA in the active conformation (III) to 
show full activity. On the other hand the constitutively active mutant RegA F262W shows 
actively different conformation (IV) when compared to the phosphorylated RegA. The 
domains in the inactive conformations are represented as rounded rectangle and the in the 
active conformations as oval. The active conformations of unphosphorylated, phosphorylated 





This work describes the novel mechanisms in the regulation of protein-protein and 
protein-ligand interactions in cAMP dependent PKA pathway. The mechanistic basis for 
cooperativity in PKA activation is reported here using amide HDXMS. The study 
provided molecular insights into the function of CNB-B domain and its communication 
with CNB-A to cooperatively regulate PKA activation. We have also reported the 
molecular details for the multiple feedback mechanisms involved in the regulation of 
PKA. The PDE, RegA from Dictyostelium discoideum, known to regulate PKA by 
catalyzing the hydrolysis of cAMP. The functional role of RegA in PKA pathway is 
controlled by several known mechanisms. Some of the previously reported regulatory 
switches are, RdeA mediated phospho-transfer on residue D212 activates RegA 
(Thomason et al., 1999), ERK2 mediated phosphorylation at T676 inhibits RegA (Maeda 
et al., 2004) and RIα-RegA interactions activates RegA (Shaulsky et al., 1998). But the 
molecular details for these mechanisms have not been understood; here in this study we 
have used amide HDXMS along with other biophysical and biochemical methods to 
monitor the conformational changes during RegA activation and also to unravel the 
structural details and functional role of RIα-RegA interactions. Our findings suggest 
several future directions to study the significance of these regulatory mechanisms in 
higher-order organisms. 
1. Mapping Interactions of PKA-RIα with RegA 
To study the binding interactions of RIα with RegA so far the RIα we used is the deletion 
mutant RIα(91-244) with one cAMP binding domain. We propose to extend our amide 
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HDXMS studies with truncated mutant RIα (91-379) having two cAMP binding domain 
and RIα full length (1-379) having two cAMP binding domain, inhibitory region and the 
dimerization domain. Here we believe that physiological RIα will mediate multivalent 
interactions with RegA leading to higher binding affinities than observed with RIα(91-
244). This will provide invaluable insight into the structure and conformational dynamics 
of this seminal macromolecular complex in cAMP Signaling. Also studying 
unphosphorylated/phosphorylated full length RegA interaction with RIα may provide 
mechanism that link the two-component system and the cAMP Signaling in 
Dictyostelium discoideum. 
2. Site directed mutational analysis to confirm the binding sites 
From our previous amide HDXMS results, it is very clear that RegA catalytic domain 
binds specifically to the cAMP binding A domain of RIα. Residues from RIα and RegA 
critical for interactions can be mutated to Ala to test and confirm the binding of RegA to 
RIα. Mutants of RIα which are critical for interactions with RegA can be tested for their 
ability to interact with and inhibit the C-subunit of PKA. This will reveal the mechanism 
of regulation of RIα-RegA interactions by the C-subunit and signal termination. Studies 
on point mutants of RegA that affect RIα-RegA interactions and point mutants that affect 
hydrolysis of cAMP will allow us to differentiate binding from enzyme activation 
mechanism. Identifying residues from RegA critical for interactions with RIα will help us 





3. Computational modelling of the RegA-RIα interface 
We are collaborating with computational biologist to map the interaction surface of RegA 
with RIα by mapping surfaces that show decreased solvent accessibility upon complex 
formation using a combination of computational docking and amide HDXMS (Anand et 
al., 2003). Results from HDX can be combined with computational modelling techniques 
with the help of our collaborator, Dr. Ivana Mihalek, Bioinformatics Institute (BII), 
Singapore. 
4. Monitoring interactions inside the cell 
Monitoring RIα mediated activation of PDEs inside the cell may lead to the finding of 
novel biological roles for this interactions. Cellular cAMP and PKA FRET reporter 
assays will be highly efficient in the activation studies. The rIa gene can be cotransfected 
into cells along with cytosolic and organelle-directed cAMP or PKA reporters to track the 
subcellular localization of separate PDE isoforms. Common cell lines such as HeLa can 
be used to monitor the activation of PDEs by RIα. HeLa cell lines can be subjected to 
siRNA knockdown of the RIα gene. The effects of decreased RIα expression on PDE 
activity can be monitored and the kinetics of cAMP hydrolysis can be compared between 
the wild-type cells and RIα knocked down cell lines. 
5. Structure determination of RIα-RegA complex 
Structures of different states of deletion mutants of cAMP-free RIα, cAMP-bound RIα 
and in complex with the C-subunit have been previously solved by crystallography. A 
high-resolution structure of the RegA-RIα complex in combination with biophysical 
methods would be invaluable in mapping the magnitude of conformational changes 
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within RIα upon complexation with RegA, This would also provide insights into the 
mechanism by which RIα functions as an activator for PDE catalysis. This would further 
test our hypothesis that RIα-RegA interactions stabilize the substrate binding pocket and 
the dimer form of RegA to increase the PDE activity of RegA. Now, we are in process of 
screening conditions for the crystallization of RIα-RegA complex. 
The outcomes from our present research have provided molecular details of a 
regulatory mechanism in an important Signaling pathway. Given the physiological and 
pharmacological importance of both PKA and PDE, these findings will greatly drive 
research in this field. So far a bulk of drug discovery efforts have been designed to target 
G-protein-coupled receptors (GPCRs) which are upstream triggers for the cAMP 
Signaling pathway. Detailed understanding of this signal termination offers an alternate 
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